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Abstract 
This study considers the molecular weight, conformation, stability and 
nanoparticle formation of the polysaccharide chitosan in relation to its 
pharmaceutical applications in the drug delivery. Chitosan has bioadhesive 
and absorption enhancing properties that augment its use in the delivery of 
therapeutic proteins and peptides across mucosal membranes. 
The molecular weights of a range of chitosans, with degree of aceytlation 
(DA) ranging form 7 to 30%, were studied using the hydrodynamic techniques 
of SEC-MALLS (size exclusion chromatography coupled with multi-angle 
laser light scattering) and analytical ultracentrifugation. It was found that 
there was reasonable agreement between the two techniques with molecular 
weights obtained ranging between 42000 and 200000 kDa. These results 
indicated that the use of SEC-MALLS as a measure of degradation during 
storage studies would be valid and this technique would be more convenient 
due to the much shorter time required for each sample. 
Conformational studies indicated that in 0.2M acetate buffer, pH 4.3, the 
chitosan samples studied appeared to have an extended conformation which is 
in agreement with studies performed by other researchers (e.g. Anthonsen, M. 
W., K. M. VArum and O. Smidsmd (1993) Carbohydrate Polymers 11: 193-
201 and Dyer, A. M., M. Hinchcliffe, P. Watts, J. Castile, I. Jabbal .. Oill, R. 
Nankervis, A. Smith and L. Illum (2002) Pharmaceutical Research 19(7): 
998-1008), non-withstanding complications in interpretation through possible 
solvent draining effects (Berth, 0., Colfen, H., Dautzenberg H (2002) Prog. 
Coil. Int. Sci. 119, 50-57). 
ii 
Degradation studies were performed using viscosity measurements and SEC-
MALLS to measure molecular weight. The effect of solution parameters such 
as pH and ionic strength were examined as well as structural parameters, e.g. 
molecular weight and DA. Degradation was found to increase as the pH of the 
solution decreased indicating that acid hydrolysis was occurring. The range of 
ionic strength studied (0.1 - 0.3M) did not have any significant effect on 
degradation rate. For the samples studied, molecular weight appeared to have 
little effect on degradation, however, the more deacetylated the 
polysaccharide, the slower the rate of degradation due to increased charged 
residues along the chain. 
Finally chitosan nanoparticles were then prepared using ionotropic gelation 
with tripolyphosphate pentasodium. This technique produced nanoparticles in 
the size range 320 - 380 run with an insulin loading capacity of 30-50%. 
Insulin-loaded nanoparticles were prepared and resuspended in acetate buffer 
at various pHs. The molecular weight and insulin loading was tested at 2-
week intervals and results indicated that chitosan degradation was reduced by 
30% compared to a control chitosan solution, and the total amount of insulin 
incorporated remained constant over the storage period. 
Hi 
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Chapter 1: Introduction 
Chapter 1: Introduction 
Treatment of various diseases requires the efficient delivery of therapeutic 
proteins and peptides. Various hormones used in deficiency conditions such 
as growth hormone, and calcitonin can be delivered subcutaneously for the 
treatment of dwarfism and osteoporisis. Of particular interest is the treatment 
of Type I diabetes that requires the administration of insulin. Presently insulin 
is delivered by subcutaneous injection, which can be inconvenient for the 
patient. The most convenient method of drug delivery is by the oral route. 
However, this is not at present possible for insulin due to its degradation in the 
gastrointestinal tract by enzymatic degradation and the highly acidic 
conditions in the stomach. However, several drug delivery companies are 
showing promising results for oral delivery of insulin using novel polymer 
systems such as Emisphere and Nobex (Angelo et al. 2002; Clement et al. 
2004). 
Extensive research also has shown that insulin may be delivered nasally and 
absorbed in sufficient quantities to obtain a therapeutic response if 
administered in conjunction with the polysaccharide chitosan (I11um et al. 
1994; Schipper et al. 1996; Schipper et al. 1996/9; Hinchcliffe and Illum 
1999; Schipper et '11. 1999; Illum et al. 2001). Chitosan is a cationic 
polysaccharide derived from chitin, which is found in the shells of crustaceans 
(Anthonsen et al. 1993; Sugimoto et al. 1998). Chitosan enables insuiin to be 
delivered intranasally by two important m€(chanisms. Firstly, chitosan is 
mucoadhesive due to its cationic nature (Lehr et al. 1992; He et al. 1998), and 
secondly, it is believed to cause a transient opening of the tight junctions 
between the mucosal epithelium cells allowing the protein insulin to be 
-1-
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absorbed through the nasal membrane (Artursson et al. 1994; Borchard et al. 
1996; Schipper et al. 1997). These properties of chitosan are discussed in 
more detail in sections 1.1 and 1.2. 
In a nasal insulin formulation, chitosan acts as an absorption enhancer and is 
therefore an essential excipient in the formulation. Changes in the molecular 
weight and structure of chitosan due to degradation processes during storage 
of the formulation, may affect its mucoadhesive properties and its ability to 
function as an absorption enhancer. In this project, the degradation of 
chitosan was investigated under various solvent conditions and evaluated by 
measurement of the molecular weight using various hydrodynamic techniques 
(described in Chapter 4 and 5). 
Further research on the formulation used to deliver insulin nasally has lead to 
the development of chitosan nanoparticles (IlIum et al. 1987; Calvo et al. 
1997; Femandez-Urrusuno et al. 1999; Janes et al. 2001; Dyer et al. 2002). 
The second part of this project was focused on the optimisation ofnanopartic1e 
formation, methods for measuring insulin loading and the stability of chitosan 
within a nanopartic1e preparation (Chapters 6 and 7). 
Firstly, we will look at the use of chitosan in drug delivery and the 
physicochemical properties of chitosan. 
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1.1 Use of Chifosan in Drug Delivery 
The development of new routes for administering therapeutic proteins and 
peptides is of considerable interest to the pharmaceutical industry. Today, 
most of these compounds are delivered parenterally due to problems with the 
use of other routes of delivery such as degradation in the stomach and in the 
gastrointestinal tract and poor permeation of the mucosa associated with oral 
delivery. The use of parenteral delivery is inconvenient for the patient and can 
lead to reduced compliance. 
Extensive research has been carried out on alternative ways of delivering 
macromolecular compounds to the body. As such, chitosan as a drug delivery 
system for nasal and oral delivery has been intensively investigated (Dlum et 
al. 1994; Davis 1999; Femandez-Urrusuno et al. 1999; Hinchcliffe and Illum 
1999; Bernkop-Schnurch 2000; Janes et al. 2001). Chitosan possesses two 
important properties, which makes it an exciting polymer in drug delivery. 
These are bioadhesion and absorption enhancement. We shall now consider 
these properties in detail. 
1.1.1 Bioadhesion 
There are a number of characteristics necessary for a polymer to exhibit 
mucoadhesion (Lehr et al. 1992). These include: 
1) strong hydrogen-bonding groups (-OH, -COOH) 
2) high molecular weight 
3) sufficient chain flexibility 
4) surface energy properties favouring spreading onto mucus. 
Chitosan possesses all of these properties (Lehr et al. 1992) and therefore 
should be mucoadhesive. Chitosan is a cationic polysaccharide, and it has 
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been suggested that positively charged polymeric hydrogels could develop 
additional molecular attraction forces by electrostatic interactions with 
negatively charged mucosal surfaces. 
Mucus is a viscoelastic substance with a characteristic stickiness which lines 
the gastrointestinal tract and other routes in the body such as the nasal cavity. 
By weight, mucus is mostly water (95.0 - 99.5%) with electrolytes, serum 
proteins, immunoglobulins and lipids. Its most important polymeric, g e l ~ ~
forming component is the mucus glycoprotein or mucin (0.5 - 5.(010). Mucins 
are large molecules with molecular weights ranging from 0.5 x 106 to over 20 
x 106 glmol and contain a large amount of carbohydrates. These 
carbohydrates are made up of several different monosaccharides, of which 
sialic acid is the most important in terms of mucoadhesion (Harding et al. 
1999). In nasal delivery, the mucociliary clearance may greatly affect the 
absorption especially of hydrophilic drugs. The importance of the continual 
clearance of the mucus layer in the GI tract for absorption is less certain. The 
addition of a mucoadhesive agent to a drug formulation will increase the time 
that the drug is in contact with the mucosal surface, and hence increase 
absorption. 
It is the electrostatic attraction between the positively charged amino groups 
on chitosan and the negatively charged sialic acid residues in m u ~ i n n that is 
believed to account for chitosan's mucoadhesive nature. This has been 
demonstrated by He et al. (1998) who studied the mucoadhesive properties of 
chitosan and poly(viuyl alcohol) by turbidimetric measurements. The results 
suggested a strong interaction between chitosan and mucin, whilst there was 
little interaction between PV A and mucin due to PV A being negatively 
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charged. The attraction between chitosan and sialic acid was also confirmed 
by the observation of greater adsorption the greater the sialic acid content of 
the mucin. 
Fiebrig et al. (1994) also demonstrated the interaction of chitosan and mucin 
using the analytical ultracentrifuge. When chitosan and mucin where mixed, 
large complexes where formed with a smixlsmucin ratio of approximately IS-38. 
This complexation was pH dependent (see below). Also, no mucin was found 
to be unreacted and the results were consistent with a strong electrostatic 
interaction. 
1.1.1.1 Effect of pH on Bioadbesion 
Several groups have observed differences in the bioadhesion of chitosan at 
different pHs (Lehr et a!. 1992; He et al. 1998; Rossi et al. 2000). 
Most studies on the bioadhesive properties of chitosan have looked at the 
effects in the gastrointestinal tract. The pH in the GI tract varies from pH 1.2 
in the stomach to pH 7.S in the large intestine. This will affect the ionisation 
of both chitosan (pKa - 6.S) and sialic acid (pKa = 2.6). 
In an acidic environment (pH<S.S), approximately 90% of the amino residues 
on chitosan exist in the ionic form. Further decreases in pH will have little 
further effect on ionis,ation. On the other hand, sialic acid is highly sensitive 
to pH changes in an acidic environment. He et al. (1998) observed a decrease 
in the number of ionised sialic acid residues when the pH changed from pH 
S.5 to pH 3.5, and furthermore, when the pH changed to pH 1.2, the zeta 
potential of mucin reversed from negative to positive. The electrostatic 
interaction between chitosan and mucin will therefore be strongest at -pHS.5 
due to the increased number of charged sialic acid residues. 
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Fiebrig et al. (1994) also studied the effect of pH on chitosan-mucin 
interaction using the analytical ultracentrifuge. The results showed that as the 
pH was lowered below pH 6.5 to below the pKa of sialic acid, the size of the 
complex reduced (-12-22) but the interaction was still significant. 
1.1.2 Absorption Enhancement 
Bioadhesion can account for some of the absorption enhancement abilities of 
chitosan since it will allow a drug to stay longer in contact with the mucosal 
surface, increasing the available time for absorption. 
Further absorption enhancement has been attributed to chitosan's ability to 
cause a transient opening of the tight junctions in the epithelial membrane 
(Artursson et al. 1994; Borchard et al. 1996; Schipper et al. 1997). This 
function is very important for the delivery of proteins and peptides, which are 
excluded from transcellular transport due to their size and hydrophilic nature. 
The paracellular absorption pathway is also limited, due to the entry of large 
molecules being restricted by the tight junctions (Artursson et al. 1994; Kotze 
et al. 1997). 
1.1.2.1 Structure and Function of Tight Junctions 
One of the functions of the epithelial cells is to provide a permeability barrier 
between the different environments on either side of the cell and to allow 
transport across the cell layer. In order to perform these functions, the 
epithelial cells contain a highly specialised cellular component: the junctional 
complex. The junctional complex contains several well defined structures of 
which the tight junction is the most relevant here. 
The tight junction separates the apical and basolateral domains and is the 
major paracellular barrier to the absorption of proteins and other compounds 
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(Denker and Nigam 1998). Several proteins are associated with the tight 
junctions; membrane bound proteins such as occludin and cytoplasmic 
proteins such as zona occludens 1 ( Z O ~ l ) . . Occludin is believed to control the 
paracellular permeability of the tight junction while ZO-I may function as part 
of a signal pathway within the cytoskeleton in controlling membrane 
permeability. In intact tight junctions these proteins are strongly associated 
with the plasma membrane, however, when tight junction formation is 
prevented e.g. A TP depletion, these proteins are relocated from the membrane 
to other cellular compartments (Smith et al. 2004). 
1.1.2.2 Effect of Chitosan on Tight Junctions 
Dodane et al. (1999) and Kotze et al. (1999) studied the effect of chitosan on 
caco-2 cell monolayers. It was found that chitosan hydrochloride and chitosan 
glutamate decreased the transepithelial electrical resistance (TEER) of caco-2 
monolayers, which indicates a decrease in the tightness of the junctions 
between cells. Chitosan hydrochloride was found to be more effective than 
chitosan glutamate, however, this could be explained by differences in the 
amount of free chitosan base in each salt. About 50% of chitosan glutamate 
by weight is the glutamate salt whereas only a small fraction (5-10%) of 
chitosan hydrochloride is the chloride salt. 
Dodane and Vilivalam (1998) and Smith et al. (2004) found that chitosan 
affected the location of ZO-l and occludin. These membrane bound proteins 
were found to have relocated to the cytoskeleton after chitosan treatment. It 
was thought that chitosan may affect the intracellular A TP levels, since a 
similar pattern of protein relocation is seen during the formation of tight 
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junctions following ATP depletion, however, measurement of ATP levels 
showed no depletion in A TP. 
Artursson et al. (1994) and Dodane and Vilivalam (1998) also found a change 
in the F -actin distribution, which is known to increase paraceUular 
permeability (Meza et al. 1982). However, this effect was not observed by 
Smith et al. (2004). In conclusion it would appear that the effects of chitosan 
on membrane permeability are due to relocation of the tight junction proteins 
resulting in their transient opening. 
Many other compounds have been studied as absorption enhancers for proteins 
and peptides, however, many of them cause damage to the epithelial 
membrane (Thanou et al. 2001). Chitosan does not cause irreversible damage 
to the epithelia as has been demonstrated by several authors. Kotze et al. 
(1997) stained caco-2 cell monolayers with trypan blue after prolonged 
incubation with chitosan. No visible intracellular uptake of this marker was 
observed indicating that the monolayers remained undamaged and functionally 
intact. Also, after removal of the polymer, the TEER of the caco-2 cells 
recovered, again showing that the cells were undamaged and functionally 
intact (Borchard et al. 1996; Dodane et al. 1999). Aspden et al. (1996) studied 
the effects of chitosan on nasal epithelia membranes and found only slightly 
more protein and enzyme release than occurred after perfusing with normal 
saline. The increased protein release was attributed to increased mucus 
production by the goblet cells, and it was concluded that chitosan would be 
safe to use as a nasal drug enhancer. 
The influence of chitosan's degree of acetylation and molecular weight on the 
permeability of caco-2 cell intestinal mon{)layers was studied by Schipper et 
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al. (1996) using chitosan solution at pH 5.5 and the non-absorbable 
paracellular marker e4C] mannitol. It was found that chitosans with a low 
degree of acetylation (DA) were effective as permeation enhancers at low and 
high molecular weight, whereas chitosans of high DA were effective at only 
high molecular weight. The effects of chitosans of both high and low 
molecular weight and degree of acetylation were further investigated as regard 
to the ability of these compounds to bind with epithelial caco-2 cell 
monolayers (Schipper et al. 1997). Both chitosans appeared to bind tightly to 
the epithelium, inducing a redistribution of F-actin and the tight junction 
protein ZO-l. No intracellular uptake of chitosan could be observed. It was 
also shown that these effects were mediated by cationic charges of chitosan, 
since the addition of the highly anionic heparin in the test solutions inhibited 
the permeation enhancing effects. 
Chitosan also has other characteristics that are considered necessary for an 
absorption enhancer (Behl et al. 1998), for example: 
• pharrnacologically inert at concentrations used, 
• non-irritating, non-toxic and non-allergenic, 
• any effect on the mucosa is completely reversible, 
• remains in COtltact with the mucosa long enough to achieve a maximal 
effect, 
• no offensive odour or taste, 
• relatively inexpensive and readily available. 
1.1.3 Oral Delivery of Polypeptides 
At present, most protein and peptide drugs are administered parenterally. This 
can be inconvenient for the patient and lead to reduced compliance. Oral 
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delivery is the most convenient method of drug delivery; however, this poses 
problems for polypeptides. 
Most protein and peptide drugs are poorly absorbed following oral 
administration due to substantial degradation in the GI tract and/or poor 
permeability of the intestinal epithelial barrier. It is known for instance that 
dietary proteins do not normally cross the intestinal epithelium intact, but must 
first be broken down to their constituent free amino acids, which are then 
absorbed. Such degradation and consequent absorption destroys all 
physiological activity of the protein and can explain why typical oral 
bioavailabilities of proteins are usually less than 1-2% (Carino and Mathiowitz 
1999). Furthermore drugs delivered orally are susceptible to first pass 
metabolism in the liver. 
The addition of chitosan to an oral formulation can reduce permeability 
problems, as it possesses bioadhesive and absorption enhancement properties, 
however, this does not solve the problems of degradation that occurs in the GI 
tract. Also, the changes in pH along the GI tract from pH 1.2 in the stomach 
to pH 7.5 in the large intestine affect the solubility and protonation of 
chitosan. 
1.1.3.1 Chitosan for Oral Absorption Enhancement 
The oral delivery of proteins is hindered by low bioavailability, poor residence 
time at site of absorption, and poor drug stability due to proteolytic ehzymes. 
Chitosan may improve absorption and residence times through its absorption 
enhancing properties and mucoadhesion, however, there is still a low 
bioavailability due to degradation of the drug both in the acidic conditions of 
the stomach and by proteolytic enzymes. It is known that chitosan does not 
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exhibit any inhibitory action on proteolytic enzymes as demonstrated by 
Lue6en et al. (1996) following oral administration of a synthetic peptide in 
rats. A potential method to overcome the acidic conditions in the stomach are 
to use a controlled delivery matrix such as hydroxypropyl methylcellulose 
(HPMC), which swells on contact with water to form a hydrated gel that 
remains sufficiently intact through the gastrointestinal tract to protect the 
incorporated drug. Unfortunately, chitosan is unable to act as an absorption 
enhancer in the small intestine due to the neutral pH at which it is insoluble 
(Hejazi and Amiji 2003). Borchard et al. (1996) investigated chitosan 
glutamate solutions at pH 7.4 for their effect in increasing the paraceUular 
permeability of [14C] mannitol and fluorescently labelled dextran (MW 
4400Da) in vitro in caco-2 cells. No effect on the permeability of the 
monolayers could be observed, indicating that at neutral pH chitosan is not 
effective as permeation enhancer. The pH dependency of chitosan's effect on 
epithelial permeability was further studied by Kotze et al. (1998). Two 
chitosan salts (hydrochloride and glutamate) were evaluated for their ability to 
enhance the transport of [14C] mannitol across caco-2 cell monolayers at two 
pH values, 6.2 and 7.4. At low pH both chitosans showed a pronounced effect 
on the permeability of the marker, leading to 25-fold (glutamate salt) and 36-
fold (hydrochloride salt) enhancement. However, at pH 7.4 both chitosans 
failed to increase the permeability, due to solubility problems. Chitosan and 
chitosan salts have poor solubility at neutral pH values since aggregation 
occurs in solutions at pH values above 6.5, and only protonated chitosan (i.e. 
in its _uncoiled configuration) can trigger the opening of the tight junctions 
(Artursson et al. 1994), thereby faciliPiting the paracellular transport of 
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hydrophilic compounds. Chitosan can only be effective as an absorption 
enhancer in a limited area of the intestinal lumen where the pH values are 
close to its pKa. For intestinal absorption the use of a chitosan derivative is 
necessary and these are discussed in section 1.1.3.2. 
An alternative delivery site of peptides and proteins is the colon, where there 
is lower proteolytic enzyme activity and a longer residence time. Tozaki et al. 
(1997) studied the use of HPMC coated chitosan capsules for the colonic 
delivery of insulin in rats. It was found that after 6 h r s ~ ~ when the capsules 
reached the colon, a hypoglycaemic effect was observed that lasted for 24 hrs. 
The HPMC outer coating protected the insulin from the acidic conditions in 
the stomach. It then dissolves in the small intestine and the inner chitosan 
capsule layer protects the insulin until it reaches the colon where the 
microflora biodegrade the chitosan capsule and the insulin is released. 
Tominaga et al. (1998) demonstrated a similar delivery system using an inner 
coating of chitosan and an outer coating of phytin, a gastric acid resistant 
material. 
1.1.3.2 Chitosan derivatives for oral absorption enhancement 
N-trimethyl chitosan chloride (TMC), a partially quaternised derivative of 
chitosan, shows much higher aqueous solubility than chitosan in a much 
broader pH and concentration range. The reason for this improved solubility is 
the substitution of the primary amine with methyl groups and the prevention of 
hydrogen bond formation between the amine and the hydroxylic groups of the 
chitosan backbone. Thanou et al. (2001) and Kotze et al. (1999) studied the 
effects of TMC on intestinal absorption. Chitosan HCI and TMCs of different 
degrees of trimethylation were tested for enhancing the permeability of the 
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radiolabelled marker e4C] mannitol in caco-2 intestinal epithelia at neutral pH 
values (PH 7.2). Chitosan HCl failed to increase the permeation of these 
monolayers and so did TMC with a degree of methylation of 12.8%. 
However, TMC with a degree of trimethylation of 60% increased significantly 
the [14C] mannitol permeability across caco-2 intestinal monolayers, indicating 
that a threshold value at the charge density of the polymer is necessary to 
trigger the opening of the tight junctions at neutral pH values. Visualisation 
studies using confocallaser scanning microscopy showed that TMC polymers 
widened the paracellular pathways in a similar way to protonated chitosan 
without causing cell membrane damage. The effect of TMC60 was studied in 
vivo in rats using the peptide drug buserelin. Buserelin formulations with or 
without TMC60 (PH 7.2) were compared with chitosan dispersions at neutral 
pH values after intraduodenal administration in rats. A remarkable increase in 
buserelin serum concentrations was observed after co-administration with 
TMC60, whereas buserelin alone was poorly absorbed. 
1.1.3.3 Chitosan nanopartieles for oral delivery 
An alternative approach for the oral delivery of proteins is using 
microspheres/capsules. There are three major mechanisms by which 
microspheres can .improve oral delivery of proteins (Carino et al. 2000): 
1. the spheres can protect the protein from proteolysis 
2. the spheres can cross over the intestinal mucosa 
3. the spheres can change the inter-tissue distribution of the protein. 
Damge et al. (1990) studied the oral delivery of insulin in rats using isobutyl 
2-cyanoacrylate microspheres. A significant reduction in blood glucose levels 
was observed that lasted for 20 days ~ d e m o n s t r a t i n g g that the microspheres 
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protected the insulin from proteolysis and was able to change the distribution 
of insulin so that a slow and prolonged release occurred. Howevert similar 
studies showed no therapeutic response and possible degradation of the insulin 
(Couvreur et al. 1980), and ineffectiveness when administered to fed rats 
(Damge et al. 1988). For intestinal uptake of micro spheres an upper size limit 
of about 10J.lIll has been observed (Ermak et al. 1995). Since it is difficult to 
control the size distribution of microspheres/nanoparticles produced, and 
hence their uptake across the intestinal mucosa, an alternative use of 
microspheres is to provide the delivery of the protein to the site of absorption 
at a high concentration. However, for this to be advantageous the addition of 
mucoadhesives and absorption enhancers is necessary and as such chitosan 
nanoparticles can provide both of these characteristics. 
Chitosan nanoparticles can be formed using several techniques. For example, 
Ohya et al. (1994) prepared nanospheres using a water-in-oil emulsion method 
followed by crosslinking with glutaraldehyde. However, the glutaraldehyde 
not only interacted with the chitosan but also with the active drug, causing 
drug immobilization rather than encapsulation. Since proteins can easily 
denatured by production methods that require harsh conditions such as high 
temperatures or crosslinking agents, the use of an ionic gelation technique has 
proved highly favourable. Chitosan nanoparticles can be formed by a mild 
ionotropic gelation met}1od using the anionic counter-ion tripolyphosphate 
pentasodium (TPP). These nanoparticles have been studied by several 
researchers (Bodmeier et al. 1989; Femandez-Urrusuno et al. 1999; Shu and 
Zhu 2000; Dyer et al. 2002). These nanoparticles show high protein loading 
(up to 50mg per 100mg of nanoparticles) and along with the absorption 
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enhancing properties of chitosan offer a very promising delivery system for 
proteins and peptides. 
1.1.4 Nasal Delivery of Polypeptides 
Oral delivery of proteins and peptides requires further research, especially if 
an oral formulation for the delivery of insulin is to be considered. An 
alternative delivery route is via the nose. The nasal cavity possesses many 
advantages for drug delivery (Behl et al. 1998; Soane et al. 1999): 
• relatively large surface area for absorption with subepithelial layer that 
is highly vascularised (only two cell layers separate the nasal lumen 
from the dense \>lood vessel network in the lamina proporia), 
• blood drains directly into the systemic circulation, avoiding first pass 
metabolism by the liver, 
• fast onset of therapeutic action, 
• non-invasive, therefore, reduced risk of infection, 
• ease of convenience and self-medication, and improved patient 
compliance. 
Despite these structural advantages for drug delivery, the bioavailability of 
most polypeptide drugs is less than 1 % since the molecules are polar and too 
large to easily pass the tight junctions in the membrane. Furthermore, the time 
available for absorption is limited due to mucociliary clearance: Chitosan can 
increase the nasal bioavailability of poorly absorbed drugs by increasing nasal 
membrane permeability and increasing the contact time for absorption by 
reducing the mucociliary clearance rate. 
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1.1.4.1 Structure of Nasal Cavity 
The nasal cavity, located mainly within the skull, is divided into two 
approximately equal halves by the nasal septum with each half beginning 
anteriorly at the nares/nostrils of the external nose and extending posteriorly to 
the nasopharynx where the two halves of the airway join together. It has a 
total volume of 15-20ml and a total surface area of about 150cm2 which can be 
divided into three functional regions: 
• the vestibular region (the anterior 10-20cm2), 
• the olfactory region (occupying 10-20cm2 in the roof of the nasal 
cavity), 
• the respiratory region (about 130cm2), which occupies the majority of 
the main part of the nasal cavity and is important for the absorption of 
drugs into the systemic circulation. 
The respiratory region contains bony "scroll-like" turbinates (inferior, middle 
and superior), which are attached to the lateral wall and project downwards 
into the main part of the nasal cavity, considerably increasing the surface area. 
In this region, the epithelium is composed of ciliated and non-ciliated cells 
(Mygind and Dahl 1998). Cilia play an important role in mucociliary 
clearance which is discussed in more detail in section 1.1.4.2.1. The lamina 
propria (a loose type of connective tissue which anchors the. mucosa to the 
underlying skeletal structure) contains many blood vessels, n e r v e ~ ~ and glands. 
Blood is supplied to the nose posteriorly by a large branch of the 
sphenopalatine artery, superiorly by a branch from the anterior ethmoid artery 
and antero-inferiorly by a branch from the superior labial branch of the facial 
artery (Jones 2001). 
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The respiratory epithelium, in addition to cilia, is covered by a mucus layer 
consisting of two distinctive layers, the aqueous periciliary layer that 
surrounds the cilia and a more gellous upper layer on top of the cilia. Both 
cilia and the mucus layer play an important role in mucociliary clearance 
which is a major barrier to nasal drug absorption. 
1.1.4.2 Factors affecting nasal absorption 
1.1.4.2.1 Mucociliary clearance 
The function of the mucociliary clearance system (MCS) is to remove foreign 
substances and particles from the nasal cavity, preventing them reaching the 
lower airways. Normal mucociliary transit time in humans has been reported 
to be. 12 to 15 minutes, with the average rate of nasal clearance being 
8mmfmin (Marttin et al. 1998). 
Cilia range in length between 5 and 10 J.Ull and in width from 0.1 to 0.3 f.Ul1. 
The number of cilia per cell is approximately 200, with a density of 6 - 8 cilia 
per f.Ul12. The beating of a cilium has three phases; an effective stroke, during 
which the cilium is extended maximally; the rest phase, in which it is parallel 
to the cell surface; and the recovery stroke. The average ciliary beat frequency 
in humans is 10Hz and is regulated by several factors: temperature, 
intracellular Ca2:+- and cAMP levels, and by extracellular ATP. An increase in 
temperature of between 5 and 20°C increases ciliary beat frequency (Marttin 
et al. 1998) and the optimum working temperature is 35-40°C (Jones 2001). . 
Mucus forms the other part of the MCS. This consists of two distinct layers: 
. the aqueous periciliary layer and a more gellous upper layer. The periciliary 
layer is a low viscosity fluid, probably formed by epithelial cell exudates, with 
a thickness that is slightly less than the length of an extended cilium. This is 
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covered by a more viscous upper layer of about 0.5-5.0 /lID deep, which is 
secreted by the goblet cells (Marttin et al. 1998). Mucus exhibits non-
Newtonian behaviour, i.e., it possesses both viscous and elastic properties. 
This enables the mucus to efficiently accept the energy transfered from the 
cilia, while its elastic properties enable it to relax sufficiently to be propelled 
towards the nasopharynx, where it is swallowed. 
The MCS is particularly susceptible to damage. This can be potentially 
harmful to the patient since impaired mucociliary clearance causes longer 
contact times of the airway mucosa with bacteria and viruses, which could 
lead to infections of the respiratory tract. The efficiency of the MCS depends 
on three factors (Marttin et al. 1998): 
I) the amount of ciliary input, determined by the length and density of the 
cilia and their beating frequency, 
2) the amount of mucus and the depth of the periciliary layer 
3) the viscoelastic properties of the mucus. 
The effect of chitosan on these factors has been studied. Aspden et al. (1995 
and 1997) for example looked at the effect of chitosan on mucociliary 
transport rates (MTR) in the frog palate model, human turbinates and human 
volunteers. T h ~ y y found that chitosan had an inhibitory effect on MTR which 
was greater and more prolonged with higher molecular weight chitosans. 
Studies on turbinates indicated that cilia continued to beat and that the effect 
of chitosans on MTR was predominantly physical. Chitosan and mucus 
. interact to form a viscous and adhesive complex (result of interaction between 
negatively charged sialic residues of mucus and cationic chitosan molecules), 
which prevents cilia transporting particles over the surface of the mucus layer. 
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In human volunteers, no significant difference was observed in saccharin 
clearance times recorded before and after 7 days of a daily chitosan 
application, indicating that the inhibitory effect of chitosan on MTR is 
transient and results in no permanent damage. 
It is also important to study the effect of the drugs and other components of 
the nasal formulation, e.g. preservatives, on the MCS. Marttin et al. (1998) 
reviewed the effect of drugs and preservatives on the MCS. Studies on insulin 
and salmon calcitonin showed little to no effect on MTR in the frog palate 
model and any cilio-inhibition observed in vitro was reversible. The 
preservative benzalkonium chloride did not alter MTR in humans, though 
cilio-inhibition and ciliostasis were observed in vitro in chicken embryo 
tracheas. 
1.1.4.2.2 Physicochemical Properties of Drugs 
1.1.4.2.2.1 Molecular Weight 
The effect of physicochemical properties of drug molecules on nasal 
absorption has been studied by several researchers (Fisher et al. 1987; 
McMartin et al. 1987; Donovan et al. 1990; Fisher et al. 1991). They found 
that whilst there was some correlation between charge and degree of 
hydrophobicity 'of a molecule on absorption, the predominant factor for 
absorption was the molecular weight of the compounds. Studies on groups of 
dextrans and polyethylene glycols of varying molecular weight demonstrated 
that absorption decreased as molecular weight increased. For example, 
. dextrans of (weight average) molecular weight 1,260 and 45,500 Da had 
bioavailabHities of 52.7% and 0.6% respectively. In general compounds with 
a molecular weight greater than 1,000 Da are not likely to result in 
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bioavailabilities greater than 10% regardless of physicochemical properties. 
Nasal absorption fell off sharply at molecular weight > 1,000 Da, while oral 
absorption declined even more steeply at molecular weights >200 Da. Rapid 
peaking occurred even when total nasal absorption was low, indicating that a 
substantial portion of the poorly absorbed compounds are eliminated from the 
site of absorption either mechanically (mucociliary clearance) or by 
degradation. 
1.1.4.2.2.2 Solubility and Dissolution Rate 
Drug solubility can limit absorption and can also affect the formulation. For 
particulate nasal products, administered as either powder inhalation or in the 
form of suspensions, the dissolution rate of a drug and saturation solubility 
becomes important. Particles deposited in the nostrils need to be dissolved 
prior to absorption. If the drug remains as particles, they may be cleared from 
the nasal cavity and absorption will not occur (Behl et al. 1998). 
1.1.4.2.3 Drug Formulation - pH and osmolarity 
Ohwaki et al. (1985), Pujara et al. (1995) and Behl et al. (1998) studied the 
effect of formulation variables on the nasal mucosa. The pH of the mt nasal 
mucosa is 7.39 and the pH of the human nasal mucosa is in the range of 5.5-
6.5. The nasal cavity of mts was perfused with solutions of various pHs and 
the perfusate examined. Protein release from the nasal mucoSa was maximal 
at pH 12 and 2 indicating membrane and intracellular damage '(both lactate 
dehydrogenase-LDH, an intracellular enzyme and 5'nucleotidase-5'ND, a 
. membrane-bound enzyme were released). Buffers within pH values of 3 and 
1 o caused very low and similar amounts of total protein release. It was 
concluded that these pH effects were due to structural changes in the epithelial 
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cells, and to avoid nasal irritation, the formulation pH should be adjusted 
between 4.5 and 6.5. 
Drug absorption through the nasal mucosa can be substantially affected by 
formulation tonicity. It was found that the absorption of secretin in rats was 
affected by the concentration of sodium chloride and absorption reached a 
maximum at a 0.462M sodium chloride concentration (hypertonic) probably 
due to the observed shrinkage of epithelial cells. The effect of osmolarity on 
the nasal epithelium was studied and it was found that pure water of zero 
osmolarity caused the most mucosal marker leakage due to swelling of the 
epithelial cells. Isotonic and hypertonic solutions demonstrated very little 
effect on the LDH release from the nasal epithelium, leading to the conclusion 
that isotonic and hypertonic solutions are less damaging than hypotonic 
solutions. In general, an isotonic formulation (0.9% NaCI) is preferable. 
1.1.4.2.4 Deposition of drug 
The clearance of a drug formulation from the nasal cavity is influenced by its 
site of deposition (Kublik and Vidgren 1998). The turbinates, which are 
covered by respiratory epithelia, are the primary sites for systemic absorption 
of nasally administered drugs. Ciliated epithelia are present in the middle and 
posterior parts of the turbinates, but are almost absent in the anterior regions. 
A drug deposited posteriorly in the nose is cleared more rapidly than a drug 
deposited anteriorly, because mucociliary clearance is slower hi the anterior 
part of the nose. Three different clearance phases following nasal delivery 
. have been distinguished. The first phase within the first minute after 
application, mainly applicable for liquid formulations and large application 
volumes, is a very rapid clearance due to swallowing or run-through of the 
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formulation into the pharynx. The following second phase occurring 15-30 
minutes after application results from progressive clearance of the material 
deposited in the ciliated area of the main nasal passages. The part of the dose 
distributed in the non-ciliated for anterior part of the nose disappears very 
slowly, this clearance phase lasts over several hours. The second and third 
phases are claimed to be responsible for the biphasic clearance pattern 
observed in nearly every deposition study. 
1.1.4.3 Formulations for nasal administration 
Developing an appropriate formulation for a given drug is vitally important. 
A good drug can be rendered useless, ineffective or mediocre by the choice of 
an inappropriate formulation. The choice of dosage form depends on the drug 
being developed, indication being pursed, and patient population. Behl et al. 
(1998), Kublik and Vidgren (1998), and Hinchcliffe and lllum (1999) 
reviewed various formulations for nasal drug delivery. 
1.1.4.3.1 Solutions and Suspensions 
Nasal solutions can be administered by simple drops or using sprays. Nasal 
drops are very simple and represent a convenient form of administering drugs. 
The development of metered dose nasal actuators enabled the delivery of 
accurate actuation volumes as low as 25 J.tl. Suspensions can also be 
administered using metered dose actuators that have been designed to account 
for the specific particle size and morphology of the drug particles. 
1.1.4.3.2 Powders 
If a suitable solution or suspension of the drug cannot be developed, a dry 
powder form may be used. Powders are not favourable products since they 
can cause irritation on the nasal mucosa, and are also more expensive to 
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manufacture because of the particle size/morphology considerations. 
Administration of nasal powders may evidently increase patient compliance, 
especially for children if the smell and taste of the delivered drug is 
unacceptable. The powder facilitates the delivery of the highest mass of active 
ingredient without the necessity of a vehicle. 
1.1.4.3.3 Gels 
Gels are either thickened/gelled solutions or suspensions of drugs. They can 
offer several advantages over other dosage systems (Behl et al. 1998). For 
example, a gel can localise the formulation on the mucosa thereby providing a 
better chance of absorption of the drug. 
1.1.4.3.4 Microspheres 
Current trends in nasal drug delivery methods appear to be focused on the use 
of microsphere technology (Hussain 1998). By using microspheres 
formulated using biocompatible materials, e.g. starch, gelation and chitosan 
(Illum et al. 1988; IlIum et al. 2001; Janes et al. 2001) a more intimate and 
prolonged contact between the drug and the mucosal membrane can be 
achieved allowing increased absorption of the drug. 
(IlIum et al. 1987 and 1988) have studied nasal delivery using starch 
microspheres in rats and sheep. Reduced clearance and increased drug 
absorption occurred due to absorption of water from the epithelial mucosa 
during the gelling process and resulted in a reversible shrinkage of the 
epithelial cells. This shrinkage could lead to the physical separation of the 
intracellular junctions and enhance paraceUular absorption. Soane et al. 
(1999) compared the clearance of chitosan solution, starch microspheres and 
chitosan microspheres to a control solution of 99m Tc-DTPA solution (99m-
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Technetium labelled diethylenetriaminepentaacetic acid). The time taken for 
50% clearance of the chitosan solution almost doubled (compared to the 
control solution) to 41 minutes, whilst the half-life of clearance for the starch 
microspheres more than tripled to 68 minutes and of chitosan microspheres 
half-life of clearance quadrupled to 84 minutes. The slow clearance of the 
chitosan and starch systems can be explained by their bioadhesive properties, 
and additional dehydration of the mucus layer causing an increase in its 
viscosity and increasing cilia resistance. The chitosan solution will also 
interact rapidly with mucins due to its cationic nature, possibly explaining its 
increased residence time. 
The effects of various microsphere systems on the bioavailability of the 
peptide insulin have been studied. Starch and dextrin microspheres. cross-
linked with epichlorohydrin were studied in rats (Edman et al. 1992). Both 
systems caused a rapid reduction in glucose levels after nasal administration 
with a maximal reduction observed within 30-40 minutes. Starch 
microspheres were more effective than dextrin microspheres in reducing blood 
sugar levels. A study by Farraj et al. (1990) using starch microspheres in 
sheep appeared to show that the absolute bioavailability of insulin from the 
starch microspheres was 4.5% compared to about 1 % for a solution of insulin 
without absorption enhancers. IlIum et al. (1994) studied the use of 
hyaluronic acid ester tnicrospheres as a nasal delivery system for insulin in 
sheep. The microsphere system evidently produced large and significant 
increases in nasal absorption similar to those obtained for bioadhesive starch 
microspheres. The mean relative bioavailability was claimed to be 11 % when 
compared with insulin administered by the subcutaneous route. 
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1.1.4.3.5 Nanoparticies 
It has been considered that chitosan nanoparticles, like microspheres, would 
intensify the contact between the protein and nasal absorptive mucosa, leading 
to increased protein concentration at the absorption site (Femandez-Urrusuno 
et al. 1999). 
Studies in vivo showed that administration of insulin loaded chitosan 
nanoparticles prepared using ionotropic gelation with TPP resulted in a fall in 
glucose levels after nasal administration (Femandez-Urrusuno et al. 1999). 
For this effect to be observed the insulin released from the nanoparticles has to 
be in its active form indicating that the preparation method was not harmful to 
the protein. Further studies by Dyer et al. (2002) in rat and sheep models also 
appeared to show a fall in glucose levels after nasal administration of chitosan 
nanoparticles loaded with insulin. 
In vitro release of insulin from chitosan nanoparticles appears to be dependent 
on the pH of the surrounding medium. Release is evidently rapid at pH 7.4 
and pH 4, but slightly slower at pH 6.4. (Femandez-Urrusuno et al. 1999). 
This could be attributed to the lower solubility of insulin at pH 6.4 (9.4 J.lglml) 
compared to at pH 7.4 (834 J.lg/ml) and pH 4 (> 1 mglml). Release of insulin 
in water was claimed by these researchers to be much slower than in a 
buffered medium suggesting that the interaction forces between insulin and 
chitosan are reversible and very weak, and that insulin releases from the 
nanoparticles by a simple dissolution mechanism (Femandez-Vrrusuno et al. 
1999; Janes et al. 2001). 
In conclusion, chitosan nanoparticles display several attractive features for the 
delivery of therapeutic proteins and peptides: 
-25-
Chapter 1: Introduction 
• fonnation under extremely mild conditions 
• great capacity for association of proteins 
• release rates of different rates depending on composition 
• increased absorption due to bioadhesive and absorption enhancing 
nature of chitosan. 
1.2 Chitosan and Degradation 
1.2.1 Chitosan 
Chitosan is a derivative of chitin, the second most abundant polysaccharide 
after cellulose «Paradossi et al. 1992; OtWy et al. 1996; Boryniec et al. 
1997». Chitin is a linear polysaccharide consisting of N-acetyl-D-
glucosamine units (Glc-NAc), and the tenn chitosan refers to a series of 
deacetylated chitins containing N-acetyl-D-glucosamine units arid D· 
glucosamine units (Glc-N) in varying proportions. The structure of chitosan is 
shown in Figure 1-1. 
1.2.1.1 Production of Chitosan 
Chitin is an abundant biopolymer like cellulose and is distributed in the shells 
of crustacea, e.g. crab and shrimp, the cuticle of insects and also in the cell 
wall of some fungi and micro-organisms (Anthonsen et al. 1993; Sugimoto et 
al. 1998). 
Chitosan can be obtained by commercial N-deacetylation of chitin, after its 
isolation from, for example, the shells of crabs (Anthonsen et al. 1993; Varum 
et al. 1994). Demineralisation is carried out at room temperature in 
hydrochloric acid, followed by deproteination using alkaline treatment in 
sodium hydroxide at 80-85°C (Tolaimate et al. 2000). Deacetylation is then 
carried out using strong alkaline solution (--40% w/w) at high temperatures 
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( ~ 8 0 ° C ) . . The influence of alkaline concentration and temperature have been 
investigated by Chang et al. (1997), who found that the kinetics of 
homogeneous and heterogeneous alkaline N-deacetylation was first order, i.e. 
the rate of deacetylation was directly proportional to the alkaline concentration 
and the reaction temperature. Temperature and alkaline concentration 
dramatically affected the rate of deacetylation, which increased with 
increasing temperature and alkaline concentration. The resulting degree of 
acetylation was found to be proportional to the reaction time (Rege and Block 
1999; Tolaimate et al. 2000). 
As well as the occurrence deacetylation, degradation of chitin ,uso takes place 
during the deacetylation process due to the high concentration of alkaline 
solution and the prolonged reaction times required to obtain significant 
deacetylation (Tolaimate et al. 2000). Under the most drastic conditions, the 
molecular weight can decrease by a factor of about 5-10. To achieve a desired 
degree of acetylation, the process may normally have to be repeated several 
times. However, Tolaimate et al. (2000) found that after two repeated alkaline 
steps the desired degree o ~ ~ acetylation can be obtained and that further 
reaction steps only lead to depolymerisation. 
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Figure 1-1: Scbematic Structure of Cbi to san; R=acetyl or H, depending on tbe degree ofacetylation 
RaAcorH 
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1.2.1.2 Physico-chemical characterisation of chitosan 
Chitosan is insoluble in water at neutral and basic pH-values (Varum et al. 
1994), however it is soluble in aqueous acidic solution. When dissolved in 
acidic media it becomes a polyelectrolyte due to the protonation of the -NH2 
groups, and the following equilibriuin reaction occurs (Rinaudo et al. 1999): 
Chitosan differs from other polysaccharides in two main ways: 
• The term chitosan does not refer to a defined structure but to a group of 
polysaccharides, whose structures differ depending on the DA. The 
DA describes the ratio of N-acetylated to deacetylated subunits. A 
structure consisting of only N-acetyl-D-glucosamine units would be 
described as having a DA of 100%, while a structure consisting of only 
D-glucosamine units has a DA of 0%. 
• In aqueous acidic media chitosan is a cationic polyelectrolyte and the 
conformation of the chitosan molecule depends on the composition of 
the solvent (especially the ionic strength). An uncharged flexible 
polymer molecule may take on any configuration compatible with its 
bond length and angles and other steric restrictions. This is also 
possible for charged polymer molecules, however, each configuration 
will have different free energies, with a relatively high free energy for 
compact configurations and a relatively low free energy for expanded 
ones. The lower the free energy of a molecule, the more stable it is, 
therefore polyelectrolytes tend 10 have an expanded configuration. 
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Changing the composition of the solvent, mainly the ionic strength, 
may alter the configuration of a charged molecule. At low ionic 
strength the polymer molecule has a more extended conformation. As 
the ionic strength is increased, the molecule will become less extended. 
This is due to shielding of the charges on the molecule as the ionic 
strength increases and thus less expansion is required to reduce the free 
energy of the molecule (Tanford 1961). 
Chitosan can also be characterised by its molecular weight. In Chapter 3 the 
molecular weight of several chitosans are determined using several 
hydrodynamic techniques, the details of which are found in Chapter 2. These 
techniques include analytical ultracentrifugation and light scattering. Chitosan 
is also a polydisperse material, that is, the sample will contain a range of 
different molecular weights. The techniques therefore measure an average 
molecular weight and this is discussed in more details in Chapter 2. 
1.2.1.3 Conformation 
The gross conformation and chain flexibility of chitosan in solution may be 
affected by solvent conditions, n a m ~ l y y ionic strength, pH and tempemture of 
the solution, as well as the molecular weight and degree of acetylation of the 
chitosan used (Tsaih and Chen 1997). The conformation of chitosan in 
solution may be affected by the DA of the chitosan in two possible ways: 
• By the presence of bulky acetyl groups - due to steric hindmnce, 
chitosan with the highest DA should therefore hold the most expanded 
conformation 
• By the number of positive charge from free amino groups in acidic 
solutions. Positive charges in solution will repel each other. The 
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chitosan with lowest DA will have the highest amount of amino groups 
and hence the highest charge effect. The repulsive effect will be 
highest and the chitosan will have the most expanded conformation. 
This effect is most important at very low ionic strengths. At high ionic 
strengths, repulsion is largely suppressed due to screening effects of 
the added salt: the electrostatic contribution to chain stiffness becomes 
small. 
For chitosan to be soluble, it needs to have a DA of less than 50%. Below this 
DA, half of the residues will possess a charged group in acidic solution, and it 
may be expected that the charge effects will determine the conformation. 
Ellipsoid modelling and bead modelling can be used to represent the 
conformation of quasi-rigid systems such as proteins. However, the stringent 
assumptions that are used make these modelling techniques unsuitable for 
flexible systems such as many polysaccharides: their polydispersity also adds 
to the complications. 
For polysaccharides, the Mark-Houwink-Kuhn-Sakurada exponents can be 
used to distinguish between classes of conformation (compact sphere, rigid 
rod and random coil). The MHKS equation relates intrinsic viscosity to 
molecular weight as shown: 
[17]=kM Q (1-2) 
where [17] is the intrinsic viscosity, M the molecular weight, a the MHKS 
exponent and k the MHKS constant (see for example Harding 1997). 
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Table 1-1 shows the values for the MHKS exponent that relate to different 
conformations. 
Table 1-1: Relationship between polymer conformation and MHKS exponent 
o Sphere 
0.5 ~ O . 8 8 Random coil 
1.8 Rod shape 
Anthonsen et al. (1993) found that for chitosans dissolved in a O.IM ionic 
strength solution, as the DA increases the value of the Mark-Houwink-Kuhn-
Sakurada exponent a increases.As DA increases the number of NH3 + groups 
will decrease, therefore the electrostatic repulsion will decrease. It would be 
expected that the chitosan molecule would become more compact, however 
the opposite occurs. This indicates that at an ionic strength of O.IM, it is the 
influence of the N-acetyl groups rather than the electrostatic effects of charged 
amino groups that determine the extension of the chitosan chain. Similar 
results from viscosity and light scattering measurements have been obtained 
(Wang et al. 1991). Draining effects may also have a significant effect on the 
value of a (see for example Berth et al, 2002). 
The Haug triangle is a graphical way of representing the relation between the 
three conformation extremes - sphere, rod and coil (Smidsmd and Andtesen 
1979). The extremes of conformation are placed at the corners of the triangle 
and the conformation of a given macromolecule can then be represented by a 
locus along the perimeter of the triangle. For example, a globular protein 
would be represented by a locus somewhere between the extremes of sphere 
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and rod (side A), a polysaccharide, DNA or a mucus glycoprotein between rod 
and coil (side B) and a denatured protein between coil and sphere (side C). 







Polysaccharides are best represented by the worm-like chain model that allows 
for continuous flexibility throughout the polymer chain. Generally the more 
charged a polysaccharide is, the more rod-like its conformation. Highly 
charged polyanions such as pectin and polycations like chitosan have 
behaviour approaching that of stiff rods, whereas those of low or no charge 
behave more like random coils e.g. pullalan. The flexibility of these worm-
like chains can be represented by various parameters such as the ratio L/Lc, 
the ratio of the contour length of the chain to its persistence length. In the 
limits L/Lc ~ ~ 0 arid L/Lc ~ ~ ex:> the conformation is rod-like and random coil 
respectively. 
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Figure 1-3: The persistence length Lp and contour length Le of a linear macromolecule 
(Harding 1997) 
~ ' P P .......... ..... ---
--..... "'" 
..... 
Further information on the stiffness/flexibility of a polysaccharide can be 
determined from relations between intrinsic viscosity and ionic strength. The 
simplest is the "Smidsroo" stiffness parameter B, which is defined by: 
where the exponent v equals 1.3, and S is measured from a plot of [r11 versus I 
and the equation [17] = [171 + ( S.r JIJ. ) • 
Flory and co-workers also estimated the stiffness of a macromolecule using 
the characteristic ratio Coo: 
where <h2> is the mean square end to end distance, n is the number of 
segments in the chain and I is the length of each segment. Coo ~ ~ 1 holds only 
for a perfectly flexible chain. In practical terms, flexible coils appear to have 
values of Coo ~ ~ 1-10 whereas very stiff polymers have Coo > ~ ~ 25-400. Coo can 
be estimated from the intercept of a plot of [T)]1M11l verSus MIll together with 
knowledge of the residue length I and residue molecular weight. 
1.2.2 Degradation 
Chitosan, like all polysaccharides, will degrade over time, mainly due to 
hydrolysis of the ~ ( l - - . 4 ) ) linkage between the monomers (BeMiller 1967). 
This normally happens faster with chitosan in solution than in the solid state 
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(Holme et al. 2001). In order to market a drug formulation it is necessary to 
ensure that the bioavailability and pharmacological effectiveness of the drug 
are not compromised over a specified shelf life, e.g. three years (Aulton 2002). 
Various factors will affect the rate of degradation of chitosan, including 
temperature, pH, and ionic strength (BeMiller 1967). 
Looking at the kinetics of polymer degradation, the simplest model assumes 
that all the bonds of the macromolecular chain are equally susceptible to 
rupture, and that rate of rupture is proportional to the number of bonds 
remaining. The degradation process is non-specific and can be describe as 
"random scission degradation" (Tanford 1961). 
In random scission degradation the rate at which bonds are broken is 
proportional to the total number of intact bonds: 
-/ct P == poe (1-5) 
where Po is the initial number of bonds and p is the number of bonds at time t. 
The degradation of a polymer can often be measured experimentally by 
change in molecular weight ~ ~ a function of time, using light scattering or 
viscosity as a measure of molecular weight. These techniques can only be 
applied if the molecular weight remains large throughout the course of the 
experiment. In this case, p will remain close to unity and so will e-kt• 
Therefore equation (1-5) can be rewritten as: 
p = Po(1- la) (1-6) 
and the change in the degree of polymerisation will be a linear function of 
time: 
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This method of determining the rate of degradation can be applied to 
polysaccharides as has been demonstrated using cellulose. The degradation of 
cellulose was studied using hydrolysis by phosphoric acid and the rate 
constant increased with increasing concentration of phosphoric acid (Tanford 
1961). 
1.2.2.1 Acid Hydrolysis 
The rate of acid hydrolysis of the glycosidic linkages in model compounds 
such as methyl-2-acetamido-2-deoxy-P-D-glucopyranose and methyl-2-
amino-2-deoxy-p-D-glucopyranose has been determined, and it was shown 
that the N-acetylated methyl-glucosaminide was hydrolysed much faster than 
the corresponding de-N-acetylated sugar (Varum et al. 2001). 
Varum et al. (2001) also measured the degradation rate constants for chitosan 
as a function of acid concentration. It was found that the degradation rate 
increased in direct proportion to the acid concentration (0.01M < [HCI] < 
0.8M), which indicated that acid hydrolysis was the mechanism by which 
chitosan was degraded. Degradation was also measured as a function of 
degree of acetylation. Degradation increased with increasing degree of 
acetylation. Degradation of a less acetylated chitosan is believed to be slower 
due the protonation of the amine group in acidic conditions. The protonated 
amine group shields the glycosidic oxygen from protonation, which is the first 
step in the acid hydrolysis reaction (Roberts 1992). 
Acid hydrolysis causes depolymerisation by hydrolysis of the O-glycosidic 
linkage, however, at the same time deacetylation occurs by hydrolysis of the 
N-acetyl linkage. In dilute acid (0.1M HCI), the rate of deacetylation and 
depolymerisation have been showri to be similar (Varum et al. 2001), whereas 
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in concentrated acid (l2.08M HCI) the rate of hydrolysis was more than ten 
times higher than the rate of deacetylation. There was also a high specificity 
observed for the hydrolysis reaction in concentrated acid, such that the 
linkages between two acetylated units (A-A) and between an acetylated and a 
deacetylated unit (A-D) were cleaved with about equal rate and three orders of 
magnitude faster than the other two linkages (D-A and D-D). These studies 
were undertaken at high temperatures (60-80°C) which would not be 
encountered under normal storage conditions for a pharmaceutical 
formulation. The effects of acidic conditions under normal storage conditions 
are investigated in Chapter 4. 
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Figure 1-4: Schematic illustration of mechanism for acid hydrolysis of glycosidic Hnkage in chitosan (from VArum et aL 2001) 
W" ' O ~ ~ A . ~ ~
~ C ~ H H + 
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1.2.2.2 Oxidative Reductive Degradation (ORD) 
Chitosan can also be degraded in the presence of molecular oxygen. ORD 
involves a series of free radical reactions that ultimately lead to chain scission. 
Reducing compounds are oxidised yielding peroxide. The decomposition of 
peroxide is catalysed by transition metals and leads to the. formation of free 
radicals. The free radicals will be involved in a series of chain reactions, some 
of which result in the attack on the polymer chain. The "Polymer radical" is 
unstable, and further reactions of unknown mechanisms result in cleavage of 
glycosidic bonds (Pettersen et al. 1997). 
Free radical degradation of chitosan using hydrogen peroxide has been 
extensively studied (Chang et al. 1999; Qin et al. 2002). When peroxide is 
dissolved in water it can dissociate into hydrogen ions and perhydroxyl ions 
(equation 1 ~ 8 ) . . The perhydroxyl anion further reacts with H202 to form the 
highly reactive hydroxyl radical (HO') (equation 1 ~ ~10). 
Like other natural polysaccharides, chitosan also containS measurable traces of 
metal ions, e.g. iron and copper. These metal ions can catalyse the 
decomposition of H 2 ~ , , and Fenton type reactions would be feasible. These 
reactions may also occur in a phannaceutical formulation since the trace metal 
~ o n s s will be present. 
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(1-10) 
The hydroxyl radical reacts with carbohydrates exceedingly rapidly 
abstracting a C-bonded H atom (hydrogen abstraction) according to the 
general equation (1-11): 
(1-11) 
Chang et al. studied the effect of adding different free radical scavengers and 
metal chelators to the degradation of chitosan by hydrogen peroxide. It was 
found that EDTA slightly decreased the chitosan degradation as measured by a 
decrease in the extent of viscosity reduction, which indicated that when some 
of the metal ions were chelated, the reaction rate decreased. However, the 
reaction was not completely blocked suggesting that the EDTA-metal ion 
complex could still participate in chitosan degradation. Some metal ions may 
also form complexes with chitosan and these were not inhibited by EDTA. 
Tanioka et al. (1996) also studied the effect of EDTA on depolymerisation 
using copper ions. It was found that EDT A only inhibited depolymerisation 
when added before initiation of the reaction. Cu(II) coordinates to three -NH2 
and one -OH groups to form intramolecular twisted chelate. EDTA showed 
no protection when added during the reaction possibility due to its low ability 
to withdraw Cu(II) from the chitosan-Cu(II) complex. It was also found that 
chitin was not depolymerised by the Cu(II)-ascorbate system, suggesting that 
the free amino group of glucosamine is important in the depolymerisation of 
chitosan (Tanioka et al. 1996). 
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Interestingly, when chitosan was degraded by H20 2 in HCI solution, the rate of 
degradation was not proportional to the concentration of HCI as described in 
section 1.2.2.1. In 0.23% HCI (PH 5.5), chitosan degraded more rapidly and 
its molecular weight dropped to 2.64 x 103 in two hours, whereas, in 9% HCl, 
the molecular weight only declined to 21.2 x 104 (Qin et al. 2002). At too low 
a concentration of HCI, chitosan was not dissolved completely, and the strong 
acidity of 9% HCI inhibited the degradation. This may be due to the 
protonation of the amino group as suggested by Roberts (1992), and in that 
study the reduction in molecular weight was due to oxidative cleavage of the 
chitosan chain. 
1.2.2.3 Ultrasonic degradation and radiation 
Chitosans can also be degraded by ultrasonic treatment and radiation. The 
principle behind these physical means of degradation is that the added energy 
needed to break chemical bonds is provided by the energy source. Chen et al. 
(1997) studied the effect of ultrasonic treatment on the degradation of chitosan 
under various conditions. It was found that chitosan was degraded faster in 
dilute solutions, possibly due the increased available energy per unit length of 
molecule. Raising the reaction temperature resulted in a lower degradation 
rate, suggesting that elevating the solution temperature is detrimental to the 
degradation process by ultrasonics. Degradation increased with prolonged 
.. 
ultrasonic time, andchitosan was degraded during storage in an acidic solution 
at ambient temperatures. Boryniec et al. (1997) studied the effect of y-
radiation from a 60Co source on chitosan degradation. The results suggested 
that the degradation was random and independent of the macromolecular 
structure and chemical composition of the polymer chains. 
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1.2.2.4 Enzymatic Degradation 
Chitosan can be enzymatically degraded by, for example, chitinases, 
chitosanases, and lysozymes (Shigemasa et al. 1994). Chitosanase type 
enzyme can catalyse the cleavage of the D-Glucosamine reducing end, while 
chitinase type enzymes can catalyse the cleavage of the N-acetyl-D-
glucosamine reducing ends. The DA of chitosan plays an important role in the 
activity of these enzymes (Shin-ya et al. 200 I). Chitinase showed increased 
activity with increasing DA, while chitosanase showed decreased activity with 
increasing DA. Degradation using pectinase increased with increasing DA 
(Shin-ya et al. 2001). 
The hydrolysis of chitosan by lysozyme is reported to be the most important 
depolymerisation mechanism in human serum (Varum et al. 1997). The 
degradation rate in human serum increased as the degree of acetylation 
increased. The same increase was also observed with hen egg white and 
human lysozyme (Varum et al. t 997). This will be important for oral delivery 
formulations since there is a large amount of proteolytic enzymes present in 
the stomach and in the small intestine. 
The specificity of chitosan degradation using lysozyme was studied by Varum 
et al. (1996). Using NMR spectroscopy the identity of the new reducing ends 
could be determined. In the study these were found to be exclusively N-
acetyl-D-glucosamine subunits. This shows that the active cleft of lysozyme 
has a much higher affinity for N-acetyl-D-glucosamine units than for D-
glucosamine units. 
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1.3 Aims and Objectives 
The objectives of this thesis were as follows: 
• to characterise the hydrodynamic behaviour of a range of chitosans 
(varying in molecular weight and degree of acetylation). Of particular 
interest was the use of a combination of hydrodynamic techniques, namely 
analytical ultracentrifugation, SEC-MALLS and viscometry, to determine 
the influence of DA on chain conformation. The validity of molecular 
weight measurements using SEC-MALLS was investigated and results 
compared to those obtained using sedimentation equilibrium experiment 
on the AUC. 
• to obtain information on the degradation mechanisms and rate of 
. degradation of chitosan under various storage conditions. The degradation 
was monitored using viscosity and molecular weight measurements (SEC· 
MALLS and AUC) to obtain quantitative measures of degradation rates. 
• to prepare chitosan nanoparticles using the counterion tripolyphosphate 
pentasodium (TPP) which could be used to deliver insulin or other 
therapeutics proteinsJpeptides across the nasal mucosa. The encapsulation 
efficiency and loading capacity of nanoparticles prepared using different 
ratios of TPP and chitosan was studied and the effect of complexation on 
the degradation rate of chitosan was also investigated. . 
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Chapter 2: Materials and Methods 
2.1 Materials 
2.1.1 Solvents 
The main solvent used in this work was a O.2M acetate buffer (PH 4.3). This 
was prepared by dissolving 12.01g1l acetic acid and 7.994g1l NaCI in pure 
water and adjusting to pH 4.29 with monovalent strong base or acid as needed. 
Acetate buffers of different ionic strengths and pH were prepared by altering 
the quantities of acid and NaCl accordingly and adjusted to the desired pH 
using monovalent strong acid or base. 
2.1.2 Chitosan 
Chitosan samples were kindly supplied by Pronova Ltd., Drammen, Norway. 
These highly purified samples were used as supplied, and the physicochemical 
details for each sample can be found in Table 3.1, Chapter 3. 
2.1.3 Insulin 
Human zinc insulin (26.3 IU/mg) was obtained from Eli Lilly (Indianapolis, 
USA). 
2.1.4 Other Materials 
All other materials were of analytical grade and supplied by Sigma, UK. 
2.2 Methods 
2.2.1 Analytical Ultracentrifugation , 
The Analytical Ultracentrifuge (AUC) was invented by The Svedberg in 1923 
(Schachman 1992) and can be used to determine the molecular weight, and 
assess the size, shape and homogeneitylheterogeneity of macromolecular 
samples e.g. proteins and polysaccharides. Although the basic principles of 
sedimentation velocity and sedimentation equilibrium were established over 
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50 years ago, the modem delivery (instrumentation, data capture and analysis 
software) makes it a very attractive tool for macromolecular characterisation 
in solution. 
2.2.1.1 Optical Systems 
Three different optical systems can be used to collect data from the ADC 
(Lloyd 1974): 
1. Absorption Optics 
2. Interference Optics 
3. Schlieren Optics 
Absorption optics depends on the macromolecule of interest containing a 
chromophore. Chitosan does not possess a chromophore in the useable part of 
the DV spectrum unless chemically modified and hence this optical system 
has not been used in this project and will not be discussed here. Both 
Interference optics and Schlieren optics depend on the refractive index of the 
sample. 
2.2.1.1.1 Interference Optics 
An interference pattern is produced by splitting a beam of coherent light and 
passing it through paired sectors of a cell in a spinning rotor (Lloyd 1974). 
The speed of light will be altered as it passes through these sectors, to an 
extent dependent upon the refractive index. When the beams are merged after 
passage through the sectors, the waves combine to form an interference 
pattern. Ifboth sectors are identical in length and contain identical solutions, a 
pattern of straight (Le. undeviated) interferences fringes will be produced 
when the beams are recombined. However, if one sector contains a reference 
solvent and the other contains the same solvent but containing also the 
dissolved sample of interest, the greater concentration in the sample sector will 
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alter the light vector as it passes through that solution more than will be the 
case in the reference sector. When these beams are recombined, the fringe 
pattern will be shifted to an extent that corresponds to the concentration 
difference between the sectors. The fringe shift is related to the concentration 
by the classical relationship: 
J=a(An)/A (2-1) 
where J is the fringe shift, equivalent to the differential number of 
wavelengths between the solvent and the solution, a is the length of the light 
path through the sample or solvents compartments, A is the wavelength of the 
light, and An is the refractive index difference between the solvent and 
solution. Since the refractive index is generally proportional to concentration, 
the fringe shift can be used to follow the redistribution of sample as a function 
of radius in the sample sector (Furst 1997). 
2.2.1.1.2 Schlieren Optics on the Model E ultracentrifuge 
Schlieren optics, like interference optics, is based on the refractive index of the 
solution (Clewlow et al. 1997). Light passing through a region in the cell 
where concentration (and hence refractive index) is changing will be deviated 
radially, as light passing through a prism is deviated towards the direction 
normal to the surface. The schlieren optical system converts the radial 
deviation of light into a vertical displacement of an image at the camera .. This 
displacement is proportional to the concentration gradient. Light passing 
through either pure solvent or a uniform concentration will not be deviated 
radially, and the image will not be vertically displaced in those regions. The 
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schlieren image is thus a measure of the concentration gradient, dc/dr, as a 
function of radial distance, r. 
2.2.1.2 Sedimentation Velocity 
In sedimentation velocity, a sample is spun at high speed (usually 40-60 K 
rpm) in the analytical ultracentrifuge until the macromolecule has sedimented 
to the base of the cell. Here follows a summary of the technique (Ralston 
1993). 
Figure 2-1: Forces acting on a solute particle in a gravitational field (from Ralston 1993) 
ID 
I r = a; mernscus 
: : : : : = : : : : : : : : : : _ - . . . - - - - 1 - : r - - - - ~ ~ ~ r = b; bottom 
---
r 
When a solute particle suspended in a solvent is placed in a gravitational field, 
it is subject to three forces acting on it (Figure 2-1). These are: 
1. Sedimenting or gravitational force. 
2 M 2 F = m{J) r = -(J) r 
S N 
A 
(2 - 2) 
In a spinning rotor, the acceleration of a particle is determined by the 
product of its distance from the axis of rotation, r, and, the square of 
the angular velocity, (J) (in radians per second). The gravitational force 
is the product of the mass, m, of a single particle and the accelaration. 
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M is the molar mass ("molecular weight") of the solute in glmol and 
NA is Avogadro's number. 
2. Buoyant force. 
F 2 - 2 b = -mow r =-mvpco r (2 -3) 
The buoyant force is related to the weight of fluid displaced, where mo is 
the mass of fluid displaced by the particle, v the partial specific volume 
and p the solution density. 
3. Frictional force. 
Fj =-fu (2-4) 
A particle moving through a viscous fluid will experience a frictional 
drag that is proportional to the velocity and the frictional coefficient, f, 
which depends on the shape and size of the particle. 
When a high centrifugal force is applied, the solute particles initially 
accelerate, but quickly reach a terminal velocity, u. At this point the three 
forces come into balance: 
M (l-vp)w2r-fu=O (2-6) 
NA 
The particles rapidly deplete from the region nearest the centre of the rotor 
(the meniscus region at the air/solution interface), forming a boundary which 
moves toward the outside of the rotor with time until finally all the 
macromolecules form a pellet at the base of the cell (Figure 2-2). 
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Figure 2-2: Position of solvent and sample menisci in a double sector centrepiece and 
boundary formed by sedimenting particles (from Ralston 1993». 
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The sedimentation coefficient, s, is essentially based on the measurement of 
the velocity of movement, u, of this boundary and is defined by: 
Equation (2-7) expresses the sedimentation coefficient in terms of molecular 
parameters on the left hand side, and measurable quantities on the right hand 
side. From this equation it is apparent that the sedimentation coefficient 
depends on: 
• Molecular properties of the sedimenting particle, such as: molecular 
weight, M, partial specific volume, v and shape (via the frictional 
coefficient, f). 
• Properties of the solution: density, p and viscosity 1'/ (since f depends on 
this). 
It is also possible to calculate the molecular weight from the sedimentation 
coefficient using the Svedberg equation (Price and Dwek 1979): 
M= RTs 
D(l-vp) (2 - 8) 
where R is the gas constant, T the absolute temperature, and D is the 
translational diffusion coefficient which can be determined from the rate of 
spreading of the sedimenting boundary. However, sedimentation velocity is 
ineffective for polydisperse samples such as chitosan, since boundary 
spreading measurements are masked by polydispersity. For these systems 
dynamic light scattering is probably the method of choice (Ralston 1993). 
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2.2.1.2.1 Analysis 0/ data using DCDT+ software 
At set time intervals during a sedimentation velocity experiment, scans are 
taken of the solute concentration across the centrifuge cell. Using the DCDT+ 
software (Philo 2000), a series of approximately ten consecutive scans are 
selected after the sedimenting boundary has travelled approximately 213 across 
the cell length. The sedimentation coefficient distribution function, g(s*), can 
then be derived. This represents the change in concentration distribution 
across the cell with time, when different components will have undergone 
radial dilution to a different extent. This is normally corrected to g(s*), the 
apparent distribution when the sample was loaded. It is possible to fit 
individual peaks in the g(s*) distribution to Oaussian functions and determine 
bOth the sedimentation coefficient (from the centre position) for individual 
species and for monodisperse systems the diffusion coefficient (from the width 
of the Gaussian peak). 
The sedimentation coefficient is converted to standard conditions (solvent -
water; temperature - 20°C) to account for differences in density and viscosity 
of the solvent using the equation: 
S20 w ::l SObS( 1JT,w X?k.X l - ~ 2 0 ' W ) )
, 'ho,w 1Jw 1-v PT,s 
(2-9) 
where S20 W is the sedimentation coefficient in terms of the standard solvent 
. . 
water at 20°C; Sobs is the measured sedimentation coefficient in the 
experimental solvent at temperature T; TJT,w and TJ20,w are the viscosities of 
water at the temperature of the experiment and at 20orespectively; TJs and TJw 
are the viscosities of the solvent and water at a common temperature; Plo,w is 
the density of water at 20°C and Pr,s the density of the solvent at the 
temperature of the solvent. 
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2.2.1.2.2 Dependence of Sedimentation CoeffICient on Concentration 
Sedimentation coefficients measured at a finite concentration will be apparent 
ones because of the effects of non-ideality. Apparent sedimentation 
coefficients are therefore concentration dependent (Wales and Holde 1954), 
the measured apparent sedimentation coefficient decreases with increasing 
concentration. By measuring the apparent sedimentation coefficient at a series 
of concentration and extrapolated to zero concentration, the infinite dilution 
sedimentation coefficient ( s ~ o , w ) ) can be determined using the equation: 
(2 -10) 
The concentration dependence arises from the increased viscosity of the 
solution at higher concentrations, and from the fact that sedimenting solute 
particles must displace solvent backwards as they sediment. Both effects 
become extremely small as concentration is decreased. 
The concentration-dependence coefficient, ks, is a useful property for 
indicating molecular shape. It has been shown that the relationship "kJ['I']]" ~ ~
1.6 for spherical particles and random coils, and tends towards --<>.2 for rod-
like particles (independent of particle size) (Harding 1995). 
2.2.1.3 Sedimentation Equilibrium 
In sedimentation equilibrium the sample is· spun in an analytical 
ultracentrifuge at a. low speed, which causes the macromolecule to move 
towards the outside of the rotor. As the macromolecule sediments towards the 
base of the cell, diffusion acts to oppose the sedimentation process. After a 
period of time, usually 2-3 days, a balance is reached between the 
sedimentation and diffusion processes, and a concentration distribution is 
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fonned that increases exponentially towards the cell base. This distribution 
depends only on molecular mass of the macromolecule and is entirely 
independent of the shape of the molecule. By measurement of concentration 
at different points in this distribution, the molecular weight can be determined. 
For a single, ideal, non-associating solute, the molecular weight can be 
calculated from the following equation: 
M = 2RT dIne 
w (l-Vp)(i}2 dr 2 (2-11) 
However, due to non-ideality, an apparent weight-average molecular weight is 
obtained from sedimentation equilibrium that will tend to be lower than the 
true molecular weight. By extrapolation of the reciprocal of the apparent 
weight average molecular weight to zero concentration the true molecular 
weight can be obtained: 
l/Mw,app = (i/MwXl+ 2BMwc) (2 -12) 
where B is the thennodynamic or "osmotic pressure" second virial coefficient. 
2.2.1.3.1 MSTAR 
The data set (concentration of solute vs. radius/distance from meniscus) 
obtained from sedimentation equilibrium experiment can be analysed using 
MSTAR program (COlfen and Harding 1997) to obtain a value for Mw,lIPP" 
Using the MSTAR program, an operational point average (Le. a function of 
radial distance at a point in the ultracentrifuge cell from the axis of rotation) 
molecular weight (M*) is calculated. This is defined by (Creeth and Harding 
1982): 
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M * (r) _ ____ c....:...(r-'-)_-r_c a=--__ _ (2 -13) 
kca(r2 -r;)+2k Jr[c(r)-ca]dr 
r. 
where k = (1 - v p)w 
2 
, c is the polymer concentration at r (radial distance 
2RT 
from centre of rotation) or a, the meniscus. Mw,app is calculated by 
extrapolation of M* to the base of the cell. 
2.2.1.3.2 Lamm Equation 
Data obtained using the Schlieren optical system on the model E differs from 
that obtained on the XLI AUC. The data obtained here is in the form of 
concentration difference vs. distance from centre of rotation and can be 
analysed by fitting to the Lamm equation (Clewlow et al. 1997) to obtain Mz• 
(2 -14) 
where n is the refractive index, r the radial position from the centre of the 
rotor, p is the density of solvent, Mz,app the z-average apparent molecular 
weight, ro the angular velocity of the rotor, R the gas constant and T the 
absolute temperature. A graph of ~ . ; . . : ) versus r2 has a slope proportional 
to the z-average molecular weight (Mz,app). 
The data set can be transformed by integrating with respect to r, distance from 
meniscus, and analysed using MSTAR program to obtain Mw,app (Colfen and 
Harding 1997). 
2.2.2 Viscometry 
the viscosity of a solution is a measure of its resistance to flow. By adding a 
substance to a solvent, its viscosity will increase since the frictional forces 
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associated with the system increase. Herein follows a summary of the 
technique (Harding 1997). 
The effect of this added macromolecule on the viscosity of the solvent can be 
described by the relative viscosity, l1rel or the reduced viscosity, l1red: 
(2 -15) 
where TJ is the viscosity of the solution, TJo is the viscosity of the solvent, TJsp is 
the specific viscosity and C is the concentration. Due to non-ideality, the 
reduced viscosity of a solution shows concentration dependence, increasing 
with increasing concentration. The intrinsic viscosity, [11], of a 
macromolecule is defined as the limit as concentration tends to zero. Two 
forms of extrapolation can be used to calculate the intrinsic viscosity. 
The Huggins equation: 
TJred = [TJ]{1 + KH[TJ]c) 
or the Kraemer equation: 
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Figure 2-3: Huggins and Kraemer plot for intrinsic viscosity. The common intercept 
gives [11], the slope are Ku[ 11)2 and KK[ 11]2. Ku is the Huggins constant and KK the 
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2.2.2.1 Capillary Viscometer 
Viscosity measurements are performed by measuring the time for a solution 
(volume, V ~ ~ usually 2ml) of a macromolecule dissolved in a solvent of 
viscosity 110 to flow through a narrow capillary tube of radius r and length L 
under hydrostatic pressure. 
The viscosity of the sample solution, T'j, given by: 
1thgpr41 
11 = 8LV (2-19) 
where h is the average liquid height; g the gravitational acceleration; and p the 
density of solution. 
Since the flow times of the solvent (110) and of various concentrations of the 
macromolecule (11) are carried out under identical experimental conditions, the 
relative viscosity can be calculated from: 
11 Ip 117 =-=--
110 10 Po 
(2-20) 
where I and 10 are the flow times of the solution and solvent respectively; and 
pand Po, the density of the solution and solvent respectively. 
Since the concentrations used for polysaccharides are usually sufficiently 
small «5mglinl) to neglect density corrections, it is reasonable to assume that 
kinematic viscosity parameters (no density correction) are approximately 
equal to dynamic viscosity parameters (corrected for density differences). 
(Tanford 1955) The intrinsic viscosity can then be calculated by extrapolation 
using the Huggins or Kraemer plot. 
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h Capillary 
Figure 2-4: Ostwald capillary viscometer (Van Holde 1971) 
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2.2.2.2 Determination of Intrinsic Viscosity 
The intrinsic viscosity of each chitosan sample was determined using the 
Ostwald capillary viscometer which was suspended in a temperature 
controlled water bath at 20.0°C. A 5 mg/ml chitosan solution was prepared in 
0.2M acetate buffer, pH 4.3. 2 ml of this solution is transferred to the Ostwald 
capillary viscometer and suspended in the water bath for 10 minutes to ensure 
the sample is at 20,0°C prior to measurement of flow time. The flow time of 
the sample is recorded ten times and an average taken. The original sample is 
diluted using 0.2M acetate buffer, pH 4.3 to give a range of concentrations 
between 1 mg/ml and 5 mg/ml. The flow times for these diluted samples is 
recorded in the same way. The flow time is also recorded for the solvent (0.2 
M acetate buffer, pH 4.3). For each sample concentration the reduced 
viscosity is calculated using equation (2-16). The reduced viscosities are then 
plotted against concentrations and the intrinsic viscosity is calculated by 
extrapolation to infinite dilution (Huggins method). 
2.2.2.3 Determination of chitosan degradation using viscosity 
measurements 
The viscosity of a macromolecule is related to its molecular weight using the 
Mark-Houwink-Kuhn-Sakarada equation - [17] = K'MQ (Harding 1997). At 
solution concentration of 1 mg/ml the reduced viscosity of a chitosan solution 
is approximately equal to its intrinsic viscosity. Therefore changes in the 
reduced viscosity of a chitosan solution can be used as an indication of 
degradation that has occurred over a period of time. 
The reduced viscosity of a chitosan solution is measured at the beginning of a 
storage trial. At two week intervals, a 2 ml aliquot of the sample is taken and 
the reduced viscosity measured. The change in reduced viscosity is used to 
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assess the degradation of chitosan under different storage conditions as 
examined in Chapters 4 and 5. 
2.2.2.4 Concentration dependence of viscosity 
As the concentration of a solution increases the relationship between viscosity 
and concentration is directly proportional. However, above a certain 
concentration a sharp increase in viscosity is observed. The cocnetration at 
which this occurs is known as the "Critical Overlap Concentration - C*". 
This can be clearly seen using a double logarithmic plot of T/sp against 
concentration (Morris et al. 1981). The increase in the gradient of the plot is 
due to the change from dilute solution conditions, where individual polymer 
molecules exist as isolated coils, to concentrated solutions where significant 
coil overlaps begins to occur. The concentration at which C* occurs is 
generally between 0.4 - 0.8 mg/ml for polysaccharides (Harding 1997). 
2.2.3 Size Exclusion Chromatography coupled with Multi-
Angle Laser Light Scattering (SEC-MALLS) 
2.2.3.1 Size-Exclusion Chromatography 
Chitosan is a polydisperse polymer, that comprises of a normally broad range 
of molecular weights. Chromatography can be used to separate the solution 
into different molecular weight fractions. Size-exclusion chromatography, as 
the name suggests, separates the chitosan sample into fractions of different 
sizes or molecular weight. The chitosan solution passes through a series of 
columns which are packed with beads of varying size. High molecular weight 
fractions are excluded from passing through the pores created between the 
packing material and pass through the columns faster than lower molecular 
weight fractions which are able to migrate into the packing material increasing 
their elution time. The results is that high molecular weight fractions elute 
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first and that a molecular weight distribution can then be obtained using the 
light scattering cell which is connected in series. 
2.2.3.2 Multi-Angle Laser Light Scattering 
The measurement of molecular weight by light scattering makes use of the 
intensity of the light scattered at some angle e as a function of the intensity 
impinging on the scattered volume, V (Wyatt 1993). 
In solution, light scattering data can be interpreted according to the fluctuation 
theory of light scattering which states that light is scattered as a result of 
changes of polarizability of the solution due to random fluctuations in the 
solute concentration in small volume elements. Based on this, the relationship 
between the Rayleigh excess factor and the physical characteristics of the 
scattering molecule has been calculated by Debye, Zimm and others as (Wyatt 
1993): 
where: 
K = the "polymer constant" = (21m2/).. ~ A ) ( d n I d c i ( 1 + c o s 2 e ) )
c = the concentration of solution 
n = the refractive index of solution 
).. = the wavelength in vacuo 
NA = Avogadro's number 
dn/dc = the specific refractive index 
A2, A3 = virial coefficients (A2 is the same as B in equation (2-12» 
Ro= the Rayleigh excess factor = RtAsolution) - RtAsolvent) 
p{e) = the form factor which depends on shape and size of the scattering 
molecules 
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At limiting conditions where B approaches zero angle, P(B) approaches unity 
irrespective of size or shape of the scattering species. At low angles and 
concentrations, equation I can therefore be rewritten as: 
(2 -22) 
If A2 is known, Mw can be determined from a single measurement of Ro, 
which enables the continuous monitoring of SEC eluents. So, from the SEC 
trace shown, the molecular weight for uniform intervals on the elution curve is 
calculated from: 
Kc; / Re,i = 1/ M w,i + 2A2c; (2 - 23) 
The concentration Cj is most usually calculated from 
Ci = (mx;)/ V;x; (2·24) 
For each elution slice (i) in SEC the concentration (Ci) is obtained from a 
concentration sensitive detector, and Ra is obtained from the MALLS (after 
extrapolation to zero angle). MW,j is then calculated according to equation (2-
23). A2 must be known from independent light scattering measurements, 
unless the sample concentration is kept so low that A2c «llMw. With SEC· 
MALLS, this is normally the case, since samples are diluted on the column. 
2.2.3.3 Method 
Acetate buffer, pH 4.3, was pumped at a flow rate of 0.8 mlImin through a 
column system consisting of TSK-G5000PW, TSK·G4000PW and TSK· 
G3000PW analytical columns protected by a guard column. Solutions of each 
chitosan sample were prepared as described in relevant study and 100 ,.u was 
injected onto the columns at ambient temperature (sample filtered through 
0.45 J..UD filter to remove any insoluble material or dust prior to injection). The 
eluting fractions were monitored using a Dawn DSP, multi-angle light-
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scattering photometer (Wyatt Technology, Santa Barbara, USA) fitted with a 5 
mW He-Ne Laser and a differential interoferometric refractometer (Optilab 
903, Wyatt Technology, Santa Barbara, USA). Apparent weight average 
molecular weights were obtained using the Debye plot method on the 
associated ASTRA software. 
2.2.4 Preparation of Nanoparticles 
2.2.4.1 Cbitosan Nanoparticles 
Chitosan nanoparticles were prepared according to the method described in 
(Dyer et al. 2002). A solution of a chitosan was prepared at a concentration of 
2 mg/ml in distilled water. To this solution tripolyphosphate pentasodium 
(TPP) solution was added dropwise at the appropriate ratio whilst 
continuously stirring. This resulted in an opalescent solution. The solution 
was then divided into aliquots which were used for either determination of 
yield, loading capacity, or for use in chitosan stability experiments (see 
Chapter 6). 
2.2.4.2 Cbitosan-Insulin Nanoparticles 
Insulin loaded chitosan nanoparticles are prepared in the same way as above 
except insulin is predissolved in the TPP solution at a concentration of 1.25 
mg/ml. As with the chitosan nanoparticles the resulting nanoparticle 
suspension is divided into aliquots for determination of yield, etc. and for use 
in stability experiments. 
2.2.5 Estimation of chitosan concentration 
During the manufacture of chitosan nanoparticles it was necessary to 
determine the amount of chitosan present in the supernatant after 
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centrifugation to allow for calculation of nanoparticle yield. The chitosan 
content was calculated by means of the ninhydrin reaction. 
Ninhydrin reacts with primary amino groups to produce a coloured product 
(diketohydrindylidene-diketodhyrindamine, also known as Ruhemann' s 
purple). The method used here is based on that used by Prochazkova et al. 
(1999) and adapted by Leane et al. (2004). 
2.2.5.1 Method 
Lithium acetate buffer (10ml) was prepared by dissolving 4.08g of lithium 
acetate in approximately 6ml of deionised water. The pH of the solution was 
adjusted to 5.2 with glacial acetic acid and the volume adjusted to IOml with 
deionised water. The ninhydrin was freshly prepared on the day of the assay 
by adding 4M lithium acetate buffer (lOmI) to 0.8g ninhydrin and 0.12g 
hydrindantin in 30ml DMSO. 
O.5ml of reagent was added to O.5ml of sample in a glass bottle and shaken by 
hand. This was then heated in boiling water for 30 minutes to allow the 
reaction to proceed during which time a change in colour to purple is 
observed. The sample is then cooled and diluted with 15ml50% ethanol and 
vortexed for 15 seconds to oxidise excess hydrindantin. The absorbance of 
each sample was measured at 570nm using a UV spectrophotometer and the 
concentration of chitosan calculated from a standard calibration curve 
(prepared on day of assay from the same chitosan used in the test sample). 
2.2.6 Estimation of insulin concentration 
The insulin concentrations of the various formulations were analyzed using a 
Gilson HPLC system fitted with a Vydac Cl8 5 ~ ~ pre-column and a Vydac 
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reverse phase C18 5 ~ ~ 150 x 4.6 mm column (Hichrom, Reading, United 
Kingdom) (Dyer et a1. 2002). Gradient conditions and a flow rate of 1.0 
mllroin ( ambient temperature) were used. The mobile phase was composed of 
eluent A, containing 95% ethanolamine (0.6%, pH 3) and 5% acetonitrile and 
eluent B, containing 40% ethanolamine (0.6%, pH 3) and 60% acetonitrile. 
The injection volume was 10 ,.d. The ultraviolet detector was set at 210 nm. 
The analysis run time was 18 min. Samples were prepared for analysis by 
dissolving/diluting the formulation in eluent B. 
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Chapter 3: Hydrodynamic Characterisation of 
Chitosan Samples 
3.1 Introduction 
For most applications of chitosan, and especially in the pharmaceutical 
industry, the molecular weight and degree of acetylation determine the 
properties and thereby the effectiveness of the chitosan for a particular 
application. Schipper et al. (1996) reported that for chitosan to enhance the 
absorption of hydrophilic drugs across mucosal surfaces, a low degree of 
acetylation and/or high molecular weight appeared to be necessary. 
In this chapter chitosan samples are characterized under similar aqueous 
conditions in terms of molecular weight (using sedimentation equilibrium and 
SEC-MALLS) and their conformation determined using data obtained from 
sedimentation velocity and intrinsic viscosity measurements. 
3.2 Methods 
3.2.1 Intrinsic viscosity 
Intrinsic viscosities were determined using an Ostwald-type viscometer of 2 
ml capacity over a concentration range of 0.2 - 2.0 mg/ml as described in 
section 2.2.2.2. The flow times were recorded at (20.00 ± 0.01) °C. From the 
solution: solvent flow time ratio the kinematic relative viscosity was obtained. 
The intrinsic viscosity ([ 1]]) was found by extrapolation to infinite dilution of 
both reduced viscosity using the Huggins equation and inherent viscosity 
using the Kraemer equation (see section 2.2.2). 
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3.2.2 Sedimentation Velocity 
A Beckman XLI Analytical Ultracentrifuge was used for the determination of 
sedimentation coefficients at 20°C and a rotor speed of 45,000 rpm. 
Sedimentation coefficients were obtained by analysis of the change in 
concentration distribution in the centrifuge cell with time using the "time 
derivative" algorithm DCDT+ (Philo 2000) and corrected to standard solvent 
conditions as described in section 2.2.1.2.1. Measurements were made at 
several concentrations (from 0.3 to 1.0 mglml) and the calculated S20,w values 
(or reciprocals thereof) were extrapolated to infinite dilution to yield s ~ o , w ' '
3.2.3 Sedimentation Equilibrium 
Low-speed sedimentation equilibrium was used to determine the molecular 
weights ( weight averages) of the various chitosan samples. Two analytical 
ultracentrifuges were employed. 
Firstly, a Beckman XLI Analytical Ultracentrifuge was used for chitosan 
solutions in the range of concentrations 0.5 - 1.0 mglml, at rotor speeds of 
14,000 rpm (chitosan G112) or 8,000 rpm (other chitosans) and a temperature 
of 20.0°C. The data collected from the Rayleigh interference optical system 
was analysed using the MST ARI program to give an apparent weight average 
molecular weight Mw,app (see section 2.2.1.3.1). 
A low concentration sample (0.3 mglml) was also analysed using a Beckman 
Model E Analytical Ultracentrifuge (at rotor speeds between 10,000 and 
20,000 rpm, and at 20.0°C) equipped with Schlieren optics (section 2.2.1.1.2). 
The data was analysed by fitting to the Lamm equation (section 2.2.1.3.2) to 
yield the .apparent z-average moleculQT weight (Mz,app). The data set was then 
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transfonned by integrating with respect to r (distance from the meniscus) and 
analysed using MST ARI program to obtain Mw,app. 
3.2.4 SEC-MALLS 
The molecular weights (weight averages) of the chitosan samples was 
determined using SEC-MALLS as described in section 2.2.3. The data 
obtained was analysed using the Debye plot method to give an apparent 
weight average molecular weight, Mw,app. 
3.3 Materials 
Chitosan samples were used as provided by Pronova Ltd., Drammen, Norway. 
Solutions were prepared in O.2M acetate buffer, pH 4.3 at appropriate 
concentrations for each method. 
Table 3-1: Commercial manufacturer's data (courtesy of Pro nova Ltd.) 
Chitosan GIU G1l4 G1l4 G213 G1IJ* CL210 
Degree of Acetylation 30 7 4 17 20 18 
(%) 
Viscosity of 1 % 5 ]8 59 79 153 126 
solution (mPas) 
NB: Chitosans G213 and G213* are different batches ofthe same chltosan 
3.4 Results and Discussion 
3.4.1 Viscosity 
The intrinsic viscosity for each chitosan sample was calculated using both the 
Huggins equation and the Kraemer equation. Table 3-2 shows the intrinsic 
viscosities obtained from each method along with the corresponding constants. 
An example of the plots obtained for chitosan G214 using the Huggins and 
Kraemer equations is shown in Figure 3-1. The intercept of these two plots 
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with the y-axis gives the intrinsic viscosity and should be equivalent 
irrespective of the method used. The non-intersection seen in Figure 3-1 
reflects the noise in the data. From the values in Table 3-2, the intrinsic 
viscosities obtained are very similar using both methods. 
The manufacturer's data from apparent viscosity of the chitosan samples 
increases across the table - from left to right (Table 3-1). Comparing these 
with the intrinsic viscosities in Table 3-2, the same trend is apparent. The 
intrinsic viscosities obtained for chitosan 0213 and chitosan CL210 are higher 
and lower, respectively, than would be expected from the manufacturer's data. 
This may be due to the different methods that have been used to obtain the two 
sets of data. The apparent viscosity is measured at a single concentration (10 
mg/ml) whereas the intrinsic viscosities are determined using several 
measurements which are extrapolated to infinite dilution. The result of this 
extrapolation means that the intrinsic viscosity value obtained is not dependent 
on the chitosan concentration, only on the solvent used. The differences may 
also be due to aging of the samples, since the samples used had different 
manufacturing dates and some degradation may have occurred during storage. 
3.4.2 Sedimentation Coefficients 
The sedimentation coefficients calculated for each cbitosan sample are shown 
in Table 3-3, with an example plot for chitosan 0214 shown in Figure 3-2 .. As 
for the viscosity data, the sedimentation coefficients also increase in the same 
trend as seen in the manufacturer's data. The values obtained (in the range 1.6 
- 3.0) are in good agreement with values obtained by other researchers for 
various chitosans (for example Rinaudo and Domard 1989; Anthonsen et al. 
-69-
Chapter 3: Hydrodynamic Characterisation of Chitosan Samples 
1993; Errington et al. 1993; Berth et al. 1998). As with intrinsic viscosity 
values, the sedimentation coefficient is dependent on the size of the 
macromolecule, and an increase in either of these parameter will indicate an 
increase in the molecular weight of the chitosan. The increasing values of the 
sedimentation coefficient agree with the molecular weight values that were 
obtained using sedimentation equilibrium and SEC-MALLS (the molecular 
weight values are discussed in section 3.4.3.). 
As discussed in Section 2.2.1.2.2., sedimentation coefficients are dependent on 
concentration, the measured apparent sedimentation coefficient decreasing 
with increasing concentration (Wales and Holde 1954). The concentration 
dependence is due to the increased viscosity of the solution with increasing 
concentration resulting in a slower sedimentation of the solute particle and 
hence a larger sedimentation coefficient. This effect can be seen from Figure 
3-2 were lIS2o,w increased with increasing concentration. From the plot of 
lIS20,w vs concentration, the concentration dependence sedimentation 
coefficient, k" can be obtained from the slope of the extrapolated trend line 
(see equation (2-10». The values for this coefficient are an indication of the 
effect that the concentration of the solute has on sedimentation coefficient. 
From Table 3-3 it can be seen that chitosan CL210 has a very large 
concentration dependence coefficient, whereas for chitosan G 112 it is quite 
low. The significant variation in the extent of concentration dependence of the 
sedimentation coefficient, highlight the importance of standardising the 
sedimentation coefficient by extrapolation to infinite dilution after the 
sedimentation coefficients at each concentration have been converted to 
standard conditions (water and temperature 20°C using equation (2-9». 
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Without this standardization, comparison of sedimentation coefficient for 
different chitosan or for the same chitosan by different researchers would be 
pointless. 
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Table 3-2: Viscometric data for cbitosan samples 
Chitosan Huggins Kraemer 
Sample 
(11) (mUg) KH (11) (mUg) KK 
GIl2 95 ±6 3.18 ± 0.66 98±6 -1.92 ± -0.56 
GIl4 323 ± 10 0.38 ± 0.07 317 ±7 -0.10 ± -0.04 
G214 551 ±6 0.68 ± 0.03 560±5 0.02 ±0.03 
G213 418 ± 8 1.26 ± 0.09 433 ±4 0.35 ± 0.06 
G213* 611 ±5 0.55 ± 0.03 615 ± 6 0.04 ± 0.03 
CL210 842 ±66 0.39 ± 0.07 882 ± 18 0.14 ± 0.02 
[T\1- intrinsic viscosity; Ku - Huggins constant; ~ ~ - Kraemer constant 
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Table 3-3: Sedimentation velocity data for chitosan samples 
Properties Units G112 G114 G214 G213 G213* CL210 
° S20,w 
S 1.67 ± 1.90 ± 2.83 ± 2.88± 2.99± 
0.04 0.08 0.15 0.27 0.09 
ks ml/g 389 ± 286± 740± 860± 884± 
33 65 86 158 50 
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3.4.3 Molecular Weight Determination 
The molecular weight of a polymer can be determined using absolute or 
relative methods. Absolute methods include analytical ultracentrifugion and 
light scattering methods and do not require calibration using materials of 
known molecular weight and identical conformation. 
The two absolute methods used here are sedimentation equilibrium using the 
analytical ultracentrifuge and size exclusion chromatography coupled with 
multi-angle laser light scattering. The two methods are compared based on the 
data obtained for several chitosan samples, and the practicability discussed. 
Table 3-4: Molecular weight of chitosan samples determined using direct and indirect 
methods 
Property UDiD GIl2 GIl4 G214 G213 G213* CUIO 
Mw (Sed. glmol 57000 ± 82000 ± 132000 ± 161000 ± - 173000 ± 
Equ.) 8000 9000 15000 18000 12000 
2BM(Sed. ml/g - 2200 4100 46000 . -
Equ.) 
Mw (SEC· g/mol 42400 ± 129000± 172000 ± 203000± 207500 ± 202000± 
MALLS) 3000 6000 6000 8000 8000 6000 
Mz(SEC· g/mol 90000± 386000 ± 246500± 442000± 417000 ± 1000000 ± 
MALLS) 11000 30000 18000 30000 41000 
Mw (Sed. Equ) - weight average molecular weight obtamed from sedimentation 
equilibrium 
2BM (Sed. Equ.) 
Mw (SEC-MALLS) - weight average molecular weight obtained from SEC-MALLS 
Mz (SEC-MALLS) - z-average molecular weight obtained from SEC-MALLS 
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3.4.3.1 Analytical Ultracentrifugation (.4UC) 
Measurement of molecular weight using the AUC requires the determination 
of molecular weight at several concentrations due to thermodynamic non-
ideality. 
In this study weight average molecular weights were determined at several 
concentrations using two AUCs. Firstly three concentrations (l.0, 0.8, and 0.5 
mg/ml) were run on the XLI AUC and the apparent molecular weight 
determined from the interference data collected using the MST AR program. 
For 0.5 mg/ml chitosan solution the effects of non-ideality are still apparent 
(as indicated by the downwards curvature in the In J versus ~ ~ plot -Figure 3-3) 
and it is therefore best to also determine the molecular weight from data 
collected at lower concentrations (molecular weight determined at 0.3 mg/ml 
using Model E AUC as described in next paragraph). Chitosan is a 
polydisperse system, and this can normally be seen from upward curvature in 
the In J versus ~ ~ plot, however, the downward curvature in Figure 3-3 
indicates that the effects of polydispersity are overshadowed by 
thermodynamic non-ideality (Colfen and Harding 1997). Figure 3-4 shows 
the w ~ i g h t - a v e r a g e e molecular weight versus ~ ~ (normalized radial displacement 
function) and from this the apparent weight average. molecular weight can be 
calculated (M. at cell base is equal to Mw,app). Data at the base of the cell 
cannot always be observed completely and therefore extrapolation is 
necessary. In Figure 3-4, the data does not follow a clear downward curvature 
that levels out towards the base as would be seen with an ideal system. The 
data observed here is quite irregular due to the non-ideality associated with a 
chitosan system. 
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The XLI AUC uses 12mm path length centrepieces, which limits the minimum 
loading concentration. Since polysaccharides generally have refractive index 
increments in the range of 0.14 - 0.16 mlIg, the minimum loading 
concentration that can be used to obtain a sufficient fringe increment for 
molecular weight determination is .....Q.5 - 0.6 mlIg in a 12 mm path length cell. 
The Model E AUC on the other hand, can use either 12 mm or 30 mm path 
length cells. By using a 30 mm cell, the minimum loading concentration is 
reduced to 0.2 - 0.3 mg/ml (Harding 1992; Jtarding 1995). An apparent 
molecular weight was determined at a loading concentration of 0.3 mg/ml 
using the Model E AUC. 
Figure 3-5 shows the schlieren image produced in the Model E AUC (the 
principles of schIieren optics are described in section 2.2.1.1.2.). Data 
collected from this image can be plotted using the Lamm equation (example 
plot shown in Figure 3-6) to give an estimate of Mz,app. and by integration of 
the data with respect to r (distance from the meniscus), it can be analysed 
using MST AR to determine Mw,app' The apparent molecular weights can be 
plotted against concentration using equation (2-12) (section 2.2.1.3.) to 
determine the true molecular weight for the chitosan. An example plot can be 
seen in Figure 3-7. 
As previously mentioned, non-ideality causes the molecular weight for 
chitosan calculated from AUC data to be lower than the true molecular weight. 
There are two major contributing factors to this phenomenon: the excluded 
volume and the polyelectrolyte effect. The excluded volume arises from one 
molecule excluding another from the space occupied by it. For a sphere the 
excluded volume is eight times the volume, and the more extended the 
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conformation of the molecule the greater the excluded volume. Another 
contribution to exclusion volume comes from the swelling of the molecule 
through "hydration" or time-averaged association with water molecules. For a 
polysaccharide molecule in solution, the swollen volume can be 100 times its 
volume in the dry state (Harding 1995). The excluded volume can also be 
affected by interactions between the solute and solvent or by repulsion 
between solute molecules. The repulsion between solute molecules will be 
high for chitosan due to the high charge density on the molecule (-90 charges 
per 100 subunits) when in aqueous acidic solution. The intermolecular 
repulsion between the charged amino groups on chitosan results in a highly 
extended conformation. Chitosan will therefore have a large excluded volume 
and highly non-ideal behaviour when in solution. Increasing the ionic strength 
of the solution medium, thus reducing the electrostatic repulsion, can reduce 
the polyelectrolyte effect. However, for chitosan, large increases in ionic 
strength lead to reduced solubility and salting out can occur. 
The term 2BM (second virial coefficient x molecular weight) is a measure of 
the non-ideality associated with the system (Van Holde 1971). For a 
spherical, uncharged molecule this would have a value of approximately 5-10 
ml/g, and the value increases as the system deviates from ideality. From Table 
3-4 it can be seen the 2BM values are in the range 1000-2000 ml/g indicating 
that chitosan is a highly non-ideal macromolecule. 
At very low solute concentrations, ideal behaviour is approached (Van Holde 
1998) and the effects of non-ideality should be small. Measurement at a single 
finite, but low (0.2 - 0.5 mglml) concentration can give an estimate of the 
apparent molecular weight within a few percent of the true molecular weight. 
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However, for chitosan the data obtained on the Model E ADC at a loading 
concentration of 0.3 mglml still showed non-ideality (deviation of data from 
trend line shown in Figure 3-6). Thus extrapolation to infinite dilution after 
measurement of the apparent molecular weight at several concentrations is 
necessary (see figure 3-7). 
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Figure 3-5: Schlieren image as produced on Model E AUC for chitosan G214 
(concentration 0.3 mglml) 
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Figure 3-7: Extrapolation to infinite dilution for Mw determination of chitosan G214 
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Figure 3-8: Light scattering (R90) and Refractive Index (RI) traces obtained using SEC-






5 10 15 20 25 30 35 40 
Volume (m I) 
-80-
Chapter 3: Hydrodynamic Characterisation of Chitosan Samples 
3.4.3.2 SEC-MALLS 
SEC-MALLS also allows the direct evaluation of the absolute molecular 
weight of a macromolecule. However, with SEC-MALLS the measurements 
take approximately 60 minutes (after appropriate equilibration of the SEC 
columns) compared to up to 3 days for AUC measurements. Another 
advantage of SEC-MALLS over AUC is that no correction for non-ideality is 
required since the sample is diluted in the columns to such an extent that the 
concentrations of the volume "slices" passing through the light scattering 
detector are much lower than the initial loading concentration. These 
concentrations are usually 0.1 mg/ml or less (depending on the molecular 
weight of the scatterer), and corrections of non-ideality are not significant 
(Wyatt 1993). 
Figure 3-8 shows an example of the trace produced using SEC-MALLS. The 
red trace shows the light scattering signal for chitosan, while the blue trace 
shows the refractive index signal. This is a measurement of the concentration 
of chitosan as it elutes and by combining the data from the two traces we can 
calculate the molecular weight distribution for each chitosan sample. From 
the light scattering traces it can be seen that in each case the peaks from the 
macromolecular component are skewed and not symmetrical. There was also 
evidence of trace amounts of high molecular weight aggregates from the 90° 
angle light scattering traces as indicated by the shoulders on the low elution 
volume or high molecular weight side of the light scattering peaks. However, 
except for sample 0112 these light scattering signals are not accompanied by 
corresponding RI (concentration) signals indicating that only negligible 
amounts «1%) are present in the samples. No such supramolecular particles 
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were observed from the sedimentation velocity g*(s) distributions obtained 
using time-derivative DCDT + analysis, which showed only a single, 
approximately symmetrical peak in each case, including Gl12. 
The molecular weights obtained from both AUC and SEC-MALLS 
measurements are in reasonable agreement (Table 3-4). Since SEC-MALLS 
is the more convenient technique, this will be used for measurement of 
molecular weight in the :furtJ:ler experiments discussed in this thesis, however, 
for characterisation purposes it is advisable to also determine the molecular 
weight using the AUC to obtain a reliable and independent verification of the 
results. 
3.4.4 Conformation of Chltosan 
The conformation of chitosan is dependent upon the degree of acetylation of 
the molecule and the solvent conditions in which it is studied. The more 
deacetylated the molecule, the more extended the conformation due to the 
increase in charged amino groups along the chain. By altering the pH and 
ionic strength of the solution medium the conformation can be changed. 
Increases in ionic strength will reduce electrostatic repulsion leading to a more 
compact conformation, as will increases in pH since less amino groups will be 
charged. 
3.4.4.1 Mark-Houwink Kuhn Sakarada relation 
The Mark-Houwink Kuhn Sakarada (MHKS) exponent can be used as a 
conformation indicator. The most common form of the MHKS equation 
relates intrinsic viscosity to molecular weight (Harding 1997): 
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where K and a both depend on the polymer conformation. This relation was 
fIrst suggested by Mark in 1938 and independently by Houwink in 1940. 
Similar relations exist for other hydrodynamic properties, e.g. sedimentation 
coefficients. The conformation of a molecule can be estimated depending on 
the value of these exponents are found in Table 3-5. 
Table 3-5: MHKS exponents for general conformation types 
Conformation tJ b E C 
Compact sphere 0 0.667 0.333 0.333 
Rigid rod 1.8 0.15 0.85 1.0 
Random coil 0.5-0.8 0.4 - 0.5 0.5-0.6 0.5-0.6 
a - intrinsic viscosity exponent; b - sedimentation coefficient exponent; e - diffusion 
coefficient exponent; c - radius of gyration exponent 
Figure 3-9 and Figure 3-10 show double logarithmic plots for the glutamate 
chitosans in terms of log S ~ ~ , I V V versus log Mw and log [11] versus log Mw 
respectively. A linear fIt to the log s ~ ~ , w w versus log Mw yielded an MHKS 
exponent b = (0.25 ± 0.04), i.e. between the limits of rod (0.15) and coil (0.4-
0.5). Similarly a linear fIt to the log [11] versus log Mw yielded an MHKS 
exponent a = (0.96 ± 0.10), again between the coil (0.5 - 0.6) and rod (1.8) 
limits. However, interpretation of such data should be done with caution 
because of the clear demonstration by others of a dependence conformation on 
the degree of acetylation (Anthonsen et al. 1993; Berth and Dautzenberg 
2002). Despite this reservation, the values obtained appear similar to those for 
three chitosans with degrees of acetylation in the range 22-31 % (Colfen et al. 
2001): a ~ ~ 1 and b ~ ~ 0.24. Furthermore, the data reassuringly shows 
consistency between the sedimentation coefficient and viscosity data. 
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Figure 3-9: Double logarithmic plot of sedimentation coefficient versus weight average 
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Figure 3.10: Double logarithmic plot of intrinsic viscosity versus weight average 
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Chapter 4: Effect of Solvent Characteristics or 
Solvent Parameters on Degradation of Chitosan 
4.1 Introduction 
In this chapter the effect of various solvent parameters on chitosan degradation 
will be examined. It is known that the pH and ionic strength of a solvent 
affects the confonnation of chitosan and these effects on confonnation will be 
discussed in tenns of the effects on degradation. Other conditions examined 
in this chapter are storage temperature; concentration of chitosan and the 
addition of scavenging agents which can be used to reduce oxidative reductive 
degradation (see section 1.2.2.2.). 
In the fIrst section of this chapter, the effect of individual parameters (pH, 
temperature, ionic strength, presence of scavenging agent) will be studied. In 
the second section, the effect of several factors is studied in a multi-factorial 
experiment. 
4.2 Effect of Individual Factors on Chitosan Degradation 
4.2.1 Materials and Methods 
Degradation of chitosan was followed using both viscosity measurements and 
sedimentation data. 1.0 mg/ml chitosan solutions (Chitosan CL210) were 
prepared in either 0.2 M HCI (PH 1.28) or O.lM acetate buffer at specifIed pH 
(PH 4 or 5) and ionic strength (I = 0.2 or O.3M). Each sample was then stored 
in closed glass bottles (clear) at the appropriate temperature (4, 25, 40°C) and 
sampled weekly. Samples were prepared in triplicate. 
In the study on the effect of scavenging agents, 7mM thiourea was added to 
the chitosan solution. 
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4.2.1.1 Viscosity data 
Sample and solvent flow times were measured at 25°C using a 2 ml Ostwald 
viscometer. The reduced viscosity calculated using equation (2-16). 
When viscosity vs time was plotted as a scatter graph, it could be seen that the 
decay or loss of viscosity followed first order kinetics. In first order 
degradation the rate of decay of a substance is proportional to the first power 
of the concentration of that substance, and independent of any other substance 
present. 
By fitting each data set to a first order degradation curve (equation 4-1), a rate 
constant (k) can be obtained: 
(4 -1) 
where "red is the reduced viscosity measured at time t, and TJresid is the residual 
viscosity after the period of study. 
4.2.1.2 Sedimentation data 
Sedimentation coefficients were determined from sedimentation velocity data 
(see section 2.2.1.2.) and converted to standard conditions using equation (2-
9). Molecular weights (Mw,app) were determined from equilibrium data at 
concentration of Imglml, 0.8mglml and O.5mglml. This data was analysed 
using MSTAR and extrapolated to zero concentration to give Mw (glmol). 
4.2.1.3 Degradation rate 
Degradation rates were determined using a method described in Varum et al. 
(2001). Solutions of chitosan (CL21 0 - DA 18%) were prepared in a range of 
acid solutions (0.01 - 0.4 M HCI) at a concentration of 0.5 mglml. Each 
sample was stirred for one hour to ensure dissolution of the chitosan. 2 ml of 
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the sample was transferred to an Ostwald capillary viscometer suspended in a 
thermostatically controlled water bath at (60.0 ± O.5°C) and allowed to 
equilibrate to temperature for 20 minutes before commencing flow time 
measurements. Flow times were recorded at 10-minute intervals over one 
hour. From the flow times, the degree of polymerisation was calculated 
(Nordtveit et al. 1994) using Mark-Houwink coefficients; a :::; 0.78, K = 
5.58xlO-2 (Anthonsen et al. 1993). Rate constants were calculated by plotting 
the degree of scission (a=IIDPn) versus time, the value of the slope being 
equal to the reaction rate. Samples were measured in triplicate. 
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4.2.2 Results 
4.2.2.1 Effects of Temperature 
Figure 4-1 shows the effect of temperature on the reduced viscosity of 
chitosan samples. Each sample had approximately the same initial viscosity, 
which decreased over the eight-week period. The rate of degradation was 
fastest at 40°C (Rate = 0.775 week-I), with a decrease in viscosity of 55% over 
the 8 week period, and slowest at 4°C (Rate = 0.087 week-\ with a decrease 
in viscosity of 15%. This suggests that chitosan has greater stability at lower 
temperatures. This result was in agreement with Jia and Shen (2002) who 
showed that the intrinsic viscosity of chitosan decreased from 320 to 70 ml/g 
after only 8h storage at 40°C, while at ambient temperature the intrinsic 
viscosity remained at -120ml/g after 35 days storages (solvent : 85% 
phosphoric acid). 
The rate constants of most reactions increase as the temperature is raised. 
Typically, the degradation of chitosan requires the cleavage of bonds along the 
chitosan chain (usually the glycosidic bond joining the two glucosamine 
residues). The breaking of chemical bonds requires energy, i.e. it is an 
endothermic process. Therefore, as shown here, the rate of degradation will 
increase as the temperature increases since more energy is available. 
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Figure 4-1: Effect of temperature on reduced viscosity of chitosan solution (ImglmJ 
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4.2.2.2 Effect of Ionic Strength 
Figure 4-2 shows the effect of solution ionic strength on chitosan viscosity and 
degradation. In contrast to the results shown in Figure 4-1 the initial 
viscosities of the samples decreased as the ionic strength increased. This can 
probably be attributed to chitosan being a polyelectrolyte: the hydrodynamic 
behaviour of chitosan is affected by changes in the degree of protonation in 
different ionic strength and/or pH solutions. However, there is still much 
debate as to whether varying the degree of acetylation of chitosan affects the 
expansion and stiffuess of the chains in solution (Ott0)' et al. 1996; Berth et al. 
1998). On one hand, a higher content of bulky acetyl groups may increase the 
stiffuess of the chains for steric reasons. This effect was demonstrated by the 
Trondheim group, who found that chitosan exhibited higher expansion and 
stiffuess with increasing DA (Anthonsen et al. 1993; Anthonsen et al. 1994; 
0tt0)' et al. ,1996). On the other hand, a lower DA means a higher amount of 
amino grpups, which are charged in aqueous acidic solution. As described in 
Tanford (1961) for flexible polymer chains, the accumulation of charge leads 
to considerable expansion due to electrostatic repulsion. Errington et al. 
(1993) found that chitosans with a higher DA appeared to exhibit a less 
extended conformation due to a decrease in electrostatic charge on the 
molecule. In low ionic strength solutions, the charge effects dominate, which 
makes the chitosan molecule exist in an extended conformation due to 
electrostatic repulsion. However, in high ionic strength solutions, the 
concentration of the counter-ions are raised which screens the protonated 
amide groups and makes the molecule more contracted (Tanford 1961; Tsaih 
and Chen 1997). This change of the chitosan molecule with increasing ionic 
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strength will cause the solution viscosity to decrease as demonstrated in Figure 
4-2. 
Figure 4-2 also shows that over the eight-week period, the rate of degradation 
over ionic strength range 0.1 - O.3M was approximately the same. This 
indicates that the changes in chitosan conformation over this ionic strength 
range have little effect on its stability in aqueous solution. 
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Figure 4-2: Effect of Ionic strength on reduced viscosity of chitosan solution (1 mglmJ 
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4.2.2.3 Effect of pH 
The main mechanism of degradation of chitosan in aqueous solution is 
believed to be acid degradation (V8.rum et al. 2001); therefore it would be 
expected to observe increased degradation in more acidic conditions, Le. low 
pH. 
Figure 4-3 shows the decrease in viscosity over an eight week period in 
chitosan solutions of different pHs. The initial viscosities at each pH are 
similar, indicating that in the pH range studied there was little change in 
chitosan conformation. It was also observed that the rate of chitosan 
degradation, as indicated by decrease in viscosity, increased as the pH of the 
chitosan solution increased (Table 4-3). This would suggest that chitosan is 
more stable in acidic conditions. In contrast, V8.rum et al. (2001) showed for a 
chitosan of different DA (DA = 62%) that as the pH of solution decreased, 
degradation increased, i.e. chitosan was susceptible to acid degradation. 
An estimation of sedimentation coefficients can give a further indication of 
stability of chitosan stored at different pHs. Figure 4-4 and Figure 4-5 show 
the apparent sedimentation coefficient distributions for each sample. The peak 
maximum gives S20,w and the peak width gives an indication of the relative 
polydispersity of the sample (complications through particle diffusion obscure 
interpretation of absolute polydispersity). The area' under the curve can be 
used to calculate the concentration of the species, however, it should be noted 
that this concentration does not include small fractions that may not have 
sedimented from the meniscus or large, aggregated fractions that will have 
rapidly sedimented to the base. Figure 4-4 shows the sedimentation 
coefficients of chitosan stored at pH 1.28. A significant decrease, as 
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expressed in Svedbergs, was observed in the first month, with minimal change 
in the second month. This decrease in sedimentation coefficient would appear 
to indicate that the chitosan has degraded by approximately 27% in the first 
month, with a much-reduced degradation ( ~ 2 % ) ) in the second month. These 
results are further supported by the weight-average molecular weights 
determined using sedimentation equilibrium (Table 4-4). 
For the chitosan solution stored at pH 5, a steady, progressive decrease in the 
sedimentation coefficients and narrowing of the peak was observed over the 
two month period (Figure 4-5), resulting in a decrease of approximately 35%, 
~ . e . . greater than for the chitosan stored at pH 1.28. 
Degradation occurred at a faster rate at a lower pH, Le. in more acidic 
conditions, which is in agreement with Varum et al. (2001), however after two 
months the extent of degradation in both cases was comparable. 
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Figure 4-3: Effect of pH on reduced viscosity of chitosan solution (1 mglml CL210; 
I=O.2M, Temp=20°C, n=3) 
• pH 1.28 
• pH4 









0 2 4 6 8 
Time (weeks) 
Table 4-3: Degradation rates for cbitosan solutions at different pHs 
% Decrease in Viscosity 
k (week-I) 0-8wks 0-2wks 2-8wks 
pH 1.28 0.107 27 9 17 
pH4 0.317 46 24 22 
pH5.5 0.442 64 39 24 
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Figure 4-4: Distribution of apparent sedimentation coefficients for chitosan (Imglml) in 
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Table 4-4: Sedimentation coefficients (from sedimentation velocity analysis) and weight-
average molecular weight (from sedimentation equilibrium) for cbitosan (ImglmJ) in 
O.2MHCI 
Time S*20,w Mw 
(S) (glmol) 
0 2.29 ± 0.01 174,000 
1 month l.68 ± 0.01 120,000 
2 months l.63 ± 0.01 121,000 
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Figure 4-5: Distribution of apparent sedimentation coefficients for chitosan (lmgfml) in 
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Table 4-5: Sedimentation coefficients and weight-average molecular weights for chitosan 
(lmgfmJ) in O.lM Acetate buffer, pH 5 
Time s*zo,.,.. M.,.. 
(S) (glmol) 
0 1.85 ± 0.01 176,000 
1 month 1.44 ± 0.01 107,500 
2 months 1.18±0.01 106,500 
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It can be seen from Figure 4-3 and Table 4-3 that the difference in degradation 
rates due to the pH of solution occurred in the first two weeks. After this 
period, degradation occurred at a similar rate, irrespective of the pH of 
solution. 
Again, a possible explanation for this may be a change in the conformation of 
chitosan. The initial viscosity reading for each sample was taken one hour 
after dissolution. During the subsequent two weeks degradation can occur at 
two possible sites; the glycosidic bonds linking the glucosamine residues or 
cleavage of the acetyl group on C4. 
Breaking of the glycosidic bonds would result in a decrease in viscosity since 
the length of the chitosan chain would decrease. However, cleavage of the 
acetyl groups would results in more amide groups on the chitosan chain. In 
acidic solutions these amide groups are protonated, which might result in a 
more extended conformation and therefore an increase in viscosity. At low 
pH there are more hydrogen ions present which increases the chances of acetyl 
groups being cleaved from the chitosan chain as well as cleavage of the 
glycosidic bonds. Any increase in viscosity due to changes in conformation 
could mask the decrease in viscosity due to degradation of the chitosan chain, 
making it appear that chitosan degrades fastest in a high pH solution. 
To confirm that acid hydrolysis does occur, the experiment reported by Varum 
et al. (2001) was repea,ted. This experiment was carried out at 'two chitosan 
concentrations and the results can be seen in Figure 4-6. The rate of 
. degradation increased as the acid concentration increased, which agrees with 
the. data for a chitosan of higher DA studied by Varum et al. (2001). 
Interestingly, the initial concentration of chitosan had an effect on the 
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degradation rate. Degradation appeared to occur faster at higher chitosan 
concentrations and this is probably due to the increased number of glycosidic 
bonds available for cleavage. 
Comparing Varum's results for a chitosan of DA=62% with the present data 
(DA::::::18%) obtained at the same concentration and using the same 
experimental conditions (Figure 4-7), there was a significant difference in the 
degradation rates (10 fold difference). This difference can be explained by the 
structural difference in the chitosans used in the two experiments (degree of 
acetylation), and is considered further in the Chapter 5. 
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Figure 4-6: Degradation rate constants as a function of acid concentration (HCI), 
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Figure 4-7: Degradation rate constants as a function of acid concentration (HCI), 
determined by the viscosity assay at 60°C. The data of Virum et aL (2001), measured at 
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4.2.2.4 Effect of Scavenging agents 
Another proposed mechanism of chitosan degradation is Oxidative Reductive 
Degradation (ORD). ORD involves a series of free radical reactions that 
ultimately lead to chain scission. 
Figure 4-8 to Figure 4-10 show the degradation of chitosan under different 
acidic solutions, in the presence of various scavenging agents, measured by 
changes in the reduced viscosity of the chitosan solution. 
As seen in Figure 4-3, as the pH of the solution increased, the rate of 
degradation increased, and this effect also occurred in the presence of 
scavenging agents (Figures 4-8 to 4-10). This may be explained by changes in 
chitosan conformation (see section 1.2.1.3.). At pH 1.28 and pH 5.5 (Figure 
4-8 and Figure 4-10) the effect of scavenger on degradation was seen to be 
minimal. By contrast, at pH 4 (Figure 4-9), the presence of scavenger in the 
solution increased the stability of chitosan by approximately 18% (based on 
reduced viscosity after 8 weeks), which is not considered significant. 
Figure 4-4 and Figure 4-11 show the degradation of chitosan at pH 1.28, with 
or without thiourea. In the absence of thiourea it can be seen that the 
sedimentation c o e f f i c i e n t , s ~ o w ' ' decreased rapidly over the first month with , 
minimal degradation in the second. Whereas, when thiourea was present 
(Figure 4-11) minimal degradation occurred over the one-month period. This 
would indicate that thiourea increased the solution stability of chitosan. 
However, comparing the initial distribution curves (time = 0) for each sample, 
. there was a marked difference. In the absence of thiourea the curve was very 
broad and flat, whereas with thiourea present, it was narrower and taller. It 
would have been expected that at the'start of each study, the sedimentation 
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coefficients for the two samples would have been similar and have a similar 
distribution. The differences in the initial distributions may be due to the 
presence of thiourea. 
The molecular weight detennined (using sedimentation equilibrium) at each 
time point (Table 4-4; pH 1.28) are in good agreement with the change in 
sedimentation coefficients for those samples not containing thiourea. 
However in the presence of thiourea, the initial calculated molecular weight 
was higher than expected (Table 4-6; pH 1.28). Again this may be due to 
some effect of thiourea on the confonnation of chitosan. 
Figure 4-5 and Figure 4-12 show the degradation of chitosan at pH 5, with or 
without thiourea. The results obtained are similar to those at pH 1.28 and 
again suggest that thiourea has had some effect on chitosan, possibly a 
confonnation effect. 
By studying the change in reduced viscosity at 60°C (Figure 4-13), the results 
indicate that as acid concentration increased the rate of degradation increased, 
which is suggestive of acid hydrolysis. However, the presence of thiourea 
does not have a significant effect (to.05,3df = 3.182; t = 1,23 therefore not 
significant) on the degradation rate (Table 4.8). 
In conclusion, .acid hydrolysis does appear to be the main mechanism by 
which degradation of chitosan occurs. There may be Some oxfdative reductive 
degradation due to free .radicals but this appears to be negligible. 
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Figure 4-11: Distribution of sedimentation coefficients for chitosan (1mg/ml) in O.2M 
HCI (pH 1.28) + 7mM Thioorea before and after storage for one month. No significant 
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Table 4-6: Sedimentation coefficients and molecular weight for chitosan (1mg/ml) in 
O.2M HCI (PH 1.28) + 7mM Thioorea 
Time 0 S20,w (S) M,,(glmol) 
Start 1.80 ± 0.01 251,000 
1 month 1.74 ± 0.01 128,500 
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Figure 4-12: Distribution of sedimentation coefficients for chitosan (lmglml) in O.IM 
Acetate buffer, pH 5 + 7mM Thiourea before and after storage for one montb, (n=3) 
5 ~ ~ ~ ~ n t h h I 
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o + - ~ ~ ~ ~ ~ r - - ~ ~ r - ~ ~ ~ ~ ~ ~ ~ ~
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 
s*:1O.W (Svedberg) 
Table 4-7: Sedimentation coefficients and molecular weigbt for cbitosan (1 mglml) in 
O.IM Acetate buffer, pH 5 + 7mM Thiourea 
Time ° S20,w (S) Mw (glmol) 
Start 1.49 ± 0.01 149,500 
1 month 1.35 ± 0.01 87,000 
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Figure 4-13: Degradation rates of chitosan as a function of acid concentration in the 
plUence or absence of thiourea (n=3) 
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Table 4-8: Rate of degradation of chitosan (0.5 mwml) in different acidic solutions 
Degradation Cone BCI (M) 
Rate 0.4 0.2 0.1 0.01 
(x 10-6 min-l ) 
Without 11.33 ± 2.3 3.67 ± 0.31 l.36 ± 0.19 0.51 ± 0.12 
Thiourea 
With 10.30 ± 0.5 3.67 ± 0.63 l.55 ± 0.44 0.53 ± 0.16 
Thiourea 
-106-
Chapter 4: Effect of Solvent Characteristics or Solvent Parameters on 
Degradation of Chitosan 
4.3 Multi-factorial Study 
So far in this chapter the effect of several environmental parameters on 
chitosan stability have been assessed individually. However, in a 
pharmaceutical fonnulation, several parameters will be encountered. In this 
... 
study four factors are looked at using a two level factorial design. 
4.3.1 Materials and Methods 
Degradation of chitosan was followed using viscosity measurements. 
Chitosan solutions were prepared in triplicate according to the details given in 
Table 4 ~ 9 . . Each sample was dissolved in O.1M acetate buffer at the specified 
pH and ionic strength and contained 0.15 mg/ml benzalkonium chloride as a 
preservative to prevent bacterial growth. Each sample was stored in closed 
glass bottles (clear) at the appropriate temperature (25 or 40°C) and sampled 
at two week intervals. 
4.3.1.1 Viscosity data 
Sample and solvent flow times were measured at 25°C using a 2 ml Ostwald 
viscometer. The reduced viscosity calculated using equation (2-16). 
At set time points of 2 weeks, Imonth, 2 months and 3 months, a sample of 
each formulation was examined using viscosity as an indication of the degree 
of degradation ( ~ s s described in section 2.2.2.3.). 
4.3.1.2 Statistical Analysis 
Statistical analysis of the viscosity data collected over the study period was 
carried out using a computer software package: Design Expert (Stat-Ease, Inc . 
. 2000). The package enables data from factorial design to be analysed and the 
significant factors are selected using ANOV A. 
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Table 4-9: Details of samples 
Sample CODC. Chito$aD IoDic Strength pH Thiourea 
(JD2/ml) M CoDC(mM) 
1 1 0.1 4.0 0 
2 1 0.1 5.5 7 
3 1 0.3 4.0 7 
4 1 0.3 5.5 0 
5 5 0.1 4.0 7 
6 5 0.1 5.5 0 
7 5 0.3 4.0 0 
8 5 0.3 5.5 7 
Table 4-10: Percentage Initial viscosity for stability study 
Sample 1 weeks 4 weeks 8 weeks 11 weeks 
1 66± 10 40± 14 51 ± 11 51 ± 12 
2 79±2 72±7 66±4 68 ±2 
3 76±6 73 ±6 69±7 67±3 
4 70±8 59±6 51 ±4 48 ± 5 
5 69±3 58±6 51 ±2 47±2 
6 48± 1 37 ± 1 27± 1 23 ± 1 
7 64± 1 55 ± 1 45 ± 1 41 ±2 
8 60±7 53 ±5 44±5 39±4 
Initial viscosity of all samples IS 100% 
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4.3.2 Results 
This study highlights the significant factors for chitosan stability. These were: 
pH, chitosan concentration and time. As was indicated in section 4.3.2., the 
ionic strength of the solution did not have a significant effect on degradation 
rate, and the presence of a scavenging agent did not improve stability. 
The ANOVA analysis of the data obtained in this study also showed that ionic 
strength and presence of a scavenging agent did not have a significant effect 
on chitosan stability in solution (P = 0.10 and P = 0.13 respectively). For the 
other factors studied (pH, chitosan concentration, time), the ANOVA results 
showed a significant effect (Time: P = 0.01; pH: P = 0.05; chitosan 
concentration: P = 0.04). 
Model graphs produced using the Design Expert software (Figure 4-14) show 
the effect of each significant factor on solution viscosity. From the graph for 
pH it can be seen that there was slightly increased stability at a low pH, but the 
difference was not high over the pH range studied here. 
In conclusion, acid hydrolysis of chitosan does occur, however, over the pH 
range which is acceptable for nasal formulations there was little difference in 
the observed degradation rates. 
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Chapter 5: Effect of Structural Factors on 
Degradation of Chitosan 
5.1 Introduction 
The structural properties of chitosan have an effect on its conformation and 
also on its functional applications. The lower the degree of acetylation of 
chitosan the more extended its conformation in solution which may make it 
more susceptible to acid degradation and attack from free radical species. 
However, it has also been stated that the charged amine groups can protect the 
subsequent glycosidic oxygen against protonation, which is the first stage in 
acid hydrolysis (Roberts 1992). 
Schipper et al. (1996/9) looked at the influence of molecular weight and 
degree of acetylation on chitosan's ability to function as an absorption 
enhancer. Chitosans with a low degree of acetylation (1 and 15%) were active 
as absorption enhancers at low and high molecular weights. However, these 
chitosans displayed a clear dose-dependent toxicity. Chitosans with degrees 
of acetylation of 35 and 49% have been shown to enhance transport of 14C_ 
mannitol and with low toxicity, but only if a high molecular weight material is 
used. So it is possible to select chitosans with maximal effect on absorption 
and minimal toxicity. 
In this chapter the effect of degree of acetylation and molecular weight on 
degradation are investi8,Rted and its attempted to relate this to the selection of 
the most appropriate chitosan for nasal delivery of therapeutic proteins and 
peptides. 
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5.2 Effect of molecular weight and degree of acetylation 
on degradation 
5.2.1 Materials and Methods 
The degradation of five chitosan samples (Table 5-1) was investigated over a 
one-month period. Samples were prepared in triplicate at a concentration of 2 
mg/ml in O.2M acetate buffer, pH 4.3, and stored at ambient temperature in 
clear glass, closed containers. 
Table S-l:Physical characteristics for chitosan samples 
ChitoS80 G112 G114 G214 G213 0213* 
Molecular 42400 129000 172000 203000 207500 
Weight* 
Degree of 30 7 4 17 20 
Acetylation (%) 
* Average molecular weight determmed usmg SEC-MALLS ID 0.2 M acetate buffer, 
pH 4.3 
Degradation of the chitosan samples was monitored using viscometry and 
SEC-MALLS. Reduced viscosities were determined for each sample 
(temperature 20.0°C) at one week intervals using equation (2-16), Chapter 2. 
Changes in reduced viscosity were used as an indication of degradation as 
described in section 2.2.2.3., Chapter 2. At two week intervals, the molecular 
weight of each chitosan sample was determined by SEC-MALLS using the 
method described in section 2.2.3.3., Chapter 2. 
5.2.2 Results and Discussion 
Table 5-2 and Table 5-3 show the reduced viscosities and the molecular 
weights for the chitosan samples over the one month period. The decrease in 
both reduced viscosity and molecular weight is also indicated as a percentage 
of the initial viscosity or molecular weight. Comparing the percentage 
decrease for the two parameters, it can be seen that reduced viscosity 
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measurements are a good indication of degradation since for all the chitosans 
except chitosan G 112, the percentage decrease is in very good agreement. For 
chitosan G 112, the percentage decrease at two weeks is in good agreement but 
at four weeks the percentage results are 74% for the reduced viscosity and 
40% for the molecular weight. The reduced viscosity was determined at one 
week intervals and based on the decrease observed over the first three weeks, a 
percentage viscosity of 74% at four weeks seems reasonable. This suggests 
that the molecular weight determined using SEC-MALLS is incorrect. This 
may be due to the low molecular weight of this chitosan and the column 
system used may not have produced enough separation for accurate 
measurement of the molecular weight below 30000kDa. 
Figure 5-1 shows the decrease in reduced viscosity of the chitosan samples 
over the one-month storage period in order of decreasing degree of acetylation 
and increasing molecular weight. With the exception of chitosan G112, the 
rate of degradation decreases with decreasing degree of acetylation. As the 
degree of acetylation decreases, the number of charged amino groups present 
on the chitosan chain will increase. As stated by Roberts (1992), the charged 
amino group is believed to protect the subsequent glycosidic oxygen against 
protonation, the. first stage in acid hydrolysis. This theory is supported by the 
results obtained here. Chitosan G 112 showed less d ~ o n n than the other 
samples, despite having the highest degree of acetylation. This may be due to 
the low starting molecular weight of this chitosan sample, and hence shorter 
chain length. V8rum et al. (2001) also examined the effect of degree of 
acetylation of degradation, and found that as the degree of acetylation 
decreased, the rate of degradation decreased (see Figure 5-2). 
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The effect of molecular weight on degradation was not as apparent as that of 
the degree of acetylation. No trend in the extent of degradation was observed 
with increasing molecular weight. Molecular weight may play a role in the 
extent of degradation but the range of molecular weights studied here may be 
too narrow for any trend to be observed. The results observed here would 
suggest that the main structural factor affecting degradation is the degree of 
acetylation. 
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Table 5-2: Reduced viscosity values (ml/g) for chitosan samples stored over a one-month 
period and as a percentage of the initial viscosity 
Cbitossn »an 
0 9 14 21 28 
G1l2 142 124 I 88% 124 I 88% 115 81% 105 74% 
±1O ±6 I ±3 ±2 ±4 
G114 404 361 I 89% 356 88% 348 86% 289 72% 
±5 ±8 I ±6 I ±4 , ±3 
G214 911 800 I 88% 787 I 86% 751 82% 686 75% 
±21 ± 14 ± 18 ±11 ±8 
I 
G213 824 643 I 78% 587 71% 532 65% 393 48% 
± 15 ± 1O I ± 10 I ±6 ±7 
I I 
G213* 989 760 77% 714 72% 648 66% 423 43% 
±22 ± 11 I ±13 ±1O I ±9 
Table 5-3: Molecular weigbt determined using SEC-MALLS for cbitosan samples stored 
over one-month period 
Chitosan Days 
0 14 28 
G112 42400 37200 16900 
88% 40% 
±3000 ±5700 ±3600 
G114 129000 101000 90500 
78% 70% 
±6000 ± 3000 ±2100 
G214 172000 140000 122000-
81% 71% 
±6000 ±3700 ±4000 
G213 203000 140000 99000 
69% 49% 
± 8000 ±4000 ±4000 
G213* 207500 160000 119000 
77% 57% 
±8000 ± 1500 ±6300 
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Figure 5-2: Degradation rate constant as a function of DA of the chitosan, determined by 
the viscosity assay at a chitosan concentration of 1.Smgfml in O.4M HCI at 60°C. 
Adopted from VArum et aL (2001). 
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5.3 Comparison of degradation of two chitosans 
differing in degree of acetylation 
5.3.1 Materials and Methods 
In this study the aim was to investigate the effect of degree of acetylation on 
degradation over a range of pH. Two chitosans were chosen; these were 
chitosan 0213* and chitosan 0214. These chitosans have similar molecular 
weights, 207,500 Da and 172,000 Da but different degree of acetylation, 20% 
and 4%, respectively. Solutions of each chitosan were prepared in either 0.2M 
HCI (PH 1.28) or O.1M acetate buffer (PH 4 or 5.5) at a concentration of 
1 mglml and stored in clear glass, closed containers at ambient temperature. 
The degradation was monitored by measuring the reduced viscosity of each 
solution over a one-month period (see section 2.2.2.3., Chapter 2 for details). 
5.3.2 Results and Discussion 
From Figure 5-3 it can be seen that chitosan 0214 appeared to degrade at a 
slower rate than chitosan 0213* over the one month storage period. Chitosan 
0214 has a lower degree of acetylation, which could account for the slower 
degradation. As previously stated, the lower the degree of acetylation, the 
slower the degradation due to the charged amino groups protecting the 
glycosidic oxygens from protonation (Roberts 1992). 
The effect of pH on chitosan degradation was also investigated. Both 
chitosans showed increased degradation with increasing pH (Table 5-4). The 
same result was observed in section 4.3.3. As discussed in section 4.3.3, the 
apparent increased stability of chitosan at low pH may be due to changes in its 
conformation. During degradation, deacetylation may also occur, which could 
lead to a more extended conformation masking the decrease in viscosity 
caused by chain scission. 
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Figure 5-3: Degradation of cbitosans G214 and G213* stored in various pH solutions 
over an 8-week period 
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Table 5-4: Reduced viscosity values for chitosans G214 and G213* solutions stored at 
various pHs over an 8-week period 
Chitosan Days 
pH 0 16 44 57 
1.28 645 556 86% 531 83% 504 79% 
G213* ±57 ±1l ±1l ±13 
4 616 492 80% 452 73% 412 67% 
± 16 ± 16 ± 15 ±6 
5.5 673 527 79% 472 70% 442 66% 
±60 ± 12 ±6 ±4 
1.28 629 543 86% 545 87% 543 86% 
G214 ±60 ±3 ±6 ±8 
4 598 543 91% 484 81% 464 78% 
±26 ±5 ±8 ±3 
5.5 488 438 90% 410 84% 377 77% 
±37 ±9 ± 12 ±1l 
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Chapter 6: Nanoparticle Preparation 
6.1 Introduction 
The absorption enhancement abilities of chitosan are in part due to ionic 
interaction with sialic acid residues in mucus. By using nanopartic1es to 
deliver a therapeutic protein, it is thought that the interaction between the 
protein and the nasal mucosa would be intensified (Fel'lUindez-Urrusuno et al. 
1999). Also, a high concentration of the protein can be achieved at the site of 
absorption leading to increased absorption. 
Chitosan nanoparticles are formed by ionotropic gelation with the anionic 
counterion tripolyphosphate pentasodium - TPP (Fel'lUindez-Urrusuno et al. 
1999). lonotropic gelation is a very mild process and occurs when the 
positively charged amino groups on chitosan interact with the negatively 
charged tripolyphosphate ions. Tripolyphosphoric acid (HSP301O) is a weak. 
polyprotic acid-like phosphoric acid. When TPP is dissolved in water it 
dissociates into both hydroxyl ions (OH) and tripolyphosphoric ions ( P 3 0 ~ O ' '
weight anions to cross-link chitosan was found to be much simpler and milder 
(Shu and Zhu 2002). It was found that polyphosphate only bound on the 
surface of chitosan droplets, while TPP could diffuse into the chitosan droplets 
or films freely to form ionically cross-linked beads or films. 
Chitosan nanoparticles prepared using this method show an excellent capacity 
for association with proteins such as BSA, tetanus toxoid or insulin. The 
mechanism of association of proteins to chitosan nanoparticles is mediated by 
the ionic interaction between both macromolecules. For example, insulin 
when dissolved in NaOH is negatively charged (PI 5.3), and electrostatic 
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interaction with the positively charged amino groups on chitosan is favoured. 
This mechanism was also supported by the observed partial neutralisation of 
the nanoparticle surface charge with increasing association with insulin 
(Femandez-Urrusuno et al. 1999; Janes et al. 2001). Although proteins of 
positive charge can form complexes with chitosan, other mechanism are 
involved in their association with chitosan nanoparticles. These include 
hydrophobic interactions, hydrogen bonding, other physicochemical forces 
dependent upon the specific nature of the associated protein and physical 
entrapment caused by gelation of chitosan with TPP in nanoparticulate form. 
These mechanisms enable significant amounts of insulin (15-30%) to be 
associated with the chitosan nanoparticles even at a pH where insulin is 
predominantly positively charged (Janes et al. 2001). 
In this chapter, the yield of nanoparticles is studied using various methods and 
the effect of chitosan properties on yield are also examined. 
6.2 Methods 
6.2.1 Preparation of Nanoparticles 
Chitosan nanoparticles were prepared using chitosan CL210 as described in 
section 2.2.4.1., Chapter 2. The ratio of chitosan to tripolyphosphate 
pentasoidum (TPP) was 6:1, as used by Dyer et al. (2002). 
6.2.2 Estimation of yield and loading of chitosan 
nanoparticles 
As with any manufacturing or production process it is important to determine 
. the yield of the final product so that the efficiency of the process can be 
evaluated. The most commonly used method for the estimation of 
nanoparticle yield is to determine the . dry weight of the nanoparticles. An 
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alternative method is to determine the concentration of chitosan in the 
supernatant layer using the ninhydrin assay. The details of these methods are 
described below. 
6.2.2.1 Dry Weight rleld 
Triplicate samples of nanoparticle suspension (1Oml each) were transferred to 
pre-weighed glass tubes and centrifuged at approximately 3660 rpm for 30 
minutes. The supernatant was discarded and the remaining pellet placed in an 
oven at 100°C until a constant weight was reached. 
The theoretical weight of the nanoparticle was based solely on the weight of 
chitosan and TPP added to the nanoparticle mixture. For nanoparticles 
prepared at a 6:1 ratio (chitosan:TPP) the theoretical yield was 16.69mg. 
Yield(%) = Weight dry nanoparticle xl 00 
Theoretical Yield 
(6 -1) 
For insulin loaded nanoparticles it is important to determine how much insulin 
is encapsulated. The amount of insulin present in the supernatant was 
determined using HPLC (as described in section 2.2.7) and from this the 
Loading Efficiency (LE) and Association Efficiency (AB) can be calculated. 
Total Insulin - Amt Insulin in Supernatant 100 LE = . . x (6-2) 
Dry weIght of nanoparticles 
= Total Insulin - Amt Insulin in Supernatant xl 00 (6 _ 3) 
AE Total Insulin 
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6.2.2.2 Measurement of Chitosan in supernatant 
The amount of chitosan present in the supernatant layer after centrifuging of 
the nanoparticle suspension can be determined using the ninhydrin assay (see 
section 2.2.5., Chapter 2). This assay is based on the reaction of ninhydrin 
with a primary amino group such as found on chitosan. The reaction results in 
a coloured product, diketohydrindylidene-diketohydrindarnine (Ruhemann' s 
purple), which has a A.max at 570 nm. By preparing a standard calibration 
curve from solutions of known chitosan concentration, it is possible to 
determine the amount of chitosan present in the supernatant. 
Yield (%) = Total Chitosan ~ ~~ t t ~ ~ i t o s a n n in Supernatant xl 00 (6 _ 4) 
o tosan 
6.2.2.3 Estimation of Insulin Loading using AUC 
The loading efficiency and association efficiency of nanoparticles can be 
calculated by measuring the insulin in solution using HPLC, and substituting 
this value into equations (6-2) and (6-3), respectively. 
An alternative method is to run a sedimentation velocity type experiment on 
the analytical ultracentrifuge using absorption optics. The theory behind this 
is that by using UV optics, the movement of insulin, both encapsulated and in 
solution can be ,observed down the cell since chitosan will be invisible. For 
UV optics, the material being studied has to possess a chromophore to absorb 
the UV light. Insulin, like most proteins possesses a chromophore and a full 
UV scan showed that A.max was at 28Onm. Since chitosan does not possess a 
, chromophore it will not absorb light in the UV region and should be invisible 
on the scans recorded. 
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Sedimentation velocity experiments were run at 2000 rpm and 45000 rpm for 
both chitosan and insulin-loaded nanoparticles. The results are discussed in 
the next section. 
6.3 Results 
6.3.1 Comparison of yields from dry weight and ninhydrin 
assay 
The results from both methods of determining nanoparticles yield were 
compared in order to determine the validity of each method. These results are 
shown in Table 6-1. 
Table 6-1: Yields for cbitosan nanoparticles as determined using dry weigbt and tbe 
ninbydrin assay (0=3) 
Method Chitos8n-inlluliD CbitosaD only 
naDopartieles nanoparticles 
Dry Weight 26±4 15 ±2 
Ninhydrin assay 29± 1 -
From comparison of the results obtained using insulin-loaded chitosan 
nanoparticles it would appear both methods produce similar results. This was 
confirmed by T -test that showed the two sample groups were not significantly 
different (to.05,3df = 3.182, t = 1.22). 
For the estimation of yield using the ninhydrin assay the most important step 
in the method is the centrifugation of the nanoparticle suspension to separate 
the nanoparticles from the supematant layer. If the centrifugation speed and 
duration is not sufficient to cause all the nanoparticles to sediment to the 
bottom of the sample tube, underestimation of yield could occur. To verify 
that the chosen speed and duration of centrifugation was sufficient to cause 
complete sedimentation of nanoparticles present, a second centrifugation step 
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was included and the supematant after both step analysed using the ninhydrin 
assay. The chitosan concentration detennined after each step was the same 
indicating that a speed of 3660 rpm and duration of 90 minutes is adequate to 
cause complete sedimentation of the nanoparticles. 
Inclusion of insulin in the nanoparticles appears to result in increased yield. 
This could be due to interaction occurring between insulin and chltosan as 
well as between chltosan and TPP. However, the magnitude of this enhanced 
yield should be treated with caution, as the amount of insulin incorporated in 
the nanoparticles was not included in the calculation of yield. 
6.3.2 Loading of nanoparticles estimated using AUC 
6 . 3 . 2 ~ 1 1 Insulin Ntlnoptlrticles 
Figure 6-1 shows a theoretical representation of the sedimentation of the 
nanoparticles during a sedimentation velocity experiment at 2000 rpm and 
45000 rpm. At 2000 rpm, insulin incorporated in the chltosan nanoparticles 
should begin to sediment (Case A), whereas insulin that is free in solution 
should not (Case B). This is due to the difference in the molecular weight of 
the nanoparticles and insulin. Case C shows the theoretical sedimentation 
profile when insulin is partially incorporated in the chltosan nanoparticle. 
Sedimentation of the insulin incorporated in the nanoparticles will occur but 
the baseline remains high due to the free insulin in solution, which does not 
sediment at 2000 rpm .. At 45000 rpm (case D), insulin in solution should in 
theory begin to sediment, although due to the low molecular weight (6000 
Da), complete sedimentation to the cell base will most likely not occur. 
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Figure 6-1: Diagrammatic representation of sedimentation of insulin loaded chitosan 
nanopartieles 
Case A: Insulin fully incorporated - 2000 rpm 
o 
r (distance from top of cell) 
Case B: Insulin NOT incorporated (NB assuming chitosan nanopartieles do not have 
significant turbidity at 280um) - 2000 rpm 
r 
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6.3.2.2 Results from sedimentation experiments - insulin nanoparticles 
Figure 6.2 shows the actual sedimentation profile for insulin (1.5 mglml) at 
high and low centrifugation speeds. At 2000 rpm, no movement of insulin 
down the centrifuge cell was observed. This is due to the low molecular 
weight of insulin (MW - 6000Da). At 45000 rpm insulin began to 
redistribute. 
As previously mentioned, since free insulin does not show significant 
redistribution at 2000 rpm, sedimentation observed at this speed should be due 
to insulin incorporated in the chitosan nanoparticles. Figure 6-3 shows the 
sedimentation of insulin loaded chitosan nanoparticles. At 2000 rpm 
sedimentation can be seen occurring over the three-hour period studied. This 
is likely to be due to the insulin encapsulated in the chitosan nanoparticles 
since chitosan should not absorb or scatter DV light at 28Onm. 
Comparison of Figure 6-3 (a and b) reveals a residual absorbance at the 
meniscus after the nanoparticles have begun to sediment to the base of the cell 
at 2000 rpm. This shows that some of the insulin has remained free in 
solution. By determining the v ~ u e e of this residual absorbance, the quantity of 
insulin that has been encapsulated in the chitosan nanoparticle can be 
estimated. 
A control experiment was carried out of chitosan only nanoparticles to show 
that chitosan does not absorb or scatter DV light at 280 nm.' The scans 
, obtained at 2000 rpm and 45000 rpm are shown in Figure 6-4. It was hoped 
that these scans would show, no absorbance, however the data obtained was 
very.similar to that in Figure 6-3 for the insulin-loaded chitosan nanoparticles. 
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Due to the density of the chitosan nanoparticles, they cause scattering of UV 
light which is picked up by the XLA AVC. 
Comparing Figure 6-3(a) and Figure 64(a), a difference in the level of 
absorbance can be seen (approximately 2.2 A and 1.4 A respectively). The 
difference in absorbance between the two nanoparticle solutions would be due 
to the insulin incorporated in the nanoparticles in Figure 6-3 (a), however, 
since chitosan nanoparticles cause scattering of light, this may mask some of 
the absorbance from insulin so a quantitative measure of the insulin 
incorporated in the nanoparticles cannot be obtained. 
In Figure 64(a), no residual absorbance was observed at the meniscus after 
the nanoparticles began to sediment, reinforcing that the residual absorbance 
observed in Figure 6-3(a) was due to free insulin in solution. 
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Figure 6-2: Sedimentation profiles of Insulin solution (1.5 mglml) 
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6.3.2.3 Results from sedimentation experiments - myoglobin 
RaRoparticies 
Since chitosan nanoparticles scattered light in the DV region, the method was 
evaluated using myoglobin incorporated into chitosan nanoparticles since 
myoglobin absorbs light in the visible region (A.max = 410nm), and at the higher 
wavelength the nanoparticles should scatter less (scattering is approximately 
proportional to 11"-4) 
Sedimentation velocity scans obtained on the XLI AUC at 2000 and 45000 
rpm should show the same behaviour for myoglobin as for insulin, with 
sedimentation only occurring at the higher speed. 
Figure 6-5 shows the sedimentation profiles for myoglobin loaded chitosan 
nanoparticles and chitosan only nanoparticles at 2000 rpm. The profiles 
obtained are the same in both the presence and absence of myoglobin. This 
shows that firstly chitosan nanoparticles still scatter light at 410 nm, and 
secondly that myoglobin does not appear to be incorporated in the 
nanoparticles since there is no difference in the level of absorbance between 
the two formulations. 
To confirm that myoglobin was not incorporated in the nanoparticles, the 
concentration of myoglobin in the supernatant after centrifugation was 
measured using DV spectrophotometry. The result revealed that the entire 
initial amount of myoglobin added was found in the supematant after 
nanoparticle formation. There may be some error in this result due to 
fragments of nanoparticIes that were not removed by filtration. Both insulin 
and myoglobin has similar isoelectric points (PI = 5.3 and 5.5 respectively) so 
both will be negatively charged during the formation of chitosan 
nanoparticles, and thus have the potential to form electrostatic bonds with the 
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amine groups on chitosan. The main difference between the two proteins is 
their molecular weight (6000 Da and 11000 Da for insulin and myoglobin 
respectively). Since the molecular weight of myoglobin is almost three times 
that of insulin this may affect its ability to penetrate within the chitosan 
network before the nanoparticle was formed by complexatiort with TPP. It is 
also possible that myoglobin could be adsorbed onto the surface on the 
chitosan nanoparticles after formation, but the high speeds used in 
centrifugation cause it to dissociate into the supematant layer. 
-135-
Chapter 6: Nanoparticle Preparation 
Figure 6-5: Sedimentation velocity scans of Cbitosan nanoparticles at 410 om 
Ca) Chitosan nanoparticles containing myoglobin at 2000 rpm 
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6.4 Effect of physicochemical properties of Chitosan on 
nanoparticle yield and loading capacity 
The aim of this set of experiments was to investigate if the physicochemical 
properties of chitosan had an effect on nanoparticle yield and also the 
association efficiency and loading efficiency of insulin. Six different chitosan 
were studied, the details of which are given in Table 6-2. 
Table 6-2: Physicochemical properties of Chitosans used in nanoparticle preparation 
Chitosan Molecular Degree of 
Weight Acetylation 
CL210 173000 18 
G112 45000 30 
G1l4 141000 7 
G214 205000 4 
G213 263000 17 
G213* 277000 20 
The nanoparticles were prepared according to the method previously described 
in section 2.2.4. The quantities of TPP and chitosan solutions mixed were the 
same for each chitosan (quantities w«re not optimised) so that a comparison 
could be made based solely on the effect of the molecular ~ e i g h t t and degree 
of acetylation on nanoparticle production. 
Nanoparticle yield was determined using both the dry weight method (section 
6.2.2.1.) and by measuring the concentration of chitosan in the supernatant 
using the ninhydrin assay (section 6.2.2.2.). The concentration of insulin in 
the supematant was measuring using HPLC (section 2.2.7) and from this the 
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association and loading efficiency of the nanoparticles was determined. Each 
measurement was carried out in triplicate. 
6.4.1 Results and Discussion 
Table 6-3: Yields and insulin loading of nanoparticles prepared from various chitosan 
samples 
Yield(%) Association Loading 
ChitoSaD Dry Weight Chitossn Efflcieney Efficieney 
Cone. (AE)% (LE) % 
0112 61 ± 11 32±6 54±7 20±6 
0114 48 ±5 37± 1 63 ±9 29±7 
0214 26± 1 27±3 34±5 29±6 
0213 28±4 18±2 72±6 55 ± 12 
0213* 30±3 21 ±2 83 ±4 59± 5 
CL210 26±4 43 ±2 - -
6.4.1.1 Yield 
The yields obtained usmg the two methods are not consistent for each 
chitosan. For chitosan 0112, the yield obtained from the dry weight method 
was almost twice that obtained using the ninhydrin assay. As mentioned in 
section 6.3, the most important step in determining the concentration of 
chitosan in the supematant layer is the centrifugation step. It was concluded 
that the speed and duration of this centrifugation step was sufficient to remove 
all the nanoparticles from the supematant layer as no decrease in chitosan 
concentration was observed after further centrifugation. This would suggest 
that in this case the results obtained from the dry weight method might be an 
overestimation of yield possibly due to inadequate drying. 
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From the yield obtained using the concentration of chitosan in the supematant, 
chitosan CL210 resulted in the highest yield of nanoparticles. Chitosan 
CL210 is a hydrochloride salt, which contains approximately 82% chitosan 
base, whereas the other chitosans studied are all glutamate salts, which 
contains about 55% chitosan base. Therefore chitosan CL210 would contain 
more chitosan base per volume, which would account for the higher yield 
observed. By studying the results obtained from the glutamate salts, the effect 
of degree of acetylation and molecular weight can be examined (Figure 6-6). 
Neither parameter showed any trend for its effect on yield. With the exception 
of chitosan GII2, there appears to be a slight tendency for decreasing degree 
of acetylation to increase yield. This could be explained by the increase in 
charged amino groups with decreasing acetylation. This would allow more 
ionic interaction to occur between chitosan and TPP leading to an increase in 
yield. With increasing molecular weight it may have been expected that the 
yield would increase due to the longer chain lengths of the chitosan molecules 
and hence an increase in charged amino groups (Figure 6-7). This effect was 
not observed, however, it is important to remember that in this study the effect 
of degree of acetylation and molecular weight could not be studied 
independently. 
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Figure 6-6: Yield of nanoparticles produced from various chitOllao shown as a function 
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6.4.1.2 Insulin Loading 
Insulin loading of the chitosan nanoparticles was determined by measuring the 
loading efficiency and association efficiency as described in section 6.2.2.1. 
Nanoparticles produced using chitosan CL210 did not appear to encapsulate 
any insulin as the amount of insulin in the supematant was the same as the 
total amount added. 
From the results obtained using the glutamate salts, the association efficiency 
and loading efficiency of the nanoparticles appeared to increase with 
increasing molecular weight of the chitosan used (Figure 6-8). This can be 
explained by the increasing chain length of the chitosans, leading to increased 
physical entrapment of insulin. Xu and Du (2003) found, in a similar manner, 
that as the molecular weight of chitosan increased (same DA), the 
encapsulation of BSA increased. Chitosan with a molecular weight of 48 kDa 
has a relatively short chain length compared to BSA, which makes entrapment 
of BSA difficult, and so encapsulation efficiency was low. For chitosans with 
a molecular weight of 210 kDa and 115 kDa, encapsulation efficiency was 
much greater, and this was atlributed to the longer chains length of the 
chitosan molecules which could entrap a greater amount of BSA when gelated 
withTPP. 
The effect of degree of acetylation on insulin loading'did not show a distinct 
trend (Figure 6-9). Xu and Du (2003) found that as the degree of acetylation 
decreased for chitosans with the same molecular weight that the encapsulation 
of BSA increased. This was attributed to the chitosans with lower DA 
containing more functional groups that could complex with the acid groups of 
BSA and gelate with TPP so increasing the encapsulation efficiency of BSA. 
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Chitosans 0213 and 0213 * show the highest loading. This may be attributed 
to their high molecular weight and relatively low degree of acetylation (17 -
20%). 
For these chitosans it would be necessary to determine the optimal 
concentrations of chitosan and TPP, so as to further increase yield and insulin 
loading. 
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Figure 6-8: Insulin loading of nanoparticles produced from various cbitosans as a 
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6.5 Optimisation of Chitosan:TPP ratios for Chitosan 
G213 
6.5.1 Methods 
Preliminary experiments were perfonned to identify the optimal chitosan 
0213 and TPP concentrations for the achievement of ionic gelation and 
nanoparticle fonnation. A range of chitosan samples was prepared over the 
concentration range 1 - 5 mglml. To these solutions, varying amounts ofTPP 
was added and the resulting solution identified as clear (no nanoparticles 
formed), opalescent (nanoparticles present), or precipitate. 
6.5.2 Results 
The results (Figure 6-10) indicate the resulting solution characteristics at each 
ratio of chitosan and TPP. For chitosan 0213 it would appear that the most 
appropriate concentration of chitosan in the final nanoparticle solution is 
between 1 - 5 mglml and for TPP between 0.25 - 0.5 mglml. These 
concentrations are similar to those obtained by Dyer et al. (2002) who found 
that opalescent suspensions were associated with fonnulations containing 1-3 
mglml chitosan and 0.2 -0.5 mglml TPP. The chitosan studied in Dyer et al. 
(2002) was the same as that used in this study. Calvo et al. (1997) 
investigated the·optimal concentrations for chitosan S e a c ~ ~ 213 and found 
these to be in the order of 1-3 mglml for chitosan and 0.2-1.0 mglml for TPP, 
which are again in agreement with the concentrations identified in this study. 
To further determine which ratios of chitosan to TPP are most efficient i.e . 
. produce the highest yield of nanoparticles and loadinglassociation efficiency, 
several chitosanffPP ratios were chosen predicted to result in an opalescent 
solution. 
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Table 6-4: Nanoparticle yields obtained using different ratios of chitosan G213 and TPP 
Cone. Initial CS Cone. Initial Ratio Yield (%) 
solution (mg/mI) TPP solution CS:TPP Dry Chitosan 
(mg/mI) (w:w) Weight Conc. 
2 1 5.7: 1 25 ±6 39±4 
3 1 6.7: 1 19 ± 3 30 ± 12 
3 5 6: 1 30±2 42±7 
4 1 6.7: 1 25 ±2 29±3 
Table 6-5: Insulin loading of ehitosan nanoparticles at different ratios of chitosan G213 
and TPP 
Ratio CS:TPP Yield Loading Efficiency Association Efficiency 
C%) (%) 
6: 1 31 ± 5 16±2 25 ±2 
7: 1 24± 1 20±3 28 ±4 
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Table 6-4 shows the yields obtained using different ratios of chitosan to TPP. 
The highest yield was obtained when the ratio was 6: 1. In general the yield 
increased as the ratio decreased. 
The yield of nanoparticles may be expected to increase as the concentration of 
chitosan increases; however, if the concentration of TPP is not high enough, 
the level of crosslinking between the two species would not be sufficient to 
cause enough aggregation to result in nanoparticle formation. This theory is 
reinforced by the observed increased yield at lower ratios, since the 
crosslinking will be denser. Femandez-Urrusuno et al. (1999) found that by 
increasing the amount of TPP with respect to chitosan, the nanoparticle yield 
increased which reinforces our findings. 
As the ratio of chitosan to TPP increases, the surface charge in the 
nanoparticles will also increase. This may result in higher loading of insulin 
due to increased ionic interaction between insulin and chitosan. Nanoparticles 
were prepared at ratios of 6:1 and 7:1 and the yield and insulin loading 
determined. The results are shown in Table 6-5. The yield of nanoparticles 
was greatest at the lower ratio due to the increased level of crosslinking as 
explained previously (Table 6-5). The loading efficiency and association 
efficiency was lowest for those nanoparticles prepared at the lower ratio 
despite the higher yield. This can be explained due to the reduced charge on 
the nanoparticles due to increased crosslinking with TPP. As mentioned 
previously insulin loading with chitosan nanoparticles is due to ionic 
interaction with the positively charged chitosan as well as hydrophobic 
interaction, hydrogen bonding and some physical entrapment As the ratio of 
chitosan to TPP increases, the amount of remaining charged amino groups on 
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chitosan increases, and this will enable more interaction with insulin, and 
hence increased loading capacity. Fern8ndez-Urrusuno et al. (1999) also 
found that the loading capacity was affected by the insulin concentration and 
the chitosan:TPP ratio. Data indicated that insulin loading was directly related 
to the amount of insulin and chitosan but inversely related to the amount of 
TPP. This suggested that there was a competition between TPP and insulin in 
their ionic interaction with chitosan. 
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7.1 Introduction 
In this chapter the effect on chitosan stability of i) complexation of chitosan 
with tripolyphosphate pentasodium (TPP) and ii) chitosan being in the solid 
state, is investigated. Chitosan nanopartic1es, as discussed in the previous 
chapter, were formed by ionotropic gelation using TPP as the counterion. In 
order to investigate the effect of complexation, and hence storage of chitosan 
in the solid state, on the stability of chitosan it is necessary to be able to 
dissociate the complex back to the starting components. To separate the 
complex formed between chitosan and TPP requires harsh conditions which 
could degrade chitosan in the process. It was therefore decided to evaluate the 
chitosan stability using a complex formed between chitosan and insulin that 
can be dissociated by altering the pH of the solution. 
7.2 Methods 
7.2.1 Preparation of Chitosan-Insulin Complex 
A 4 mg/ml chitosan solution (chitosan 0213*) was prepared by dissolving 200 
mg chitosan 0213 in 40 ml ultra pure water and adjusting the pH to 5.5 by 
adding 0.1 M NaOH and making up the volume to 50 ml with ultrapure water. 
A 4 mg/ml human zinc insulin solution was prepared by dissolving 200 mg 
zinc insulin in 40 ml ultrapure water adjusted to pH 4.0 with O.lM NaOH . 
. When the insulin was dissolved the pH was adjusted to 7.0 with O.lM HCl and 
the volume made up to 50 ml with water. 
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The complexes were prepared by adding dropwise 50ml of 4 mglml insulin 
solution to 50ml of the 4 mglml chitosan solution under vigorous stirring with 
a magnetic stirrer. The pH of the final solution was between 5.5 - 5.7. 
The complex was divided into 10ml aliquots and stored under ambient 
conditions until the required testing date. 
7.2.2 Molecular Weight Determination 
To determine the molecular weight of chitosan after the stated storage period, 
dissociation of the complex is necessary. The isoelectirc point of insulin is 
5.3; above this pH insulin is negatively charged and will form ionic interaction 
with chitosan resulting in a complex. Below this pH, insulin becomes 
predominantly positively charged. Therefore by lowering the pH of the 
medium in which the chitosan-insulin complex is suspended, the complex will 
dissociate since both components are now positively charged, soluble and will 
repel each other. 
The 10ml aliquot was divided into two, one 5ml aliquot is centrifuged and the 
supematant removed and stored. To the supematant and the other 5 ml aliquot 
a drop of 1M HCI is added to dissociate any complex (PH of solution - 4). 
This solution is then filtered through a 0.45 J.Ull filter and analysed using SEC-
MALLS as described in Section 2.2.3.1. and the molecular weight determined. 
The use of SEC-MALLS to determine the molecular weight of chitosan in this 
solution is possible since the insulin, which will still be present in the solution, 
will not be detectable on the column system used here. 
7.2.3 Stability of Chltosan .. lnsulin Complex 
Duritig storage it is possible that the chitosan-insulin complex may dissociate. 
To determine the stability of the complex over the storage period, the amount 
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of chitosan and insulin in the supernatant was determined at each time interval 
using the ninhydrin assay and HPLC respectively (see sections 2.2.6. and 
2.2.7.). 
7.3 Results 
7.3.1 Stability of Chitosan in complex 
As mentioned in section 7.2.2., the determination of the molecular weight of 
chitosan using SEC-MALLS is possible without the removal of insulin from 
the solution since insulin is not detectable in the system used. Insulin has a 
molecular weight of 9000 kDa whereas the chitosan used in the study has an 
initial molecular weight of 207500 kDa. The system chosen will elute the 
insulin at the end of the run (volume 30ml). An example of the SEC-MALLS 
traces for insulin and chitosan 0213* are shown in Figures 7-1 and 7-2 
respectively. The insulin trace shows no recorded light scattering or 
refractive index signal during the experimental run time. 
Table 7-1 shows the molecular weight determined using SEC-MALLS for 
chitosan stored as a complex over a two-month period. Degradation of 
chitosan does occur with a decrease in molecular weight of approximately 
10% (to.05,3df= 3.182; t = 1.22 therefore not significantly different). The same 
chitosan (0213*) was stored in acetate buffer, pH 4.3 for a two-month period 
and a decrease in molecular weight of approximately 43% was observed 
(results also shown in Table 7.1). 
From these results it would appear that by storing chitosan as a complex and 
thereby in the solid state, and also possibly in nanoparticle form, the stability 
in aqueous solution is increased. However, it should be noted that the pHs of 
the two storage media were different. The complex was suspended in water at 
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approximately pH 5.7, whereas the chitosan solution was in acetate buffer, pH 
4.3. As was shown in Figure 4.6, Section 4.3.3., as the pH of the chitosan 
solution decreases, the rate of degradation of chitosan increases due to acid 
hydrolysis occurring. These effects were also shown by Vdrum et al. (2001). 
The results obtained here should therefore be treated with caution due to the 
different storage conditions. In order to clarity that storage of chitosan in 
nanoparticle form or as a complex does improve its stability, it would be 
necessary to compare its degradation in solution at the same pH as the medium 
in which the nanoparticles/complex are suspended. 
7.3.2 Stability of Chitosan-Insulin Complex 
It has been demonstrated that storage of chitosan as a complex may improve 
its stability. However, it is also necessary to show that the chitosan-insulin 
complex remains intact over the storage period. To demonstrate this, the 
amount of insulin and chitosan in the supematant was determined over the 
two-month period, as well as the total amount present after dissociation of the 
complex. The results are shown in Table 7-2. 
After two weeks, the amount of chitosan and insulin present in the complex 
has increased. This would indicate that after the initial measurement, that 
further complexation occurred. Over the next six weeks, the amount of 
chitosan and insulin complexed remained constant, indicatillg that the 
chitosan-insulin complex was steady over the two-month storage period. 
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Table 7-1: Molecular Weight of chitosan determined using SEC-MALLS after storage in 
solution and as a complex with insulin 
Time (weeks) Chitosan-Insulin Complex G213* (O.lM 
Complex SuperBatant acetate buffer, 
p84.3) 
0 204500 ± 8000 193000 ± 7000 207500 ± 8000 
4 189000 ± 9000 - 160000 ± 1500 
8 185000 ± 6000 - 119000 ± 6300 
Table 7-2: Insulin and Chitosan concentrations in complex over two-month storage 
period under ambient conditions 
Time Insulin (mglml) Chitosan (mglml) 
(weeks) Complex SuperBatant Complex SuperBatant 
0 0.67 ± 0.10 0.34 ± 0.05 0.74 ± 0.13 0.22 ± 0.10 
2 0.84 ± 0.07 0.12 ± 0.02 0.91 ± 0.17 0.05 ± 0.03 
4 0.82 ± 0.13 0.16 ± 0.03 0.93 ± 0.14 0.11 ± 0.06 
6 0.87 ± 0.08 0.15 ± 0.10 0.92 ± 0.11 0.05 ± 0.02 
8 0.83 ± 0.11 0.19 ± 0.08 0.89 ± 0.13 0:17 ± 0.09 
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Work 
In this study I have investigated the characterisation of a range of chitosan 
samples using various hydrodynamic techniques. These studies have highlighted 
the problems that are encountered when determining the molecular weight of 
chitosan due to non-ideality and how the use of SEC-MALLS can provide a quick 
and accurate measure. The main focus of the project has been the degradation of 
chitosan in solution and the possibilities of constructing stable chitosan based 
nanoparticles for nasal delivery of therapeutic proteins and peptides. 
8.1 Mo/ecular Weight Determination and Conformation 
The measurement of molecular weight of a polymer can provide information on 
its potential applications in the pharmaceutical industry. It is therefore important 
to be able to accurately measure the molecular weight by a convenient method. 
The molecular weight of chitosan was determined using two absolute techniques: 
sedimentation equilibrium using the analytical ultracentrifugation (AUC) and 
SEC-MALLS. The time required for these techniques is very different. AUC 
requires the measurement of molecular weight at several concentrations, and the 
experiment takes approximately three days to perform. Several concentrations are 
required due to non-idealiD> as was explained in Chapter 3. SEC-MALLS, on the 
other hand, only requires the measurement of the molecular weight using one 
concentration and the experiment only take one hour to perform. The effects of 
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non-ideality are negligible due to dilution of the sample that occurs as it flows 
through the column system. 
The column system chosen for SEC-MALLS provided good separation of the 
chitosan sample and there was excellent sample recovery ( ~ 9 ( ) o 1 o ) , , which 
indicated that the chitosan did not interact with the column packing material. The 
results obtained from both techniques were in good agreement showing that SEC-
MALLS can be used as a quick and simple method for the determination of the 
molecular weight of chitosan. 
Information on the conformation of chitosan can help us to understand the 
application of chitosan as a bioadhesive material in drug delivery. From the 
information we gathered using the power-law or "Mark Houwink Kuhn Sakurada 
exponents, we can see that chitosan exists as an extended coil in aqueous acidic 
solutions (power law coefficients b = 0.25 ± 0.04 and a = 0.96 ± 0.10). These 
parameters appear consistent with the data obtained from other groups 
(Anthonsen et ai, 1993, and Berth, COlfen and Dautzenberg 2002), although 
interpretations in terms of conformation can be complicated by the existence of 
possible solvent draining effects from the chain (see Berth, Colfen and 
Dautzenberg, 2002). Since chitosan exists in an extended conformation there is 
likely to be a greater chance of interaction between that negatively charged sialic 
acid groups present in the mucus lining the mucosal membranes and the positively 
charged amino groups on chitosan. This will favour increased bioadhesion and 
facilitate improved absorption of the protein or peptide that is being delivered, 
vindicating the choice of chitosan as a mucoadhesive system. 
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8.2 Degradation of Chitosan in aqueous solution 
In the first section of this thesis, the stability of chitosan was investigated. It was 
found that an increase in temperature increased the degradation rate and that 
changes in ionic strength over the range studied had no effect on degradation rate. 
The ionic strength range that was studied was narrow and it may have been found 
that over a greater range an effect on degradation may have been observed. This 
may have been due to changes in the confonnation of chitosan with larger 
increases in ionic strength. If the ionic strength were increased sufficiently, 
chitosan would exist as a coiled molecule in solution due to shielding of the 
charged amino groups along the chain. This may increase its stability, as it would 
be harder for the hydroxyl ions to penetrate into the coiled molecule and 
hydrolysis the glycosidic bonds. 
The most important factor was found to be the pH of the solution. It was found 
that as the pH of the solution decreased, i.e. as the solution became more acidic, 
the rate of degradation increased. This result indicates that acid hydrolysis, which 
results in the cleavage of the glycosidic bonds, plays an important role in the 
degradation of chitosan. 
Initial studies on the effect of pH showed the opposite effect, i.e. increased 
degradation at elevated pH, but I attributed this to incomplete dissolution of the 
chitosan under low-acidic conditions, a consequence of the cationic nature of this 
polysaccharide. Scavenging agents, which will be effective in reducing 
degradation caused by oxidative reductive degradation, were also investigated but 
showed no significant effect on degradation, suggesting that oxidative degradation 
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was not a accountable for a significant amount of chitosan degradation in 
solution. 
In conclusion, the main mechanism of degradation of chitosan in aqueous solution 
appears to be acid hydrolysis, and, encouragingly, for the pH range that would be 
used for a nasal formulation, the amount of degradation is not significant as was 
shown by the multi-factorial three month stability study. 
The effect of molecular weight and degree of acetylation on chitosan degradation 
is also worthy of serious comment. For the molecular weight range studied, no 
significant effect was observed. However, it was found that the rate of 
degradation decreased as the DA of the chitosan decreased. I attributed this to the 
increase in the number of charged amino groups on chitosan as the DA decreased, 
which protects the glycosidic oxygen from protonation i.e. the first stage in acid 
hydrolysis. As the number of charged groups on the chitosan molecule increases, 
there may also be enhanced bioadhesion which would also be advantageous in 
drug delivery via mucosal membranes. Taking into account these two parameters 
(degradation and degree of bioadhesion) it would appear that the most important 
structural parameter to consider when selecting a chitosan is its degree of 
acetylation. 
B.3 Nanopartic/e Production and Chitosan Stability 
For the nasal delivery of'insulin, current research is focussed on the use of 
chitosan nanoparticies. These possess both the mucoadhesive and absorption 
enhancing properties of chitosan as well as delivery the drug to the site of 
absorption in a high concentration. 
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The effect of molecular weight and degree of acetylation of the yield and loading 
capacity of chitosan nanoparticles was investigated. It was found that to improve 
the yield of nanoparticles a decrease in the degree of acetylation, DA of the 
chitosan molecule was beneficial. This can be explained by the increase in the 
number of charged groups on the chitosan molecule, which increases the possible 
sites for interaction between chitosan and tripolyphosphate. TPP. To increase the 
loading of the nanoparticles it was found that higher molecular weight chitosans 
were best. By increasing the molecular weight, the chain length of the chitosan 
molecule will increase, which could increase the physical entrapment of insulin. 
The effect of DA on loading capacity did not show any distinct trend but it would 
be expected that as with yield, a lower DA would be best due to the increased 
number of charged amino groups. 
I also investigated the effect of formulating nanoparticles on the stability of 
chitosan was investigated. The stability of the nanoparticles was assessed by 
determining the molecular weight of chitosan using SEC-MALLS after the 
chitosan-insulin complex had been dissociated. The results obtained were 
compared with the degradation of chitosan only in a solution of the same pH. The 
results showed a small improvement in stability (approximately 30%), but this 
was not significant. 
It is worth making the comment that the time scale of the stability trail was 
relatively short (only two months) and this is rather short compared with the 
storage data that would be required for a marketed pharmaceutical product. It 
may be. found that over a longer storage period, the amount of degradation 
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observed when chitosan is in a dispersion in complexed nanoparticle form 
compared to the case of a molecular solution form, is significantly different -
this is clearly a case for further study. 
8.4 Further Work 
It is still not sure how the level of degradation observed in both chitosan solution 
and chitosan nanoparticles will affect the absorption enhancing properties of 
chitosan. 
This could be investigated by simultaneously measuring degradation and 
bioadhesion. A factorial experiment could be carried out to look at the effect of 
molecular weight and degree of acetylation (over a wider range tan covered in this 
thesis) on degradation and along side the molecular weight or viscosity 
measurements taken a measure of bioadhesion could be taken. 
After evaluation of these experiments, a study could be carried out in sheep using 
a selected range of chitosan sample (best, worst and middle), to investigate the 
effect of degradation of the absorption enhancing properties. 
These experiments could be carried out using both a simple chitosan solution as 
well as using chitosan nanoparticles. From this study we may find that as the 
chitosan sample is degraded the bioadhesion and absorption enhancing properties 
decrease due to a reduced number of charged amine groups on the chito.san chain. 
-159-
References 
Angelo, R., D. Malkov, H. Tang, H. Wang, E. Flanders, S. Dinh and I. 
Gomez-Orellana (2002). Oral Insulin Absorption with EMISPHERE Drug 
Delivery Agents. Mechanistic Studies using Intestinal Epithelial Cells. 2nd 
Annual Diabetes Technology Meeting. 
Anthonsen, M. W., K. M. VArum and O. Smidsmd (1993). "Solution 
properties of chitosans: conformation and chain stifthess of chitosans with 
different degrees of N-acetylation." Carbohydrate Polymers 22: 193-201. 
Anthonsen, M. W., K. M. VArum, A. M. Hermansson, O. Smidsroo andD. A. 
Brant (1994). "Aggregates in acidic solutions of chitosans detected by static 
laser light scattering." Carbohydrate Polymers 25: 13-23. 
Artursson, P., T. Lindmark, S. S. Davis and L. lllum (1994). "Effect of 
chitosan on the permeabliltiy of mono layers of intestinal epithelial cells (caco-
2)." Pharmaceutical Research 11: 1358-1361. 
Aspden, T. J., J. Adler, S. S. Davis and L. Illum (1995). "Chitosan as a nasal 
delivery system: Evaluation of the effect of chitosan on mucociliary clearance 
rate in the frog palate model. lI International Journal of Pharmaceutics 122: 
69-78. 
-160-
Aspden, T. J. t L. Illum and O. Skaugrud (1996). "Chitosan as a nasal delivery 
system: evaluation of insulin absorption enhancement and effect on nasal 
membrane integrity using rat models." European Journal of Pharmaceutical 
Sciences 4: 23-31. 
Aspden, T. 1., J. D. T. Mason, N. S. Jones, J. Lowe, O. Skaugrud and L. mum 
(1997). "Chitosan as a Nasal Delivery System: The Effect of Chitosan 
Solutions on in Vitro and in Vivo Mucociliary Transport Rates in Human 
Turbinates and Volunteers." Journal of Pharmaceutical Sciences 86(4): 509-
513. 
Aulton, M. E. (2002). Pharmaceutics: The Science of Dosage Form Design. 
London, Churchill Livingstone. 
Behl, C. R., H. K. Pimplaskar, A. P. Sileno, 1. deMeireles and V. D. Romeo 
(1998). "Effects of physicochemical properties and other factors on systemic 
nasal drug delivery." Advanced Drug Delivery Reviews 29: 89-116. 
Behl, C. R., H. K. Pimplaskar. A. P. Sileno, W. J. Xia, W. J. Gries, 1. C. 
deMeireles and V. D. Romeo (1998). "Optimization of systemic nasal drug 
delivery with pharmaceutical excipients." Advanced Drug Delivery Reviews 
29: 117-133. 
BeMiller, J. N. (1967). "Acid-catalyzed hydrolysis of glycosides." Advances in 
Carbohydrate Chemistry 22: 25-108. 
-161-
Bernkop-Schnurch, A. (2000). "Chitosan and its derivatives: potential 
excipients for peroral peptide delivery systems." International Journal of 
Pharmaceutics 194: 1-13. 
Berth, G., H. Dautzenberg and M. G. Peter (1998). "Physico-chemical 
characerization of chitosans varying in degree of acetylation." Carbohydrate 
Polymers 36: 205-216. 
Berth, G. and H. Dautzenberg (2002). "The degree of acetylation of chitosans 
and its effect on the chain conformation in aqueous solution." Carbohydrate 
Polymers 47: 39-51. 
Berth, G., H. Colfen and H. Dautzenberg (2002). Prog. Coll. Polym. Sci. 119: 
50-57 
Bodmeier, R., H. Chen and O. Paeratakul (1989). itA novel approach to the 
delivery of microparticles or nanoparticles." Pharmaceutical Research 6: 413-
417. 
Borchard, G., H. L. LueBen, A. G. de Boer, J. Coos Verhoef, C.-M: Lehr and 
H. E. Junginger (1996). "The potential of mucoadhesive polymers in 
enhancing intestinal peptide drug absorption. ill: Effects of chitosan-glutamate 
and carbomer on epithelial tight junctions in vitro." Journal of Controlled 
Release 39: 131-138. 
-162-
Boryniec, S., O. Strobin, H. Struszczyk, A. Niekraszewicz and M. Kucharska 
(1997). "OPC Studies of Chitosan Degradation." International Journal of 
Polymer Analysis and Characterisation 3: 359-368. 
Calvo, P., C. Remunan-Lopez, J. L. Vila·Jato and M. J. Alonso (1997). "Novel 
Hydrophilic Chitosan-Polyethylene Oxide Nanoparticles as Protein-Carriers." 
Journal of Applied Polymer Science 63: 125-132. 
Carino, O. P., J. S. Jacob and E. Mathiowitz (2000). "Nanosphere based oral 
insulin delivery." Journal of Controlled Release 65: 261-269. 
Carino, O. P. and E. Mathiowitz (1999). "Oral insulin delivery." Advanced 
Drug Delivery Reviews 35: 249-257. 
Chang, K. L. B., M.-C. Taiand F.-H. Cheng (1999). "Kinetics and Products of 
the Degradation of Chitosan by Hydrogen Peroxide." American Chemical 
Society. 
Chang, K. L. B., O. Tsai, J. Lee and W. Fu (1997). "Hetergeneous N-
acetylation of chitin in alkaline solution." Carbohydrate Research 303: 327-
332. 
Chen, R. H., J. R. Chang and J. S. Shyur (1997). "Effects of ultrasonic 
conditions and storage in acidic solutions on changes in molecular weight and 
polydispersity of treated chitosan." Carbohydrate Research 299: 287-294. 
-163-
Clement, S., P. Dandona, J. Gordon Still and G. Kositic (2004). "Oral 
Modified Insulin (HIM2) in patients with Type I Diabetes Mellitus: Results 
from a Phase IIII Clinical Trial." Metabolism. 
Clewlow, A. C., N. Errington and A. J. Rowe (1997). "Analysis of data 
captured by an on-line image capture system from an analytical ultracentrifuge 
using schlieren optics." European Journal of Biophysics 25: 311-317. 
Colfen, H. and S. E. Harding (1997). "MSTARA and MSTARI: interactive PC 
algorithms for simple, model independent evaluation of sedimentation 
equilibrium data." European Journal o/Biophysics 25: 333-346. 
Colfen, H., G. Berth and H. Dautzenberg (2001). "Hydrodynamic studies on 
chitosans in aqueous solution." Carbohydrate Polymers 45: 373-383. 
Couvreur, P., V. Lenaerts, B. Kante, K. Roland and P. Speiseret (1980). "Oral 
and parenteral administration of insulin associated to hydrolzable 
nanopartic1es." Acta Pharmaceutical Technology 26: 220-222. 
Creeth, J. M. and S. E. Harding (1982). "Some observations on a new type of 
point average molecular weight." Journal 0/ Biochemical and Biophysical 
Methods 7(1): 25-34. 
Damge, C., M. Michael, A. Aprahamian and P. Couvreur (1988). ''New 
approach for oral administration of insulin with poly-alkyl cyanoacrylate 
nanocapsules as oral carrier." Diabetes 37: 247-251. 
-164-
Damge, C., C. Michel, A. Aprahamian, P. Couvreur and J. P. Devissaguetet 
(1990). "Nanocapsules as carriers for oral peptide delivery." Journal of 
Controlled Release 13: 233-239. 
Davis, S. S. (1999). "Delivery of peptide and non-peptide drugs through the 
respiratory tract." Pharmaceutical Science and Technology Today 2(11): 450-
456. 
Denker, B. M. and S. K. Nigam (1998). "Molecular structure and assembly of 
the tight junction." American Journal of Physiology 274: FI-F9. 
Dodane, V. and V. D. Vilivalam (1998). "Pharmaceutical applications of 
chitosan." Pharmaceutical Science and Technology Today 1(6): 246-253. 
Dodane, V., M. Amin Khan and J. R. Merwin (1999). "Effect of chitosan on 
epithelial permeability and structure." International Journal of Pharmaceutics 
182: 21-32. 
Donovan, M. D., O. L. Flynn and O. L. Amidon (1990). "Absorption of 
polyethylene glycols 600 through 2000: the molecular weight dependence of 
gastrointestinal and nasal absorption." Pharmaceutical Research 7: 863-868. 
Dyer, A. M., M. Hinchcliffe, P. Watts, J. Castile, I. Jabbal-GiU, R. Nankervis, 
A. Smith and L. lllum (2002). "Nasal Delivery of Insulin Using Novel 
-165-
Chitosan Based Formulations: A Comparative Study in Two Animal Models 
between Simple Chitosan Formulations and Chitosan Nanoparticles." 
Pharmaceutical Research 19(7): 998-1008. 
Edman, P., E. Bjork and L. Ryden (1992). "Microspheres as a nasal delivery 
system for peptide drugs." Journal of Controlled Release 21: 165-172. 
Ermak, T. H., E. P. Dougherty, H. R. Bhagat, Z. Kabok and J. Pappo (1995). 
"Uptake and transport of copolymer biodegradable microspheres by Rabbit 
Peyer's patch M cells." Cell Tissue Research 279: 433-436. 
Errington, N., S. E. Harding, K. M. Varum and L. Illum (1993). 
"Hydrodynamic characterization of chitosans varying in degree of 
acetylation." International Journal of Biological Macromolecules 15: 113-
117. 
Farraj, N. F., B. R. Johansen, S. S. Davis and L. Illum (1990). "Nasal 
administration of insulin using bioadhesive microspheres as a delivery 
system." Journal of Controlled Release 13: 253-361. 
Fernandez-Urrusuno, R., P. Calvo, C. Remurum-L6pez, J. L. Vila-Jato and M. 
J. Alonso (1999). "Enhancement of Nasal Absorption of Insulin Using 
Chitosan Nanoparticles." Pharmaceutical Research 16(10): 1576-1581. 
-166-
Femandez·Urrusuno, R., D. Romani, P. Calvo, J. L. VHa-Jato and M. J. 
Alonso (1999). "Development of a freeze-dried fonnulation of insulin-loaded 
chitosan nanoparticles intended for nasal administration." S. T.P. Pharma 
Sciences 9(5): 429-436. 
Fiebrig, I., S. E. Harding, B. T. Stokke, K. M. Varum, D. Jordan and S. S. 
Davis (1994). "The potential of chitosan as a mucoadhesive drug carrier: 
studies on its interaction with pig gastric mucin on a molecular level." 
European Journal of Pharmaceutical Sciences 2: 185. 
Fisher, A. N., K. Brown, S. S. Davis, O. D. Parr and D. A. Smith (1987). "The 
effect of molecular size on the nasal absorption of water-soluble compounds in 
the albino rat." Journal of Pharmacy and Pharmacology 39: 357-362. 
Fisher, A. N., L. lllum, S. S. Davis and E. H. Schacht (1991). "Di-iodo·L-
tyrosine-labelled dextrans as molecular size markers of nasal absorption in the 
rat." Journal of Pharmacy and Pharmacology 44: 550-554. 
Furst, A. (1997). "The XL-I analytical ultracentrifuge with Rayleigh 
interference optics." European Journal of Biophysics 35: 307-310. 
Harding, S. E. (1992). Sedimentation analysis of polysaccharides. Analytical 
Ultracentrifugation in Biochemistry and Polymer Science. S. E. Harding, A. J. 
Rowe and J. C. Horton. Cambridge, Uk, Royal Society of Chemistry. 
-167-
Harding, S. E. (1995). "Some recent developments in the size and shape 
analysis of industrial polysaccharides in solution using sedimentation analysis 
in the analytical ultracentrifuge." Carbohydrate Polymers 28: 227-237. 
Harding, S. E. (1997), "The intrinsic viscosity of biological macromolecules. 
Progress in measurement, interpretation and application to structure in dilute 
solution." Progress in Biophysics and Molecular Biology 68(2/3): 207-262. 
Harding, S. E., S. S. Davis, M. P. Deacon and I. Fiebrig (1999). "Biopolymer 
Mucoadhesives." Biotechnology and Genetic Engineering Reviews 16: 41-85. 
He, P., S. S. Davis and L. Illum (1998). "In vitro evaluation of the 
mucoadhesive properties of chitosan microspheres." International Journal of 
Pharmaceutics 186: 75-88. 
Hejazi, R. and M. Amiji (2003). "Chitosan-based gastrointestinal delivery 
systems." Journal of Controlled Release 89: 151-165. 
Hinchcliffe, M. and L. Illum (1999). "Intranasal insulin delivery and therapy." 
Advanced Drug Delivery Reviews 35: 199-234. 
Holme, H. K., H. Foros, H. Pettersen, M. Dornish and O. SmidsrOO (2001). 
"Thermal depolymerization of chitosan chloride." Carbohydrate Polymers 46: 
287-294. 
-168-
Hussain, A. A. (1998). "Intranasal drug delivery." Advanced Drug Delivery 
Reviews 29: 39-49. 
lllum, L., N. F. Farraj, H. Critchley and S. S. Davis (1988). ''Nasal 
administration of gentamicin using a novel microsphere delivery system." 
International Journal of Pharmaceutics 46: 261-265. 
lllum, L., N. F. Farraj and S. S. Davis (1994). "Chitosans as a novel nasal 
delivery system for peptide drugs." Pharmaceutical Research 11: 1186-1189. 
Illum,L., A. N. Fisher, I. Gill, M. Miglietta and L. M. Benedetti (1994). 
"Hyaluronic acid ester microspheres as a nasal drug delivery system for 
insulin." Journal of Controlled Release 29: 133-141. 
Illum, L., A. N. Fisher, I. Jabbal-Gill and S. S. Davis (2001). "Bioadhesive 
starch microspheres and absorption enhancing agents act synergistica1ly to 
enhance the nasal absorption of polypeptides." International Journal of 
Pharmaceutics 222: 109-119. 
Illum, L., I. Jabbal-Gill, M. Hinchcliffe, A. N. Fisher and S. S. Davis (2001). 
"Chitosan as a novel nasal delivery system for vaccines." Advanced Drug 
Delivery Reviews 51: 81-96. 
-169-
lllum, L., H. Jorgensen, H. Bisgard, O. Krogsgaard and N. Rossing (1987). 
"Bioadhesive microspheres as a potential nasal drug delivery system." 
International Journal of Pharmaceutics 39: 189-199. 
Janes, K. A., P. Calvo and M. J. Alonso (2001). "Polysaccharide colloidal 
particles as delivery systems for macromolecules." Advanced Drug Delivery 
Reviews 47: 83-97. 
Jia, Z. and D. Shen (2002). "Effect of reaction temperature and reaction time 
on the preparation of low-molecular-weight chitosan using phosphoric acid." 
Carbohydrate Polymers 49(4):393-396 
Jones, N. (2001). "The nose and paranasal sinuses physiology and anatomy." 
Advanced Drug Delivery Reviews 51: 5-19. 
Jumel, K. (1994). PhD Dissertation, University of Nottingham, U.K. 
Kotze, A. F., B. J. de Leeuw, H. L. Lue6en, A. G. de Boor, J. C. Verhoof and 
.H. E. Junginger (1997). "Chitosans for enhanced delivery of therapeutic 
peptides across intestinal epithelia: in vitro evaluation in caco-2 cell 
monolayers." International Journal o/Pharmaceutics 159: 243-253. 
Kotze, A. F., H. L. Lue6en, B. J. de Leeuw, A. G. de Boer, J. C. Verhoef and 
H. E. Junginger (1998). "Comparison of the effect of different chitosan salts 
-170-
and N-trimethyl chitosan chloride on the permeability of intestinal epithelial 
cells (Caco-2)." Journal o/Controlled Release 51: 35-46. 
Kotze, A. F., M. Thanou, H. L. Lue6en, A. O. de Boer, J. C. Verhoef and H. 
E. Junginger (1999). "Enhancement of paracellular drug transport with highly 
quatemized N-trimethyl chitosan chloride in neutral environments: i,n vitro 
evaluation in intestinal epithelial cells (caco-2)." Journal 0/ Pharmaceutical 
Sciences 88: 253-257. 
Kublik, H. and M. T. Vidgren (1998). "Nasal delivery systems and their effect 
on deposition and absorption." Advanced Drug Delivery Reviews 29: 157-177. 
Leane, M. M., R. Nankervis, A. Smith and L. Illum (2004). "Use of the 
ninhydrin assay to measure the release of chitosan from oral solid dosage 
forms." International Journal o/Pharmaceutics 271(1-2): 241-249. 
Lehr, C.-M., J. A. Bouwstra, E. H. Schacht and H. E. Junginger (1992). "In 
vitro evaluation of mucoadhesive properties of chitosan and some other 
natural polymers." International Journal 0/ Pharmaceutics 78: 43-48. 
Lloyd, P. H. (1974). Optigal Methods in Ultracentrifugation. Electrophoresis 
and Diffusion. Oxford. 
Lue6en, H. L., B. J. de Leeuw, A. O. Langemeyer, A. O. de Boer, J. C. 
Verhoef and H. E. Junginger (1996). "Mucoadhesive polymers in peroral 
-171-
peptide drug delivery. VI. Carbomer and chitosan improve the intestinal 
absorption of the peptide drug buserelin in vitro." Pharmaceutical Research 
13: 1668-1672. 
Marttin, E., N. O. M. Schipper, J. C. Verhoefand F. W. H. M. Merkus (1998). 
"Nasal mucociliary clearance as a factor in nasal drug delivery." Advanced 
Drug Delivery Reviews 29: 13-38. 
McMartin, C., L. E. F. Hutchinson, R. Hyde and O. E. Peters (1987). 
"Analysis of Structural Requirements for the Absorption of Drugs and 
Macromolecules from the Nasal Cavity." Journal 0/ Pharmaceutical Sciences 
76(7): 535-540. 
Meza, I., M. Sabanero, E. Stefani and M. Cereijido (1982). "Occluding 
junctions in MOCK cells: Modulation of transepithelial permeability by the 
cytoskeleton." Journal o/Cellular Biochemistry 18(4): 407-421. 
Mygind, N. and D. Dahl (1998). "Anatomy, physiology and function of the 
nasal cavities in health and disease." Advanced Drug Delivery Reviews 29: 3-
12. 
Nordtveit, R. J., K. M. Varum and O. SmidsrOO (1994). "Degradation of fully 
water-soluble, partially N-acetylated chitosans with lysozyme." Carbohydrate 
Polymers 23: 253-260. 
-172-
Ohwaki, T., H. Ando, S. Watanabe and Y. Miyake (1985). "Effect of dose, pH 
and osmolarity on nasal absorption of secretin in rats." Journal of 
Pharmaceutical Sciences 74: 550-552. 
Ohya, Y., M. Shiratani, H. Kobayashi and T. Ouchi (1994). "Release 
behaviour of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-
fluorouracil coated with polysaccharides and their cell specific cytotoxicity. tI 
Journal of Macrolmolecular Science - Pure and Applied Chemistry A31(5): 
629-642. 
OtWy,M. H., K. M. V8rum and O. Smidsroo (1996). "Compositional 
hetergeneity of heterogeneously deacetylated chitosans." Carbohydrate 
Polymers 29(1): 17-24. 
0tWy, M. H., K. M. VArum, B. E. Christensen, M. W. Anthonsen and O. 
SmidsrOO (1996). "Preparative and analytical size-exclusion chromatography 
of chi to sans." Carbohydrate Polymers 31: 253-261. 
Paradossi, G., E. Chiessi, M. Venanzi and B. Pispisa (1992). "Branched-chain 
analogues of linear polysaccharides: a spectroscopic and conformational 
investigation of chitosan derivatives." International J o ~ r n a l l of Biological 
Macromolecules 14: 73-80. 
Pettersen, H., A. Sannes, H. K. Holme, A. H. Kristensen, M. Dornish and O. 
Smidsroo (1997). Thermal depolymerization of chitosan salts. 7th 
-173-
International Conference on Chitin and Chitosan, L y o ~ ~ France, Jacques 
Andre. 
Philo, J. S. (2000). "A Method for Directly Fitting the Time Derivative of 
Sedimentation Velocity Data and an Alternative Algorithm for Calculating 
Sedimentation Coefficient Distributions Functions." Analytical Biochemistry 
279: 151-163. 
Price, N. C. and R. A. Dwek (1979). Solutions of Macromolecules. Principles 
and problems in physical chemistry for biochemists. Oxford, Clarendon Press. 
Prochazkova, S., K. M. VArum and K. 0stgaard (1999). "Quantitative 
determination of chitosans by ninhydrin." Carbohydrate Polymers 38: 115-
122. 
Pujara, C. P., Z. Shao, M. R. Duncan and A. K. Mitra (1995). "Effects of 
formulation variables on nasal epithelial cell integrity: Biochemical 
evaluations." International Journal o/Pharmaceutics 114: 197-203. 
Qin, C. Q., Y. M. Du and L. Xiao (2002). "Effect of hydrogen peroxide 
treatment on the molecular weight and structure of chitosan." Polymer 
Degradation and Stability 76: 211-218. 
Ralston, G. (1993). Introduction to Analytical Ultracentrifugation. 
-174-
Rege, P. R. and L. H. Block (1999). "Chitosan processing: influence of 
process parameters during acidic and alkaline hydrolysis and effec of the 
processing sequence on the resultant chitosan's properties." Carbohydrate 
Research 321: 235-245. 
Rinaudo, M. and A. Domard (1989). Solution Properties of Chitosan. Chitin 
and Chitosan: Sources, Chemistry.. Biochemistry, Physical Properties and 
Applications. G. Skjak-Braek, T. Anthonsen and P. Sandford. London, 
Elsevier Applied Science: 71-86. 
Rinaudo, M., G. Pavlov and J. Desbrieres (1999). "Influence of acetic acid 
concentration on the solubilization of chitosan." Polymer 40: 7029-7032. 
Roberts, G. A. F. (1992). Chemical Behaviour of Chitin and Chitosan. Chitin 
Chemistry. London, MacmilIian Press Ltd: 249-261. 
Rossi, S., F. Ferrari, M. C. Bonferoni and C. Caramella (2000). 
"Characterization of chitosan hydrochloride-mucin interaction by means of 
viscoimetric and turbidimetric measurements." European Journal of 
Pharmaceutical Sciences 10: 251-257. 
Schachman, H. K. (1992). Is There a Future for the Ultracentrifugation? 
Analytical Ultracentrifugation in Biochemistry and Polymer Science. S. E. 
Harding, A. J. Rowe and J. C. Horton. Cambridge, The Royal Society of 
Chemistry. 
-175-
Schipper, N. G. M., K. M. varum and P. Artusson (1996/9). "Chitosans as 
absoprtion enhancers of poorly absorbable drugs: influence of molecular 
weight and degree of acetylation. It European Journal of Pharmaceutical 
Sciences 4(1): 8153. 
8chipper, N. G. M., K. M. varum and P. Artursson (1996). "Chitosans as 
absorption enhancers for poorly absorbable drugs. 1. Influence of molecular 
weight and degree of acetylation on drug transport across human intestinal 
epithelial (Caco-2) cells." Pharmaceutical Research 13: 1686-1692. 
Schipper, N. G. M., S. Olsson, J. A. Hoogstraate, A. G. deBoer, K. M. varum 
and P. Artursson (1997). "Chitosans as absorption enhancers for poorly 
absorbable drugs. 2. Mechanism of absorption enhancement. It Pharmaceutical 
Research 14: 923-929. 
8chipper, N. G. M., K. M. varum, P. Stenherg, G. Ocklind, H. Lennemas and 
P. Artursson (1999). "Chitosans as absorption enhancers of poorly absorbable 
drugs 3: Influence of mucus on absorption enhancement. It European Journal 
of Pharmaceutical Sciences 8: 335-343. 
Shigemasa, Y., K. 8aito, H. Sashlwa and H. Saimoto (1994). "Enzymatic 
degradation of chitins and partially deacetylated chitins." International 
Journal of Biological Macromolecules 16(1): 43-49. 
-176-
Shin-ya, Y., M.-Y. Lee, H. Hinode and T. Kajiuchi (2001). "Effects of N-
acetylation degree on N-acetylated chitosan hydrolysis with commercially 
available and modified pectinases." Biochemical Engineering Journal 7: 85-
88. 
Shu, X. Z. and K. J. Zhu (2000). "A novel approach to prepare 
tripolyphospate/chitosan complex beads for controlled release drug delivery." 
International Journal of Pharmaceutics 201: 51-58. 
Shu, X. Z. and K. J. Zhu (2002). "The influence of multivalent phosphate 
structure on the properties of ionically cross-linked chitosan films for 
controlled drug release." European Journal of Pharmaceutics and 
Biopharmaceitics 54: 235-243. 
Smith, 1., E. Wood and M. Domish (2004). "Effect of Chitosan on Epithelial 
Cell Tight Junctions." Pharmaceutical Research 21(1): 43-49. 
Soane, R. J., M. Frier, A. C. Perkins, N. S. Jones, S. S. Davis and L. mum 
(1999). "Evaluation of the clearance characteristics of bioadhesive systems in 
humans." International Journal of Pharmaceutics 178: 55-65. 
Sugimoto, M., M. Morimoto, H. Sashiwa, H. Saimoto and Y. Shigemasa 
(1998). "Preparation and characterization of water-soluble chitin and chitosan 
derivatives." Carbohydrate Polymers 36: 49-59. 
-177-
Tanford, C. (1955). "Intrinsic Viscosity and Kinematic Viscosity." Journal of 
Physics and Chemistry 59: 798. 
Tanford, C. (1961). Flexible Linear Polyelectrolyes. Physical Chemistry of 
Macromolecules. London, John Wiley & Sons: 489-508. 
Tanioka, S., Y. Matsui, T. Irie, T. Tanigawa, Y. Tanaka, H. Shibata, Y. Sawa 
and Y. Kono (1996). "Oxidative Depolymerization of Chitosan by Hydroxyl 
Radical." Bioscience, Biotechnology and Biochemistry 60(12): 2001-2004. 
Thanou, M., J. C. Verhoef and H. E. Junginger (2001). "Oral drug absorption 
enhancement by chitosan and its derivatives." Advanced Drug Delivery 
Reviews 52: 117-126. 
Tolaimate, A., J. Desbrieres, M. Rhazi, A. Alagui, M. Vincendon and P. 
Vottero (2000). "On the influence of deacetylation process on the 
physicochemical c h a r a c t e r i ~ i c s s of chitosan from squid chitin." Polymer 41: 
2463-2469. 
Tominaga, S., T. Takaizawa and M. Yamada (1998). Colon drug delivery 
system. Journal of Polymer Application. 10: 642. 
Tozaki, H., J. Komoike, C. Tada, T. Maruyama, A. Terabe, T. Suzuld, A. 
Yamamoto and S. Muranishi (1997). "Chitosan capsules for colon-specific 
-178-
drug delivery: improvement of insulin absorption from the rat colon." Journal 
o/Pharmaceutical Sciences 86: 1016-1021. 
Tsaih, M. L. and R. H. Chen (1997). "Effect of molecular weight and urea on 
the conformation of chitosan molecules in dilute solutions." International 
Journal 0/ Biological Macromolecules 20: 233-240. 
Van Holde, K. E. (1971). Viscosity. Physical Biochemistry. New Jersey, 
Prentice-Hall. 
Van Holde, K. E. (1998). Principles of Physical Biochemistry. 
VArum, K. M., M. H. 0tt0y and O. Smidsroo (1994). "Water-solubility of 
partially N-acetylated chitosans as a function of pH: effect of chemical 
compostition and depolymerisation." Carbohydrate Polymers 25: 65-70. 
VArum, K. M., H. K. Holme, M. Izume, B. T. Stokke and O. Smidsmd (1996). 
"Determination of enzymatic hydrolysis specificity of partially N-acetylated 
chitosans." Biochimica et BiophysicaActa 1291: 5-15. 
VArum, K. M., M. M. Myhr, R. J. N. Hjerde and O. Smidsmd (1997). "In vitro 
degradation rates of partially N-acetylated chitosans in human serum." 
Carbohydrate Research 299: 99-101. 
-179-
Varum, K. M., M. H. Ottey and O. Smidsroo (2001). "Acid hydrolysis of 
chitosans." Carbohydrate Polymers 46: 89-98. 
Wales, M. and V. Holde (1954). "The Concentration Dependence of the 
Sedimentation Constants of Flexible Macromolecules." Journal 0/ Polymer 
Science 14: 81-86. 
Wang, W., S. Bo, S. Li and W. Qin (1991). "Determination of the Mark-
Houwink equation for chitosans with different degrees of deacetylation." 
International Journal o/Biological Macromolecules 13: 281-285. 
Wyatt, P. J. (1993). "Light Scattering and the absolute characterization of 
macromolecules." Analytica Chimica Acta 272: 1-40. 
Xu, Y. and Y. Du (2003). "Effect of molecular structure of chitosan on protein 
delivery properties of chitosan nanoparticles." International Journal 0/ 
Pharmaceutics 250:215-226. 
-180-
Eur Biophys J (2003) 32: 457-464 
DOl 10.1 007/s00249-003-03 17-8 
Monica Fee' Neil Errington . Kornelta Jumel 
Lisbeth IlIum . Alan Smith . Stephen E. Harding 
Correlation of SEClMALLS with ultracentrifuge and viscometric 
data for chitosans 
Received: 7 January 2003/ Revised: 28 March 2003/ Accepted: 8 April 2003/ Published online' 14 J 2003 
© EBSA 2003 . une 
Abstract Attempts have been made to correlate estimates 
of molecular weight for a group of cationic polysac-
charides known as chitosans between the highly popular 
technique of size-exclusion chromatography coupled to 
multi-angle laser light scattering, "SEC-MALLS", and 
the less convenient but more established technique of 
sedimentation equilibrium in the analytical ultracentri-
fuge. Four pharmaceutical grade chitosans of various 
molecular weights and degrees of acetylation (4-30%) 
were chosen. Better correlation than previous was 
achieved, although some batch variability was observed. 
Despite the broad spectrum in degree of acetylation, 
a logso2o.w versus 10gMw scaling plot appeared to fit 
a straight line with power-law exponent b = 0.25 ± 0.04, 
i.e. between the limits of rod (0.15) and coil (0.4-0.5), 
although this may be the average of a lower b value at 
low Mw and higher b at high Mw' With regard to vis-
cosity, a 10g[l1] versus 10gMw scaling plot appeared to 
also fit a straight line with power-law exponent 
a = 0.96 ± 0.10, again between the coil (0.5-0.7) and rod 
(1.8) limits. 
Keywords Chitosan' Conformation . Molecular 
weight. SEC-MALLS' Sedimentation equilibrium 
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Introduction 
I?espite their increasing importance in the pharmaceu-
tical an? h e a l t h c ~ r : : industries, chitosans [cationic poly-
sacchandes cons.lstmg of N-acetyl-D-glucosamine units 
a ~ d d D-glucosamme u ~ i t s s in varying proportions (see 
FIg. 1)] have p r ~ v e d d dIfl?cult to characterize with regard 
to ~ ~ l e c u ! a r r ~ e I g h t t owmg to their polycationic nature. 
ThIS IS pnmartly because of the failure of results from 
SEC:-MALLS ( s ~ e - e x c l u s i o n n chromatography coupled 
on-hne to a m u l t I - a n g l ~ ~ 1.a.ser l i ~ b t - s c a t t e r i n g g detector) to 
agree ?r show compatibIlity With other techniques such 
as sedImentation eqUilibrium in the u l t r a c e n t r i f u ~ e e or 
measurements from viscometry. These difficulties have 
l ~ r g e l y y b e ~ n n attributed to anomalous behaviour on the 
s l ~ e - e x c l u s ~ o n n columns that have been available, and 
d l s ~ r e p a n c l e s s of over an order of magnitUde in the 
weIght a v e ~ a g e e molecular weight have been observed. 
When dIssolved in aqueous acidic medium chitosan b e c ? ~ e s s a cationic polyelectrolyte, making it ; potential 
e x c l p l e ~ t t fO.r m a n ~ ~ applications in the food and phar-
maceutical mdustnes. These include, for example, con-
tr?lled drug a n ~ ~ flavour ~ e l e a s e e from tablets or using 
mlcroencapsulatlon techmques, film formation or as 
fillers in d!etary ~ o o d s , , etc. (lllum 1998; Skaugrud et al. 
1 9 9 ~ ) . . C ~ l t o s a n n IS. of I > ~ t i c u l a r r interest to the pharma-
ce,:tlcal Industry SInce It possesses mucoadhesive prop-
erties ~ s e ~ , , for example, Harding et al. 1999), which 
r e s u ~ t t tn mcreased contact'time with a mucosal surface 
leadIng to enhanced drug absorption, and has also been 
dem?nstrated to enhance the, delivery of proteins and 
peptldes across mucosal membranes (Artursson et a!. 
1994; IlIum et al. 1994, 2001; Natsume et al. 1999; 
~ e n g a m n u a ~ ~ et al. 2000; Davis 2001). The mucoadhe-
slve properties have been attributed to interactions 
betwee? the -NH3 + groups left after deacetylation of 
the chltm and the tenninal -COO- (sialic acid) on 
~ u c o s a ! ! surfaces, reinforced through hydrophobic 
m t e r a ~ t l o n n b e ~ w e e n n groups of un-deacetylated residues 




Fig. 1 Schematic representation of chitosan; R = acetyl or H, 
depending on the degree of acetylation 
Chitosan has also been shown to cause a transient 
widening of the tight junctions of the epithelial cells in 
vitro, which is thought to contribute to enhanced drug 
permeability (IlIum and Davis 2001; IlIum et aI. 2001). 
For many applications of chitosan, and e s p ~ i a J J y y in 
the pharmaceutical industry, the molecular weight and 
degree of acetylation d i c t a ~ e e the properties .and thereb.y 
the effectiveness of the chltosan for a particular applI-
cation. For example, Schipper et al. (1996) have reported 
that both these properties are very important for its 
absorption enhancement of hydrophilic drugs across 
mucosal surfaces. They found that a low degree of 
acetylation and/or high molecular w ~ i g h ! ! appeared ~ ~ ~ be 
necessary for chitosans to increase epltheJtal permeabilIty. 
It is clear that the pharmaceutically important 
properties of chitosan (including solubility) are not only 
dependent on their chemical nat';lre ( d l ~ t a t e d d by t.he 
degree of acetylation), but also t h e l ~ ~ physical propertles 
(molecular weight and conformation) .. Altho';lgh the 
degree of acetylation can be measured With considerable 
confidence [e.g. by NMR (Varum et aI. 1991)], it is also 
important to be able to attach some degree of confidence 
to the SEC/MALLS determination m ~ t h o d d for m?le-
cular weight. Successful molecular weIght determma-
tions of chitosan by SEC/MALLS have been rCJ?orted 
by Beri et al. (1993). However, these a u t ~ o r s s did not 
compare their results with those from o t ~ e r r m d e p e n ~ e n t t
techniques. Attempts at molecular weIght d e ~ e r m m a a
tions by SEC/MALLS in our own laboratones have 
previously proved difficult due to the anomalous 
behaviour of chitosan on our SEC columns, a n ~ ~ results 
were generally incompatible with t h o ~ e e obtamed by 
sedimentation equilibrium in the analrtical u l t r ~ c e n t n n
fuge. The cationic nature of c h i t o ~ ~ IS r e s p o n s l ~ l e e for 
its wide range of desirable interactions; however, It ~ a y y
also cause interactions with the SEC c o l u ~ n n packing 
material and/or residues from other p r e v ~ o u s l y y run 
samples. A dedicated column system for chltosan was 
therefore used for the re-examination of the use of SEC/ 
MALLS which was considered important due to: 
I The ease of obtaining absolute molecular weight 
. data from SEC-MALLS compared with the use of 
other methods. Since 1991 (Horton et al. 1991; 
Rollings 1991, 1992), this method has become !he 
most popular for c h a r ~ c t e r i z i n g g ,Polysaccharide 
molecular weights in solution, and, smce 1996, also 
glycoconjugates such as mucus glycoproteins (Jumel 
et al. 1996, 1997). 
2. The belief that there is a clear link between the 
functional properties of chitosans and their muco-
adhesive and epithelial absorption enhancement 
capabilities for drug delivery and film forming po-
tential for healthcare products (e.g. shampoos). 
This paper explores the use of SEC/MALLS for four 
polysaccharides of pharmaceutical grade covering a 
range of degree of acetylation, DA (4-30%), and 
molecular weight. Comparative molecular weight data 
were obtained by sedimentation equilibrium in the 
analytical ultracentrifuge. A correlation of the Mark-
Houwink-Kuhn-Sakurada (MHKS) power-law type is 
also attempted between weight average molecular 
weight, Mw, and both the intrinsic viscosity or the sed-
imentation coefficient to check for consistency between 
the data and to see if these particular chitosans of dif-
ferent DA and Mw approximate a homologous series. 
Materials and methods 
Materials 
Four chitosans were provided by Pronova Biomedical, Oslo, 
Norway (G112, G\ 14, G213 and G214). These were glutamate salts 
with DA values ranging from 4 to 30% and of reputedly different 
molecular weight, as indicated by the dynamic viscosity values (of 
1 % solutions) provided by Pronova (Table I). A separate batch of 
G213 was also supplied. 
For all experiments, the chitosan samples were dissolved in a 
0.2 M acetate buffer (pH 4.3). For sedimentation equilibrium 
experiments, samples were dialysed against the buffer solution 
overnight so that the chemical potential of the solvent was equal in 
both the sample solution and the reference solvent (dialysate). 
Methods 
Molecular weight: sedimentation equilibrium 
Low-speed sedimentation equilibrium was used to determine the 
molecular weights (weight averages) of the various chitosans. Two 
analytical ultracentrifuges (AUCs) were employed. Firstly, a 
Beckman XL-l Analytical Ultracentrifuge was used for cltitosan 
solutions in the range of concentrations 0.5-1.0 mg/mL, at a rotor 
speed of 14,000 rpm (sample G112) or 8000 rpm (the other sam-
ples) and a temperature of 20.0 °C. The data collected from the 
Rayleigh interference optical system were analysed using the 
MSTARI algorithm (Colfen and Harding 1997) to give an appar-
ent weight average molecular weight, Mw.app. A low concentration 
sample (0.3 mg/mL) was also a n a l y ~ d d using a Beckman Model E 
Table 1 Commercial manufacturer's data (courtesy of PrOIlOva, 
Dramrnen, Norway) 
Chitosan* G112 G114 G213(a) G213(\» G214 
Degree of 30 7 17 20 4 
acetylation (%) 
Viscosity of 1% 5 18 79 153 59 
solution (mPa s) 
*G213(a), batch no. 610-583-09; G213(\», batch no. FPI-A-708-01 
Analytical Ultracentrifuge (at rotor speeds between 10,000 and 
20,000 rpm and a temperature of 20.0 0c) equipped with Schlieren 
optics, adapted with a CCD camera system (Clewlow et al. 1997) 
for automatic capture of the optical data. Use was made of the long 
optical path cells (30 mm), impossible to use in the XL-I. The data 
were analysed by fitting to the Lamm equation (see, for example, 
Clewlow et aL 1997): 
(I) 
where v is the partial specific volume (mL/g) determined by pre-
cision densimetry for each chitosan (Kratky et al. 1973), P the 
solvent density ( m ! l . ~ ~ R is the gas constant and T the ~ e m p e r a t u r e e
(K). A plot of I n ( ~ f r ) ) versus ,2 has a slope proportional to the 
apparent z-average molecular weight (Mz•app)' The data set was 
then transformed by integrating with respect to r (distance from the 
centre of rotation in cm) and analysed using MST ARI (Colfen and 
Harding 1997) to obtain Mw.app. 
To account for non-ideahty, the reciprocal of the apparent 
weight average molecular weights Mw,.pp determined over. a range 
of concentrations, c, were e x t r a p o l a t e . ~ ~ to zero ~ o ! " c e n t r a t l ~ n . . The 
thermodynamic or "osmotic pressure second vmal c o e ~ c l e n t , , B, 
and the "ideal" or "true" weight average molecular weight, "'!w, 
were estimated from plots of I/Mw,.pp versus concentratIOn 
according to (see. for example, Harding I 995a): 
l/Mw,app = (l/Mw)(l + 2BMwc) (2) 
Molecular weight: SEC-MALLS 
The molecular weights (weight averages) of the chitosan samples 
were then also determined by using S E C - M A ~ L S . . Acetate buffer, 
pH 4.3, was pumped at a flow rate of 0.8 mL/mm through a column 
system consisting of TSK-G5000PW, TSK-G4000PW and TSK-
G3000PW analytical columns protected b ~ ~ a guard column. Solu-
tions of each chitosan sample were prepared m a c e t ~ t e . . buffer. pH 4.3, 
at a concentration of 5 mg/mL and 100 j.lL was mJected onto the 
columns at ambient temperature (sample f i l t e ~ d d t h ~ 0 ' ; 1 g h . 0 . 4 5 5 j.Iffi 
filter to remove any insoluble material or dust pnor to m J e c t l O ~ ) . . The 
eluting fractions were monitored using a Dawn DSP multt-angle 
light-scattering photometer (Wyatt T e c h n o l o ~ y , , S a ~ t a a .Barbara, 
USA) fitt d 'th a 5 mW He-Ne laser and a differential mterfero-
metric r e ! r a c ~ ~ m e t e r r (Optilab 903, Wyatt Technology, Santa Bar-
bara USA) Apparent weight average molecular weights, Mw,app, 
w e r e ' o b t a i n ~ d d using the so-called Debye plo.t Tetho.d (see, e.g, Wyatt 
1992 1993) where a plot of R( 0)/ Kc versus sm 0/2 Yields M ~ , . p p p from 
. • '. . le R(O) the Rayleigh excess the mtercept, () bemg the s c a ~ t e n n g g ang " 2 2 n de 2 A 4N ' 
scattering ratio and K, theopttcal constant, IS 4n ~ ~ (d / ) ( 0. A), 
n is the solvent refractive index, dn/dc is ~ e e s P ~ C 1 l f i ~ ~ r : ~ ~ ~ ~ ~ : I : ~ ~ ~ ~
increment(mL/g),NAisAvogadro'snum eran ."'U IS •• d 
of the scattered light in vacuo (cm). The specific refractive 111 ex 
Table 2 Thermodynamic and hydrodynamic data 
Property* Units Fraction 
GIl2 G114 
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increment was calculated from the DA using the equation of 
Anthonsen et aI. (1994): 
dn/dc = 0.201 - 0.056(DA) (3) 
Because of the low concentrations after dilution from the column, 
the contribution from the 2BMwc term in Eq. (2) CIln be reasonably 
assumed to be ",,0, so to a good approximation M ~ M w . a p p . .
Sedimentation coefficient measurements 
A Beckman XLI AnalytiClll Ultracentrifuge was used for the 
determination of the sedimentation coefficients at 20.0 °C and a 
rotor speed of 45,000 rpm. Sedimentation coefficients (Sobs) were 
obtained by analysing 10 consecutive scans using the "time deriv-
ative" algorithm DCDT+ (Philo 2000). These were corrected to 
standard solvent conditions (the density and viscosity of water at 
20.0 0c) using the equation (see Schachman 1959): 
S20,w = {(I - iiP2o,w)/{1 - iiPT,b)} {1JT,b/'120,w }SObs (4) 
where S20.w is the sedimentation coefficient in terms of the standard 
solvent water at 20°C; Sobs is the measured sedimentation coeffi-
cient in the experimental solvent/buffer at temperature T; P20,w and 
'120,w are the density and viscosity of water at 20°C and PT,b is the 
density and viscosity of the buffer used for the experiments at 
temperature T. Measurements were made at a series of low con-
centrations (0.3-1.0 mg/mL) to minimize non-ideality; nonetheless, 
S20,w values (or reciprocals thereof) were then extrapolated to infi-
nite dilution to yield sOzo,w' 
Determination of intrinsic viscosity 
Intrinsic viscosities were determined using an Ostwald-type vis-
cometer of 2 mL capacity over a concentration range of 0.2-2.0 mg/ 
mL. The flow times were recorded at 20.00::1:0.01 cC. From the 
solution/solvent flow-time ratio the kinematic relative viscosity was 
obtained. Because of the low concentrations used ( < I mg/mL), the 
density corrections were assumed to be negligible and the kinematic 
viscosities were assumed to be approximately equal to the dynamic 
viscosities (Tanford 1955). The intrinsic viscosity was found by 
extrapolation to infinite dilution of the reduced viscosities using the 
Huggins equation (see, for example, Harding 1997). 
Results and discussion 
Molecular weight 
For four of the chitosans, much better agreement than 
previous is seen between the two totally independent 
G2J3(a) G21J<b) G214 
Mw (sed. eqm.) gmol- I 57,O{)Q::I:800 82,000::1: 9000 161,000::1: 18000 132,000::1: 15000 
Mw (SEC-MALLS) g mol-I 42,400::1:3000 129,000:1:6000 203,000:1: 8000 207,500::1:8000 172,000::1:6000 
Mz (sed. eqm.) g mol- I 90,000:1: 11,000 386,000:1: 30,000 442,000::1: 30,000 417,000:1:41,000 246,500::1: 18,000 
2.2 3.4 Mw/Mn=M./Mn 
mLg-1 2200 2BM (sed. eqm.) 
1.76::1:0.04 1.99:1:0.05 S020,w S 310::1: 15 
r'll mLg-1 100:1:8 
... d ),' ht e a e molecular weight obtained from 
M.w (se .. eqm .. ~ ~ I g . . av r g SEC-MALLS): weight average s e d l l n e n t a t l O n . ~ e q U 1 b b r t . u m . . Mw ( MALLS M (sed. eqm.): : ~ ~ : ~ ~ ~ ~ : ~ : : ~ ~ l ; b : ~ ~ ~ ~ ~ ~ : n ~ J ~ ; o m m s e d i t ~ e n t ~ t i o n n equilib-
2.5 2.9 1.5 
4600 4100 
2.71::1:0.22 2.69:1:0.07 2.74:1:0.12 
420:1:20 610:1:30 550:1:20 
rium. MwlMn =MJMw: identity holds for a log-normal distribu-
tion (Fujita 1962). BM: product of second virial coefficient (B) and 
molecular weight 
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Fig. 2a-e SEC-MALLs elution 
volume for each chitosan 
fraction. Signals from the 
refractive index or RI 
(concentration) and 90° angle 
light-scattering detectors are 
shown in each case. The vertical 
lines indicate the regions of the 
two traces chosen to calculate 
the weight average molecular 
weight corresponding to 
10 20 30 40 I) 
Table 2. The additional pair of 
vertical lines on the left for 
chitosans G2I4 and GIl2 at 
low elution volume correspond 
to the peaks for the trace 
amounts of supramolecular 
aggregate. The RI peaks at high 
elution volume correspond to 
salt elution 
Volume\mll VQWm!l{mL) 
Fraction G112 Fraction G213 














techniques of sedimentation equilibrium and SEC-
MALLS (Table 2) for the weight average molecular 
weights, Mw, although, with the e x c e ~ t i o n n o ~ ~ 0112, 
sedimentation equilibrium molecular weIghts stdl come 
out somewhat lower. 
Figure 2 shows the light-scattering an? refractive 
ind.ex (RI, measurement of c o n c e n t ~ a t l o n ) ) traces 
obtained from SEC-MALLS for each chItosan sample. 
From the light-scattering traces it can be seen that in 
each case the peaks from the macromolecular compo-
nent are skewed and not symmetri9al. There was also 
evidence of persistently occurring trace amounts of high 
molecular weight aggregate from the 90° angle light-
scattering traces, as indicated by the shoulders on the 
low elution volume or high molecular weight side of the 
light-scattering peaks. However, except. for sample 
0112 these light-scattering signals are not accompanied 
by c o ~ r e s p o n d i n g g RI (concentration) signals, indicating 
that only negligible amounts « 1%) are present in 
the samples. No such supramolecular particles were 
-ru 
observed from the sedimentation velocity g*(s) distri-
butions obtained using time-derivative DCDT + anal-
ysis, which showed only a single, approximately 
symmetrical, peak for in each case, including 0112 
(Fig. 3), and no fast moving supramolecular boundary 
was observed. 
Significance of non-ideality: advantage of SEC-MALLS 
Both the SEC-MALLS and the sedimentation equilib-
rium methods allow direct evaluation of the absolute 
molecular weight of the macromolecule. However, the 
time scale for each method varies greatly, with the SEC-
MALLS measurement taking approximately 60 minutes 
(after appropriate equilibration of the SEC columns). 
The sedimentation equilibrium method, on the other 
hand, can require up to 3 days for equilibrium to be 
reached per sample. Further, since higher concentrations 
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Fig. 3 g*(S20.w) versus szo.w plot for chitosan GI12 from a 
sedimentation velocity experiment (45,000 rpm, 20.0°C) and 
DCDT + analysis 
charges per 100 monomer residues) when in aqueous 
acidic solution. Such effects can normally be suppressed 
by charge shielding simply by increasing the ionic 
s t r ~ n g t h h of the solution medium. Unfortunately for 
chltosans, large increases in ionic strength lead to re-
duced solubility and salting out can occur. 
thermodynamic non-ideality effects cannot be neglected 
and measurements at several concentrations (and 
extrapolation to infinite dilution) are normally required. 
The problem is particularly acute for chitosans because 
suppression of one of the two main causes of solution 
non-ideality - polyelectrolyte behaviour - by increasing 
ionic strength is only partially possible because of sol-
ubility problems. 
We explain further: non-ideality causes the molecular 
weight for chitosan calculated from AUC data to be 
lower than the true molecular weight. There are two 
major contributing factors to this phenomenon: the ex-
cluded volume and the polyelectrolye effect. The ex-
cluded volume arises from one molecule excluding 
another from the space occupied by it. For a sphere the 
excluded volume is eight times the molecular volume: the 
more extended the molecule (e.g. through intramolecular 
charge repulsion effects if the molecule is charged), the 
greater the excluded volume. Another contribution to 
exclusion volume comes from the swelling of the mole-
cule through "hydration" or time-averaged association 
with water molecules. For a polysaccharide molecule in 
solution, the swollen volume can be 100 times its volume 
in the dry state (see, for example, Harding 1995b). The 
second contribution to solution thermodynamic non-
ideality comes from polyelectrolyte phenomena through 
intermolecular repulsions. Such effects will be large for 
chitosan owing to the high charge density on the mole-
cule (e.g. for a molecule of ",10% DA, there will be ",90 
To illustrate the significance of the non-ideality we 
have included in Table 2 values for the term 2.BM 
(2xsecond virial coefficientxweight average molecula'; 
weight) in Eq. (2). For a spherical, uncharged molecule 
this would h a v ~ ~ a value of approximately 5--10 mL/g, 
and the value mcreases as the system deviates from 
ideality. From Table 2 it can be seen that values calcu-
~ a t e . d d f?r this t e r ~ ~ are i ~ ~ the ~ a n g e e 1000-2000 mL/g, 
mdlcatmg that chltosan IS a hIghly non-ideal macro-
molecule [a comparative table for polysaccharides is gi-
ven in Harding (1995b)J. 
At very low solute concentrations, ideal behaviour is 
approached (Van Holde 1998) and the effects of non-
ideality should be small. For many systems of biological 
macromolecules, parycularly globular proteins, 
measurement at a single finite, but low (0.2--0.5 mgjmL) 
concentration can give an estimate of the apparent 
molecular weight within' a few percent of the 
true molecular weight. However, even with loading 
concentrations as low as 0.2 mgfmL there can be non-
negligible underestimates of the true molecular weight 
(Harding 1992) for those polysaccharides yielding 
solutions of high 2BM w values; chitosan a,ppears to be 
in that category (Harding I 995b). The problem is 
compounded since the modern commercial instrument 
(XL-I) permits a minimum concentration of not 0.2 but 
0.5 mg/mL. 
462 
With SEC-MALLS, however, there is normally no 
need to correct for non-ideality in the system so long as 
the sample is diluted in the columns to such an extent 
that the concentrations of the volume "slices" passing 





than the initial loading concentration. These concen-
trations are usually 0.1 mg/mL or less (depending on the ~ ~
molecular weight of the scatterer), and corrections °Wo 
arising from thermodynamic non-ideality are not sig- t 




Inertness of the SEC column 
Although the SEC-MALLS method of determining the 
molecular weight of chitosan is very quick and simple, 
there may still remain some uncertainties in terms of the 
"inertness" of the column packing materials and in the 
extrapolation of the angular intensity functions to zero 
angle, as highlighted by Harding (l995b). The former 
appears to be particularly important in the case of 
cationic polyelectrolytes; however, it seems that the 
use of a dedicated column system can eliminate most 
of these uncertainties. Nevertheless, it is still advisable 
to determine the molecular weight using the AUC to 
obtain a reliable and independent verification of the 
results. 
Conformation 
The conformation of chitosans has been the subject of 
considerable interest over the last decade, particularly 
with the regard to the effect of the degree of acetylation 
of the molecule, the molecular weight and the solvent 
conditions in which it is studied (see, e.g. Wang et al. 
1991; Anthonsen et al. 1993; Errington et al. 1993; Ott0Y 
et al. 1996; Berth et al. 1998; C61fen et al. 2001; Berth 
and Dautzenberg 2002). 
Many methods for assaying the conformation of 
chitosan and other polysaccharides in solution appear 
to be based on the dependence of a solution parameter 
(such as intrinsic viscosity, radius of gyration or sedi-
mentation coefficient) with molecular weight. The 
simplest are the Mark-HQuwink-Kuhn-Sakurada type 
of scaling or power-law plots of log(parameter) versus 
10g(Mw) (see, e.g. Smidsr0d and Andresen 1979; 
Tombs and Harding 1997). Figures 4 and 5 shows such 
plots for the four chitosans of this study in terms of 
logso2o.w versus 10gMw and log[tl] versus 10gMw, 
respectively. The SEC-MALLs values for Mw have 
been included, and an additional data point has 
been included corresponding to a separate batch of 
G213, called G213(b. A linear fit to the logso2o,w 
versus 10gMw data yielded an MHKS exponent 
b = 0.25 ± 0.04, i.e. between the limits of rod (0.15) and 
coil (0.4--0.5). Similarly, a linear fit to the log[tl) versus 
10gM w scaling data yielded an . MHKS exponent 
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Fig. 4 Double logarithmic plot of sedimentation coefficient versus 













Fig. 5 Double logarithmic plot of intrinsic viscosity versus weight 
average molecular weight (SEC-MALLs values) 
(1.8) limits. However, interpretation of such data 
should be done with caution because of claims by 
others of a dependence of conformation on the degree 
of acetylation (see, e.g. Anthonsen et al. 1993). Despite 
this reservation, the values obtained appear similar to 
those for three chitosans of DA in the range 22-31% 
(C6lfen et al. 2001): ~ 1 1 and b ~ 0 . 2 4 . . Furthermore, 
the data reassuringly show consistency between the 
sedimentation coefficient and viscosity data. More 
advanced analyses, such as involving normalized scal-
ing relations (Pavlov et al. 1997, 1999), can be used to 
take into account the differences in DA, but these 
await knowledge of the mass per unit length of chito-
sans as a function of DA. It should also be pointed out 
that if the sedimentation equilibrium values for Mw are 
used instead, different values of a and b are returned 
(",1.5 and 0.5, respectively), although these values are 
based on only four data points. 
Conclusions 
Confidence in our ability to measure molecular weight 
and conformation accurately is of particular relevance to 
the use of chitosans for the delivery of substances across 
the mucosal membrane through bioadhesion and 
absorption enhancement through transient widening of 
tight junctions (Kotze et al. 1997). Larger molecular 
weights and more extended conformations would appear 
to offer more opportunities for interaction. 
In conclusion, however, although much better agree-
ment is now possible between SEC-MALLs and sedi-
mentation equilibrium, some caution still needs to be 
exercised when interpreting molecular weight data for 
these materials, particularly with regards to the trace 
amounts of high molecular weight material appearing in 
the SEC-MALLs profiles. The use of two independent 
methods for determining the molecular weights for these 
substances is still highly recommended. 
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